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The first total syntheses of (±)-melicolone A and (±)-melicolone B was 
accomplished in a combined overall yield of 12.3% and a mere 9 steps from commercially 
available reagents. The synthesis features a novel rhodium(II) catalyzed 1,3-dipolar 
cycloaddition reactions of carbonyl ylide generated from an aliphatic aldehyde with 
rhodium carbene and an unsaturated vinylogous ester dipolarophile.  
Two new carbazole photocages were designed, synthesized, and characterized.  
Both new carbazole photocages showed superior decaging properties compared with 
reported NDBF photocaged which are illustrated by the benzoic acid model system study 
at 390 nm and 400 nm. The decaging properties of modified photocage for phenol 
derivatives were evaluated by a modified tyrosine substrate, and efficient decaging was 
achieved at 360 nm. Lastly, a caged fluoroquinolone system was conducted to demonstrate 
the potency of modified photocage in anti-bacterial growth inhibition studies. 
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TOTAL SYNTHESES OF (±)-MELICOLONES A AND B 
Chapter 1: Total Syntheses of (±)-Melicolones A and B 
1.1 ISOLATION AND BIOLOGICAL ACTIVITIES 
Melicope is a genus comprising around 230 shrubs and trees in the Rutaceae family, 
which is widely distributed in the tropical regions around the world, including the Hawaiian 
islands across the Pacific Ocean to tropical Asia, Australia and New Zealand.1,2 Many of 
the Melicope species were utilized as folk medicines due to their pharmacological activities 
and previous studies revealed the presence of acetophenones, furoquinolines, coumarins, 
flavones, benzopyrans in these plants.3-7 Prenylated acetophenones are regarded as the 
chemotaxonomic markers among all the constituents found in Melicope species.8 Previous 
studies also showed the acetophenones isolated from Melicope species are usually 
substituted by prenyl or geranyl groups, and the aromatic structures have been mostly 
retained. Only limited number of examples having nonaromatic acetophenone compounds 
have been reported so far.9 
(±)-Melicolone A (1.1) and (±)-melicolone B (1.2) were isolated from the leaves of 
Melicope ptelefolia by Luo and Kong groups in 2015 as a pair of prenylated acetophenone 
epimers with an unusual 9-oxatricyclo[3.2.1.1] nonane core (Figure 1.1).10 Structurally, 
melicolones A and B represent the first examples of rearranged nonaromatic acetophenone 
derivatives with the 9-oxatricyclononane core structures, with a total of five stereogenic 
centers and a oxygen bridge. The highly dense functionality of these natural products 




Figure 1.1. Chemical structures of (±)-melicolone A (1.1) and (±)-melicolone B (1.2). 
A plausible biosynthetic pathway for the melicolones has been proposed by Luo 
and Kong.10 Starting from the acetophenone precursor 1.3 that has also been identified in 
the leaves of Melicope ptelefolia, a sequence of oxidation and prenylation of 1.3 afforded 
intermediate 1.4, which then went through a nonface-selective epoxidation of the prenyl 
chain and a cyclization to afford intermediate 1.5 with four possible isomers. The 
intermediate 1.5 underwent an acyloin rearrangement followed by a methylation to 
generate stereoisomers 1.6 and 1.6’. Then the C-12 on the prenyl chains of 1.6 and 1.6’ 
could cyclize with the C-1 below or above the plane respectively to form intermediates that 
would readily undergo dehydration to form the oxygen bridge moiety and form two 



















Scheme 1.1. Proposed biosynthesis of (±)-melicolone A (1.1) and (±)-melicolone B (1.2). 
Previous studies have revealed the antioxidant activities from the leaves of 















































































enantiomers of (±)-melicolone A and (±)-melicolone B have protective effects against 
oxidative stress induced by high glucose level.10,11 
In 2019, Luo and Kong group reported the isolation of melicolones C-K (1.7-1.15) 
from the leaves of Melicope Ptelefolia (Figure 1.2).12 Specifically, melicolones G-K (1.11-
1.15) share the unprecedented 9-oxatricyclo[3.2.1.1] nonane core structure found in 
melicolones A (1.1) and B (1.2). Melicolone C (1.7) is an acetophenone analogue sharing 
a novel spirocyclic skeleton, and melicolones D-F (1.8-1.10) bear an unusual octalactone 
moiety. The putative biosynthetic pathways to all melicolone compounds were also 
proposed starting with the same acetophenone precursors that generated three different 
types of carbon scaffolds via different biosynthetic pathways (Scheme 1.2). The inhibitory 
effects of 1.11-1.15 against multidrug resistance were also evaluated using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method in MCF-7 








































Melicolone G (1.11) Melicolone H (1.12)





































































































1.2 MARTIN GROUP APPROACH TO (±)-MELICOLONES A AND B 
Martin group has long been focused in the total syntheses of novel bioactive natural 
products, and we were intrigued by the remarkable structures and interesting bioactivities 
of the melicolone natural products. Herein, we decided to develop the total syntheses of 
melicolones A and B. Considering the multiple melicolone family natural products share 
the same unprecedented 9-oxatricyclo[3.2.1.1] nonane core structures, we were interested 
to develop an unified approach to construct the core structure and potentially accomplish 
the syntheses of multiple melicolones natural products from the same intermediate.  
To our knowledge, there was no report of any synthetic work diverted toward any 
melicolone natural products when we started, although we became aware that multiple 
groups were working in the area.13,14 We envisioned that a racemic mixture of melicolones 
A and B can be formed from 1.16 via the sequential epoxidation of the alkene of the prenyl 
group and an acid catalyzed regioselective epoxide opening with the enol hydroxyl group 
(Scheme 1.3). 1.16 would be accessible from cycloadduct 1.17 with the transformation of 
stereoselective prenylation of the carbon α to the vinylogous ester followed by a base 
catalyzed aldol cyclization. Oxabicycloheptane 1.17 would be generated from a novel 
intermolecular dipolar cycloaddition of the dipolarophile 1.17 and the cyclic carbonyl ylide 
1.19, which would be generated in situ by the rhodium(II)-catalyzed cyclization of the 
diazo compound 1.20. Cycloadditions of carbonyl ylides are well known in previous 
literature, but the intermediate carbonyl ylides are generally formed by cyclization of a 
metallocarbene with the carbonyl oxygen atom of a ketone, ester or amide.15-23 We are 
aware of only two examples involving the same aliphatic aldehyde.24,25 Another unusual 
aspect of the proposed cycloaddition of 1.18 and 1.19 is the predicted regiochemistry. 
Based upon the usual electronic effects that dictate these cycloadditions, we would predict 
the formation of the opposite isomer as the preferred product. However, we reasoned that 
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steric effects between the geminal dimethyl groups and the vinylogous ester group would 
control the formation of 1.17 as the preferred regioisomer. We envisioned that 1.20 would 
be accessible from the inexpensive starting material hydroxy pivalic acid 1.22. 1.22 would 
undergo malonic ester synthesis conditions to form 1,3 dicarbonyl compounds which was 
subsequently treated with diazo transfer reagent to generate diazo intermediate. Finally, the 
hydroxyl group in the diazo intermediate can be oxidized to form the diazo aldehyde 1.20. 
Vinylogous ester 1.18 would be prepared from the commercially available methyl 
carbonate 1.21. The ketone carbonyl of 1.21 would first be protected as vinyl methyl ether 
in the presence of acid, and the ester moiety would be transformed to its Weinreb amide 
followed by a vinyl Grignard addition to generate 1.18. We also envisioned that 
cycloadduct 1.17 would be able to serve as the unified intermediate to synthesize other 
melicolone family natural products such as melicolones G (1.11) and I (1.13). Moreover, 
chiral rhodium catalysts have been developed to construct oxabicycloheptane structures 
enantioselectively, which maps with the core structure of proposed cycloadduct 1.17, thus 




Scheme 1.3. Retrosynthetic analysis for the syntheses of (±)-melicolones A (1.1) and B 
(1.2). 
1.3 SYNTHESIS OF THE DIAZO ALDEHYDE 
We initiated our synthesis with the preparation of the key diazo aldehyde 1.20. We 
were inspired by a similar procedure reported by Hashimoto, who started with the 
activation of the carboxylic acid 1.23 with carbonyl diimidazole (CDI) followed by the 
reaction with the dianion formed by the treatment of mono malonic ester with base to afford 
β-carbonyl ester 1.24 (Scheme 1.3).28 Finally, the diazo transfer reaction of 1.24 with 







Melicolone A (1.1) : R1 = OH, R2 = H








































Scheme 1.4. Reported procedure of the preparation of diazo carbonyl compounds. 
With this precedented procedure, we sought to prepare our diazo aldehyde 1.20 in 
a similar fashion. Starting the synthesis with commercially available hydroxy pivalic acid 
1.22, we were concerned the free primary hydroxyl group in 1.22 could cause side reactions 
in the transformation with CDI. However, in a reported procedure by Heng, the primary 
hydroxyl carboxylic acid 1.26 was activated by CDI in the presence of a primary hydroxyl 
group, followed by the treatment with dianion generated from mono ethyl malonate to yield 
β-ketoester 1.27 in good yields (Equation 1.1).29 However, when we attempted the same 
transformation with the starting material hydroxyl pivalic acid 1.22, the reaction gave a 
complex mixture (Equation 1.2). We decided to break down the reaction sequence and 
analyze the reaction mixture after the treatment of 1.22 with CDI (Equation 1.3). The 
LCMS result gave several major masses that correspond to the intermediate that were 
formed by the reaction of CDI with both the primary alcohol and carboxyl group. The 
primary hydroxyl group was identified as the cause of the side reactions, so we sought to 
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We turned our attention to picking the protecting group for the primary hydroxyl 
group in 1.22. We favored the protection of this alcohol with the triethylsilyl (TES) ether 
group, due to the effective methods of protection and deprotection as well as its relatively 
robust nature in the following transformation steps. Another promising feature of TES ether 
group is that can be removed and oxidized in one step.30 Hydroxyl pivalic acid 1.22 was 
treated with chlorotriethylsilane (TESCl) in pyridine to afford TES ether 1.30 in 95% yield 
(Equation 1.4).31 The yield slightly dropped to 88% in multigram scale reactions. 
 
 
With TES ether 1.30 in hand, we treated 1.30 with CDI in THF, and we confirmed 
the clean generation of imidazolide on the carboxyl group with NMR analysis. 
Subsequently we treated the imidazolide with the dianion which was generated from the 
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treatment of methyl hydrogen malonate with iPrMgBr at 45 ºC, and the solution was stirred 
at room temperature overnight. To our delight, after the reaction completed, β-ketoester 
1.31 and its enol tautomer 1.31’ were isolated in 65% yield with a ratio of 3 :1 (Equation 
1.5). When the reaction was conducted on multigram scale, we isolated a mixture of 1.31 
and 1.31’ in 62% yield with a ratio of 3.5 :1. 
 
 
With β-ketoester 1.31 in hand, we investigated the diazo transfer reaction. The most 
commonly used diazo transfer reagents include p-toluenesulfonyl azide (TsN3), 
methanesulfonyl azide (MsN3), trifluoromethanesulfonyl azide (TfN3) and imidazole-1-
sulfonyl azide hydrochloride.32-35 TsN3 was found to be the most utilized diazo transfer 
reagent with a long history, but difficulties have been reported in the chromatographic 
separation of the desired product from excess reagent and p-toluenesulfonamide following 
the reactions.36  While as an alternate to TsN3, MsN3 was reported to have an easier 
separation by using 10% NaOH aqueous solution, as well as an efficient diazo transfer 
rate.37 TfN3 is easy to separate but it has a relative poor shelf live, which necessitates its 
preparation in solution prior to use, and more significantly, the expense of 
trifluoromethanesulfonyl anhydride that is used to prepare TfN3 prohibits its use in large 
scale reactions.38 Imidazole-1-sulfonyl azide hydrochloride was developed as an alternate 
to TfN3, and it is more widely used in the conversion of amine to azide.38 Based on the 
research, we started our investigation with MsN3 and TsN3 as the diazo transfer reagents. 
The preparations of MsN3 and TsN3 are fairly straightforward, and the treatment of MsCl 
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and TsCl with NaN3 gave MsN3 and TsN3 in 92% and 93% yield, respectively (Equations 




We started our condition screening by treating β-ketoester 1.31 with MsN3 (1.1 eq.) 
and Et3N (1.4 eq.) in MeCN, and the solution was stirred at room temperature overnight 
(Table 1.1 entry 1). Contradictory to what has been reported, the reaction was very sluggish 
and only afforded a 1:10 mixture of 1.32 and 1.31. We also tried to prolong the reaction 
time to 48 h, but only 42% of 1.32 with 45% of unreacted 1.31 was isolated (Entry 2). 
Increasing the equivalents of MsN3 and Et3N gave better conversion, but starting materials 
were still isolated (Entry 3). We then tried using the similar amount of TsN3 as the diazo 
transfer reagent, and to our delight, starting material was fully consumed when excess TsN3 
(1.5 eq.) and Et3N (2.0 eq.) were used, and we obtained 94% of the desired diazo compound 
1.32 (Entry 5). We then carried out the reaction in a multigram scale which afforded 1.32 

































entry diazo transfer reagent base % yield 1.32a % recovered 1.31a 
1 1.1 eq MsN3 1.4 eq Et3N 7 79 
2 1.1 eq MsN3 1.4 eq Et3N 45b 42b 
3 1.5 eq MsN3 2.0 eq Et3N 42 45 
4 1.1 eq TsN3 1.4 eq Et3N 73 20 
5 1.5 eq TsN3 2.0 eq Et3N 94 0 
a Isolated yield after chromatographic purification for reacting overnight. b Isolated yield after 
chromatographic purification for reacting for 48h. 
 
With 1.32 in hand, we started investigating the conditions of deprotecting the TES 
ether protecting group. Spur group reported that primary TMS and TES ethers could be 
selectively deprotected and oxidized to afford aldehydes or ketones in one pot using the 
Swern oxidation.39 Encouraged by the promising precedents, we initiated our investigation 
on oxidative deprotection of the TES ether 1.32 using a Swern oxidation. We treated 1.32 
with the premixed solution of oxalyl chloride and DMSO at -78 ºC, followed by the 












(Equation 1.8). Unfortunately, we only observed trace amounts of the desired aldehyde 
1.20 with most 1.32 unreacted. However, we found after the addition of 1.32 at -78 ºC, 
warming the reaction up to – 40 ºC was essential to help facilitate the deprotection of TES 
ether group prior to the formation of alkoxysulfonium ion, which further underwent 





 However, with 1.20 obtained via the Swern oxidation, we found that residual 
Me2S generated in the Swern oxidation was difficult to remove in reactions over 200 mg 
scale. Unfortunately, Me2S would consequently poison the Rh(II) catalysts used in the 
subsequent dipolar cycloaddition reaction.40 This difficulty occurred consistently when we 
conducted the Swern oxidation on a 200-mg scale, thereby limiting the feasibility of the 
reaction. In order to quickly scale up the preparation of 1.20, this particular issue led us to 









































CrO3/pyridine has been reported by Muzart to convert TES ethers when α to aryl 
rings as well as double, or triple bonds.41 We investigated this transformation of TES ether 
to aldehyde method by treating 1.32 with CrO3 and pyridine in CH2Cl2 at room temperature 
for 72 h, which afforded 1.20 in 63% yield. The 1.20 thus obtained could be used to 
generate carbonyl ylide in the presence of Rh(II) catalysts without any issue (Equation 
1.10). However, the reaction was relatively sluggish, and the yield was modest, so we 
decided to examine alternative conditions. Conditions reported by Wu group were found 
to be efficient at transforming the TES ether 1.32 to diazo aldehyde 1.20.42  Namely 
treatment of TES ether 1.32 in the presence of 2-iodoxybenzoic acid (IBX) in DMSO and 
H2O at room temperature afforded 1.20 in 89% yield, providing scalable and reliable 
conditions for generating the diazo aldehyde 1.20 for the subsequent Rh(II) catalyzed 
cycloaddition reaction (Equation 1.11). 
 
 
1.4 RHODIUM(II) CATALYZED CARBONYL YLIDE CYCLOADDITION 
1.4.1 Rh(II) Catalyzed Carbonyl Ylide Cycloaddition 
The Rh(II)-catalyzed formation of carbonyl ylides have played an important role in 




































effectively construct heterocyclic ring systems in natural product total syntheses.43-46 The 
carbonyl ylide cycloaddition reactions have been known since as early as 1885; however, 
before the introduction of the concept of 1,3-dipoles, these reactions were considered to 
proceed through a diradical mechanistic pathway. 47,48 The Huisgen group was the first 
group to examine the reaction in detail by trapping a carbonyl ylide with various reagents, 
including carbonyl compounds, to generate dioxolanes.49 In their early studies, dimethyl 
diazomalonate (1.33) was treated with benzaldehyde in the presence of catalysts including 
Rh2(OAc)4, Cu(acac)2, and CuOTf to furnish a mixture of isomeric 1,3-dioxolanes 1.34 
(Figure 1.3A). Doyle and coworkers reported the selective formation of a dioxolane 1.35 
or an epoxide 1.36 via influencing the stability of the intermediate carbonyl ylide species 
in their follow-up studies to the early Huisgen publication (Figure 1.3B).50,51 Ibata and 
coworkers first demonstrated the utility of intramolecular carbonyl ylide formation by 
studying the Cu(II) catalyzed decomposition of o-alkoxycarbonyl-α-diazo-acetophenone 
1.37 in the presence of different dipolarophiles (Figure 1.3C).52 ,53  The utility of the 
carbonyl ylide formation-cycloaddition sequence was further extended by the 
intramolecular trapping of the carbonyl ylide with a C-C double bond within the 
molecule. 54  The Rh(II) catalyzed decomposition of diazo ketone 1.39 followed by 
carbonyl ylide formation was then trapped by the olefin forming the final cycloadduct 1.40 




Figure 1.3. Early examples of carbonyl ylide formation. 
Common methods to generate carbonyl ylides include the thermolysis or photolysis 
of epoxides with electron-withdrawing functional groups or the thermal extrusion of 
































































metallocarbene onto the oxygen atom of a carbonyl compound, especially after the advent 
of the rhodium(II) catalysts for generating carbenoids from the decomposition of α-diazo 
carbonyl compounds.59 ,60 Rhodium mediated carbenoid generation generally proceeds 
under milder reaction conditions compared with Cu and its complexes. Carbonyl ylides 
readily react with π-bonds via an addition to generate wide range of cycloadducts. An 
attractive feature of the tandem carbonyl ylide formation-cycloaddition method is the 
opportunity to control the stereochemistry of the product at several centers. The final 
product represents a highly functionalized cyclic intermediate that can be further subjected 
to synthetic elaborations. Padwa and co-workers have made pioneering contributions to the 
field of synthetic application of the tandem carbonyl ylide cyclization-cycloaddition 
sequence.19 Indeed, a wide variety of oxapolycyclic ring systems have been prepared by 
Padwa featuring the tandem carbonyl ylide cyclization-cycloaddition sequence. Inspired 
by this highly effective synthetic method, we intended to utilize it constructing the tricyclic 
core structure in the melicolone natural products.61-68  
1.4.2 Rh(II) Catalyzed Carbonyl Ylide Cycloaddition Model Studies 
With cycloaddition precursor 1.20 in hand, we initiated the 1,3-dipolar 
cycloaddition studies. Most precedents of carbonyl ylide generation involve cyclization of 
ketones, esters, and amides with a metallocarbene.24,25,59 Precedents of intermolecular 
cycloaddition of carbonyl ylides generated from alkyl aldehydes were limited, so we 
decided to start with simplified model studies to demonstrate the reactivity of 1.20 (Table 
1.2).15 We used dimethyl acetylenedicarboxylate (DMAD) as the dipolarophile to react 
with the carbonyl ylide generated from 1.20, since it is highly electrophilic, and the 
cycloaddition product would not have regioisomers or diastereoisomers thus simplifying 
the analysis. In terms of catalysts, we tested both Rh2(OAc)4 and Rh2(OPiv)4 as they were 
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each reported to promote 1,3-dipolar cycloaddition reactions with diazo compounds. 
Rh2(OPiv)4 was shown to have better solubility in the solvents for same type of reactions. 
As for solvents, both CH2Cl2 and toluene were tested since they were commonly used in 
1,3-dipolar cycloadditions. We started with Rh2(OAc)4 in CH2Cl2 at room temperature, but 
no product was isolated (Entry 1). Switching the catalyst from Rh2(OAc)4 to Rh2(OPiv)4 
afforded the desired product 1.41 at room temperature in toluene and CH2Cl2 (Entries 2 
and 3). When reactions were heated, they proceeded much faster in toluene and CH2Cl2 
and provided higher yields (Entries 4-7). The best result was obtained by refluxing the 
solution 1.20 and DMAD in CH2Cl2 in the presence of Rh2(OPiv)4 for 6 h to afford 1.41 in 
87% yield (Entry 6). These results indicated that the diazo aldehyde 1.20 cyclized to a 
carbonyl ylide in the presence of Rh(II) catalyst and that this ylide further reacts with 














Table 1.2. Condition screening of the cycloaddition reaction of 1.20 and DMAD. 
 
 
entry catalyst solvent temperature time % yielda 
1 Rh2(OAc)4 CH2Cl2 rt overnight NR 
2 Rh2(OPiv)4 toluene rt overnight 42 
3 Rh2(OPiv)4 CH2Cl2 rt overnight 20 
4 Rh2(OAc)4 toluene 100 ºC 1 h 26 
5 Rh2(OPiv)4 toluene 100 ºC 1 h 52 
6 Rh2(OAc)4 CH2Cl2 reflux 6 h 87 
7 Rh2(OPiv)4 CH2Cl2 reflux 6 h 58 
a yields are based upon products purified by column chromatography 
Another aspect of the proposed 1,3-dipolar cycloaddition we needed to address was 
the regioselectivity of the reaction. The regioselectivity of Rh(II) catalyzed 1,3-dipolar 
cycloadditions is largely determined by electronic properties of the dipole and 
dipolarophile, and one of the easiest ways to predict the regioselectivity for the 
cycloaddition reaction is via the polarization analysis of carbonyl ylides and the 























Based on the precedents, the regioselectivity can be varied by using different 
dipolarophiles (Figure 1.4). For electron deficient dipolarophiles such as methyl propiolate 
1.43, cyclopentenone 1.45, and cyclohexanone 1.47, the carbonyl ylide generated from 
1.42 reacts with the dipolarophile to afford a single regioisomer (Figure 1.4A-C).72,73 
When the same carbonyl ylide generated from 1.42 reacts with more electron rich 
dipolarophiles such as methyl propargyl ether 1.49, the opposite regioisomer was obtained 
as the dominant product (Figure 1.4D).72 A similar regioselective outcome was also 
obtained when 1.51 reacts with chloropropene 1.52 (Figure 1.4E).74  
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Figure 1.4. Examples of different regioselectivity outcomes of 1,3-dipolar 
cycloadditions. 
Based on the analysis of regioselective outcomes of known 1,3-dipolar 
cycloaddition reactions with various dipolarophiles, we decided to initiate our investigation 









































































regioselectivities were obtained in reported examples of 1,3-dipolar cycloadditions with 
electron rich dipolarophiles.72,74 The allyl methyl ether 1.58 was synthesized following a 
reported procedure by Deslongchamps (Scheme 1.5).75 The synthesis commenced with 
methyl acetoacetate (1.21), which underwent ketal formation with ethylene glycol giving 
ketal 1.54 in 73% yield. Reduction of ester 1.54 with LAH afforded alcohol 1.55 in 89% 
yield, and the oxidation with IBX furnished aldehyde 1.56 in 88% yield. However, the 
aldehyde 1.56 was found to be unstable, so it was directly treated with vinyl magnesium 
bromide to afford allyl alcohol 1.57 in 79% yield. Finally, the methylation of 1.57 with 
MeI and NaH yielded target allyl methyl ether 1.58 in 96% yield.  
 
 
Scheme 1.5. Synthesis of dipolarophile 1.58. 
With the allyl methyl ether 1.58 in hand, we investigated the cycloaddition of diazo 































of 1.20 and 1.58 in the presence of 2 mol% Rh2(OAc)4 in CH2Cl2 at room temperature only 
afforded trace amounts of product 1.59. To our delight, when we heated the solution of 
1.20 and 1.58 under reflux with 2 mol% Rh2(OAc)4 in CH2Cl2, 1.59 was isolated in 50% 
yield. We were able to confirm the structure of 1.59 based on 2D NMR spectra (HSQC, 
HMBC and COSY). When the solution of 1.20 and 1.58 in the presence of Rh2(OAc)4 or 





The structure assignment of 1.59 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, and COSY). The characteristic peak having a chemical 
shift of d 4.29 ppm, which is a doublet, arises from the bridgehead proton at C1 (Figure 
1.5). This assignment is made based upon the HMBC spectrum, in which correlations 
between C1-H and C2, C3, C4 are observed (Figure 1.6). HMBC typically shows 
correlations between protons and carbons that are one, two and sometimes in conjugated 


















2 mol% Rh2(OAc)4, CH2Cl2, rt trace
2 mol% Rh2(OAc)4, CH2Cl2, reflux 50
2 mol% Rh2(OAc)4, toluene, reflux 48





The correlations between C1-H and both C2 and C3 indicate C2 and C3 are within two C 
atoms from C1-H. There is no correlation between C1-H and C5 because C5 is three atoms 
away from C1-H in 1.59, whereas in the other regioisomer it would be two atoms removed. 



















Figure 1.6. Key HMBC correlations of 1.59. 
With these encouraging results, we next attempted to simplify the synthetic route 
by using alternative dipolarophiles. The allyl methyl ether 1.58 in model system study was 
synthesized in over five steps, and we will have to deprotect the methyl ether group in later 
stage of the synthesis, which could be potentially problematic. Although we were not aware 
of any reports on the cycloaddition reaction with allyl alcohol dipolarophiles, we were 
interested in the cycloaddition with allyl alcohol 1.57 as the dipolarophile. Allyl alcohol 
1.57 which was the intermediate used to prepare 1.58, requires one less step to make, and 
it has a similar polarity distribution as the dipolarophile 1.58. The solution of 1.20 with 
1.57 in toluene was heated under reflux in the presence of 2 mol% Rh2OAc4, but to our 





Since hemiacetals and hemiketals have been reported to undergo oxidation with 
PDC to form the corresponding aldehyde or ketone, we attempted to convert 1.60 to 1.61 
using these conditions. 76  However, the desired ketone 1.61 was not isolated by the 





Because the hemiketal 1.60 formed from the cycloaddition reaction was generated 
from a very sterically hindered ketone, we wondered whether lowering the reaction 
temperature could potentially suppress the formation of hemiketal 1.60 and generate 1.62. 
To test this hypothesis, we treated 1.20 with 1.57 in the presence of 2 mol% Rh2(OAc)4 in 
toluene at 40 ºC, and we isolated 20% of the desired product 1.62 (Equation 1.15). We also 
tested the reaction of 1.20 with 1.57 in the presence of 2 mol% Rh2(OAc)4 in CH2Cl2 under 
reflux, and the desired product 1.62 was isolated in 45% yield, with another 15% 











































With 1.62 in hand, we attempted to oxidize alcohol 1.62 to ketone 1.61. Toward 
the end, a solution of 1.62 with IBX in EtOAc was heated under reflux but desired product 
1.61 was not formed. Gratifyingly, when we switched to the Swern oxidation condition, 




At this juncture, we sought to further simplify the sequence. Accordingly, we 
explored the 1,3-dipolar cycloaddition between 1.20 and enone 1.63, even though neither 
the regioselectivity analysis based on polarity, nor the relevant precedents indicated the 
desired regioisomer would be the major product.73,77 However, we anticipated that the 





























































interactions with the ketal moiety of 1.63 in the transition state of the cycloaddition 
reaction, thus disfavoring the formation of the undesired regioisomeric cycloadduct and 
favoring the desired cycloadduct. Moreover, we were also interested to have more insights 
into the determining factors in the regioselectivity of the 1,3-dipolar cycloadditions in 
general. The synthesis of enone dipolarophile 1.63 was fairly straightforward, and it was 





With enone 1.63 in hand, we next investigated the carbonyl ylide cycloaddition of 
1.20 and 1.63. A solution of 1.20 and 1.63 in toluene was heated under reflux in the 
presence of 2 mol% Rh2(OAc)4 (Equation 1.19). To our delight, we isolated three pure 
diastereomers 1.64 (35%), 1.65 (4%), and 1.66 (3%) from the reaction mixture. All three 
structures have been confirmed by 1H NMR, 13C NMR, HSQC, HMBC, COSY, and 
NOESY characterization. The regioselective outcome of this 1,3-dipolar cycloaddition was 
relatively unexpected based on the fact that almost all similar reactions gave the 
regioselectivity outcomes consent to the polarity analysis. However, as we anticipated, the 
regioselective outcome of this 1,3-dipolar cycloaddition reaction appears to be controlled 
by the steric interactions discussed before. With the quick access to grams of cycloadduct 
1.64 and 1.65 via the conditions we developed, we were able to move forward to explore 
the alkylation of the cycloadduct. 
 







The structure assignment of 1.64 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, COSY and NOESY). The characteristic peak having a 
chemical shift of d 4.47 ppm, which is a doublet, arises from the bridgehead proton at C1 
(Figure 1.7). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C2, C3, C4 are observed (Figure 1.8). HMBC typically 
shows correlations between protons and carbons that are one, two and sometimes in 
conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and both C2 and C3 indicate C2 and C3 are 
within two C atoms from C1-H. There is no correlation between C1-H and C5 because C5 
is three atoms away from C1-H in 1.64, whereas in the regioisomer 1.66 it would be two 
























































Figure 1.8. Key HMBC correlations of 1.64. 
The NOESY spectrum of 1.64 was also used to support its structural assignment 
(Figure 1.9). Of particular importance are the observed correlations between C2-H and C6-
H, C2-H and C3-H. The NOESY correlation between the proton on C2 and the C6-CH3 
gem-dimethyl group suggests this proton is endo, because there would be no correlation of 
this proton with either of the gem-dimethyl groups if it were exo. The correlation between 
the endo-proton at C2 with the proton at C3 suggests that the C3-H is also endo. Moreover, 
the coupling constant between C3-H and the assigned endo C2-H is 9.4 Hz that is greater 
than that of C3-H and the assigned exo C2-H which is 6.4 Hz.These observations support 





Figure 1.9. Key NOESY correlations of 1.64. 
The structure assignment of 1.65 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, COSY and NOESY). The characteristic peak having a 
chemical shift of d 4.39 ppm, which is a doublet, arises from the bridgehead proton at C1 
(Figure 1.10). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C2, C3, C4 are observed (Figure 1.11). HMBC typically 
















conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and both C2 and C3 indicate C2 and C3 are 
within two C atoms from C1-H. There is no correlation between C1-H and C5 because C5 
is three atoms away from C1-H in 1.65, whereas in the regioisomer 1.66 it would be two 
atoms removed. This observation supports the regiochemistry of the major product as being 
1.65. The stereochemistry was not able to assigned from NOESY due to the overlap of both 
protons on C2; However, with the extensive evidence to confirm the stereochemistry of 




















Figure 1.11. Key HMBC correlations of 1.65. 
The structure assignment of 1.66 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, COSY and NOESY). The characteristic peak having a 
chemical shift of d 4.68 ppm, which is a singlet, arises from the bridgehead proton at C1 
(Figure 1.12). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C2, C3, C4, C5 are observed (Figure 1.13). HMBC 
typically shows correlations between protons and carbons that are one, two and sometimes 
in conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and C2, C3, C5 indicate C2, C3 and C5 are 
within two C atoms from C1-H, whereas in the regioisomers 1.64 and 1.65, C5 would be 
three atoms removed. This observation supports the regiochemistry of the major product 





















Figure 1.13. Key HMBC correlations of 1.66. 
The NOESY spectrum of 1.66 was also used to support its structural assignment 
(Figure 1.14). Of particular importance is the observed correlation between C2-H and C6-
H. The NOESY correlation between the proton on C2 and the C6-CH3 gem-dimethyl group 
suggests this proton is endo, because there would be no correlation of this proton with 
either of the gem-dimethyl groups if it were exo. Moreover, the coupling constant between 
C2-H and the assigned endo C3-H is 9.0 Hz that is greater than that of C2-H and the 
assigned exo C3-H which is 4.6 Hz. These observations support the stereochemical 





Figure 1.14. Key NOESY correlations of 1.66. 
1.5 STUDIES TOWARDS REGIOSELECTIVE GENERATION OF ENOLATES 
With cycloadduct 1.64 and 1.65 in hand, we next investigated the stereoselective 
prenylation of the tertiary α-carbon of the cycloadduct. In order to successfully form the 
prenylated product, we need to selectively generate the desired enolate under basic 
conditions (Equation 1.20). In cycloadduct 1.64, there are two different sets of α-protons 
on C-1 and C-2. However, we hoped we could use a suitable strong base to selectively 
















nature of our hypothesis, but the experiments were easy to try. The subsequent addition of 




There was problem associated with enolate generation that involved β-elimination. 
For example, Padwa reported examples of base-induced β-elimination of the oxa-tricyclic 
species 1.68 and 1.70.73,78 They found that a carbanionic center adjacent to the oxy bridge 
of 1.68 led to the ring opening process in their studies towards the total synthesis of illudins 
(Equation 1.21).73 A similar reaction pathway was observed when treating 1.70 with 

























































With further analyses, we decided to initiate our investigations by screening 
conditions to generate desired enolate first (Table 1.3). We first treaed cycloadduct 1.64 
with LDA, which was generated in situ by treating diisopropylamine with n-BuLi in THF, 
and the solution was stirred at -78 ºC for 30 min before being quenched by the addition of 
D2O (Entry 1). The reaction mixture was worked up and analyzed by NMR, but no desired 
deuterium incorporation was observed; rather starting material 1.64 was recovered. We 
next tried treating 1.64 with LDA in THF at -78 ºC followed by warming the reaction up 
to -40 ºC, but only a complex mixture was obtained after D2O quenching (Entry 2). We 
next screened common strong bases such as LiNEt2, LiNMe2, NaHMDS, KHMDS; 
however, we were not able to obtain the desired deuterium incorporation products. Instead, 
by treatment of 1.64 with LiNEt2 at -78 ºC, a mixture of 1.64, 1.64’’ and 1.64’’’ was 
obtained after 60 min (Entry 3). Treatment of 1.64 with LiNMe2 furnished a complex 
mixture, whereas treatment of 1.64 with NaHMDS and KHMDS both furnished formation 
of 1.64’’’ (Entries 4-6). 
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Table 1.3. Deuterium incorporation studies of cycloadduct 1.64. 
 
 
entry base temperature time result 
1 LDA -78 ºC 60 min 1.64 
2 LDA -78 ºC to -40 ºC 30 min complex 
3 LiNEt2 -78 ºC 60 min 1.64 1.64’’ 1.64’’’ 
4 LiNMe2 -78 ºC 30 min complex 
5 NaHMDS -78 ºC 30 min 1.64’’’ 
6 KHMDS -78 ºC 30 min 1.64’’’ 
 
With the extensive studies of the regioselective deprotonation of 1.64 with various 
bases, we were still unable to find out the optimal conditions to selectively generate the 
desired enolate. Ultimately, we proposed alternative cycloaddition and alkylation 










































1.6 ALTERNATIVE CYCLOADDITION & ALKYLATION SEQUENCE 
1.6.1 Weinreb Amide Cycloadduct Transformation Sequence 
With the regioselective enolate formation step being problematic, we proposed an 
alternative route to tackle the problem (Scheme 1.6). Instead of using a ketal protection 
group, we proposed to have the Weinreb amide cycloadduct 1.73, which only has single α-
proton thus making the enolate generation and alkylation steps more straightforward. 
Moreover, the Weinreb amide moiety can be further converted towards the natural product. 
 
 
Scheme 1.6. Proposed alternative route to prenylated cycloadduct 1.74. 
1.6.1.1 Synthesis of the Weinreb Amide Cycloadduct 
To explore the feasibility of the proposed alternative route, we initiated our 
investigation by synthesizing the Weinreb amide dipolarophile 1.72 (Scheme 1.7). 







































CH2Cl2 to prepare Weinreb amide 1.72 in 70% yield. Subsequently, the 1,3-dipolar 
cycloaddition of 1.72 and 1.20 in the presence of Rh2(OAc)4 furnished cycloadduct 1.73 in 
47% yield after isolation. The structure assignment of 1.73 is based upon extensive 
evidence derived from 2D NMR spectra (HSQC, HMBC, COSY and NOESY). The 
structures of 1.76 and 1.77 are putative based on the characteristic peaks of the C1 bridge 
head proton on the NMR of crude mixture of 1.73, 1.76, and 1.77, and the yields of 1.76 
and 1.77 are calculated based on the ratio of C1 protons of 1.73, 1.76, and 1.77 (Figure 
1.15). The putative C1 proton of 1.76 having a chemical shift of 4.42. The peak is a doublet, 
which arising from the splitting between C1-H and exo C2-H. The endo C2-H typically 
doesn’t split with C1-H due to the torsional angle close to 90 ºC. The putative C1 proton 
of 1.77 having a chemical shift of 4.58. The peak is a singlet, since the endo C2-H typically 
doesn’t split with C1-H due to the torsional angle close to 90 ºC. The putative structures of 
1.76 and 1.77 with the yields calculated from the ratio of C1-H account for the regio and 
stereoselectivity that is consistent with the result we obtained from similar 1,3-dipolar 






Scheme 1.7. Synthesis of Weinreb amide cycloadduct 1.73. 
 
 
Figrue 1.15. NMR of crude mixture of 1.73, 1.76, and 1.77. 
The structure assignment of 1.73 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, COSY and NOESY). The characteristic peak having a 













































(Figure 1.16). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C2, C3, C4 are observed (Figure 1.17). HMBC typically 
shows correlations between protons and carbons that are one, two and sometimes in 
conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and both C2 and C3 indicate C2 and C3 are 
within two C atoms from C1-H. There is no correlation between C1-H and C5 because C5 
is three atoms away from C1-H in 1.73, whereas in the regioisomer 1.77 it would be two 























Figure 1.17. Key HMBC correlations of 1.73. 
The NOESY spectrum of 1.73 was also used to support its structural assignment 
(Figure 1.18). Of particular importance are the observed correlations between C2-H and 
C6-H, C2-H and C3-H. The NOESY correlation between the proton on C2 and the C6-CH3 
gem-dimethyl group suggests this proton is endo, because there would be no correlation of 
this proton with either of the gem-dimethyl groups if it were exo. The correlation between 
the endo-proton at C2 with the proton at C3 suggests that the C3-H is also endo; there is 
no NOESY correlation between the exo-proton at C2 with C3-H. These observations 



























1.6.1.2 Enolate Generation Studies of cycloadduct 1.73 
With cycloadduct 1.73 in hand, we started the investigated the feasibility of 
generating the proposed enolate 1.73’ by deuterium incorporation studies (Scheme 1.8). 
The cycloadduct 1.73 was treated with various strong base in THF at -78 ºC followed by 
D2O quenching, and the reaction mixture was analyzed via NMR to determine whether the 
desired enolate had been generated. Unfortunately, we screened commonly used strong 
base such as LDA, LiNEt2, LiNMe2, and NaHMDS, and all of them gave returned starting 
material 1.73 except for LiNMe2, which furnished complex mixture. We rationalized the 
observation from a stereoelectronic perspective. Namely due to the steric repulsion 
between the substituent on Weinreb amide nitrogen atom in 1.73 and the CO2Me group, 
the α proton was not aligned perpendicular to the carbonyl group which is required for 
efficient enolate generation. Moreover, the pKa of amides in DMSO is 35, whereas esters 
are around 29. 
 
 




























1.6.2 Vinylogous Ester Cycloadduct Transformation Sequence 
1.6.2.1 Synthesis of Vinylogous Ester Dipolarophile 1.18 
We were thus forced to develop another route to the prenylated cycloadduct 1.78, 
and we examined the cycloaddition of 1.20 and 1.18 (Scheme 1.9). Instead of using 
Weinreb amide dipolarophile, the vinylogous methyl ester 1.18 which would serve as the 
dipolarophile. Enolate generation from the proposed cycloadduct 1.17 was anticipated to 
be more straightforward, considering that there is only single proton α to the carbonyl, and 
it could be aligned perpendicular to the carbonyl which would be required for the enolate 
generation stereoelectronically. Moreover, the α proton of this ester cycloadduct is more 
acidic than that of the Weinreb amide. 
 
 

































To investigate the alternative route, the vinylogous ester dipolarophile 1.18 was 
prepared according to a literature procedure (Scheme 1.10).79 Starting from commercially 
available methyl acetoacetate (1.21), treatment with CH(OMe)3 with catalytic amount of 
concentrated H2SO4 afforded vinylogous carbonate 1.79 in 85% yield. 80  1.79 was 
converted to its Weinreb amide 1.80 in 70% yield by treatment with N,O-
dimethylhydroxylamine and trimethyl aluminum. The addition of vinyl Grignard reagent 
to the Weinreb amide afforded the desired dipolarophile 1.18 in 82% yield. 
 
 
Scheme 1.10. Synthesis of vinylogous methyl ester dipolarophile 1.18. 
1.6.2.2 1,3-Dipolar Cycloaddition of 1.20 and 1.18 
With 1.18 in hand, we turned our attention to the 1,3-dipolar cycloaddition reaction 
of 1.20 and 1.18. We extensively screened catalysts, catalyst loading, solvents and reaction 
temperature for the reactions, and we listed some of the representative conditions and the 
yields related (Table 1.4). We initiated our investigation by refluxing the solution of 1.20 
and 1.18 in the presence of 2 mol% Rh2(OAc)4 in CH2Cl2 overnight, and the reaction 
furnished a mixture of two diastereo-isomer 1.81 (44%) and 1.82 (5%) with regio isomer 
























formation as well as increase the yield (Entry 2). We observed the reaction completed in 
only 2 h, while the yield did not change much compared with lower catalyst loading. We 
have also investigated different Rh(II) catalysts, as ligands was reported impacting the 
chemoselectivity of the metallocarbene reactivity based on literature report. 81 , 82  We 
explored using 2 mol% Rh2(OPiv)4 as the catalyst, but unfortunately we did not detect any 
formation of the product, and decomposition product was detected instead (Entry 3). Then 
we tested Rh2(NHAc)4 as the catalyst, which we first tested refluxing the solution of 1.20 
and 1.18 in the presence of 2 mol% of Rh2(NHAc)4 in CH2Cl2 that afforded 1.81 (34%), 
1.82 (3%) and 1.83 (3%) (Entry 4). Treatment of 1.20 and 1.18 in the presence of 2 mol% 
of Rh2(NHAc)4 in toluene under reflux overnight afforded 44% of 1.81, 3% of 1.82 and 
3% of 1.83 (Entry 5). After further condition screening, we found that treatment of 1.20 
and 1.18 in the presence of 2 mol% of Rh2(NHAc)4 in toluene at 100 ºC for 1 h furnished 
the best combined overall yield of 1.81 and 1.82 in 65% with 15:1 dr accompanied with 
4% of undesired regioisomer 1.83 (Entry 6). The structure of cycloadduct 1.81 was 

















catalyst solvent T (ºC) time (h) 
% yield 
(1.81, 1.82, 1.83) 
1 2 mol% Rh2(OAc)4 CH2Cl2 reflux overnight 44, 5, 5 
2 5 mol% Rh2(OAc)4 CH2Cl2 reflux 2 42, 5, 4 
3 2 mol% Rh2(OPiv)4 CH2Cl2 reflux overnight NA 
4 2 mol% Rh2(NHAc)4 CH2Cl2 reflux overnight 34, 3, 3 
5 2 mol% Rh2(NHAc)4 toluene 100 overnight 44, 3, 3 
6 2 mol% Rh2(NHAc)4 toluene 100 1 61, 4, 4 
 
The structure assignment of 1.81 is based upon extensive evidence derived from 





































chemical shift of d 4.48 ppm, which is a doublet, arises from the bridgehead proton at C1 
(Figure 1.19). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C2, C3, C4 are observed (Figure 1.20). HMBC typically 
shows correlations between protons and carbons that are one, two and sometimes in 
conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and both C2 and C3 indicate C2 and C3 are 
within two C atoms from C1-H. There is no correlation between C1-H and C5 because C5 
is three atoms away from C1-H in 1.81, whereas in the regioisomer 1.83 it would be two 

















Figure 1.19. Key assignments of 1.81 on 1H spectrum. 
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Figure 1.20. Key HMBC correlations of 1.81. 
The NOESY spectrum of 1.81 was also used to support its structural assignment 
(Figure 1.21). Of particular importance are the observed correlations between C2-H and 
C6-H, C2-H and C3-H, C3-H and C6-H. The NOESY correlation between the proton on 
C2 and the C6-CH3 gem-dimethyl group suggests this proton is endo, because there would 
be no correlation of this proton with either of the gem-dimethyl groups if it were exo. The 
correlation between the endo-proton at C2 with the proton at C3 suggests that the C3-H is 
also endo. The correlation between the proton on C3 and the C6-CH3 gem-dimethyl group 
further suggests both groups are endo. Moreover, the coupling constant between C3-H and 
the assigned endo C2-H is 9.3 Hz that is greater than that of C3-H and the assigned exo 






























The structure assignment of 1.82 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, COSY and NOESY).  The characteristic peak having 
a chemical shift of d 4.38 ppm, which is a doublet, arises from the bridgehead proton at C1 
(Figure 1.22). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C2, C3, C4 are observed (Figure 1.23). HMBC typically 
shows correlations between protons and carbons that are one, two and sometimes in 
conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and both C2 and C3 indicate C2 and C3 are 
within two C atoms from C1-H. There is no correlation between C1-H and C5 because C5 
is three atoms away from C1-H in 1.82, whereas in the regioisomer 1.83 it would be two 




















Figure 1.23. Key HMBC correlations of 1.82. 
The NOESY spectrum of 1.82 was also used to support its structural assignment 
(Figure 1.24). Of particular importance are the observed correlations between C2-H and 
C6-H, C2-H’ and C3-H. The NOESY correlation between the proton on C2 and the C6-
CH3 gem-dimethyl group suggests this proton is endo, because there would be no 
correlation of this proton with either of the gem-dimethyl groups if it were exo. The 
correlation between the exo-proton at C2 with the proton at C3 suggests that the C3-H is 
exo. Moreover, the coupling constant between C3-H and the assigned exo C2-H is 11.2 Hz 
that is greater than that of C3-H and the assigned endo C2-H which is 4.6 Hz. These 




















Figure 1.24. Key NOESY correlations of 1.82. 
The structure assignment of 1.83 is based upon extensive evidence derived from 
2D NMR spectra (HSQC, HMBC, COSY and NOESY).  The characteristic peak having 
a chemical shift of d 4.65 ppm, which is a singlet, arises from the bridgehead proton at C1 
(Figure 1.25). This assignment is made based upon the HMBC spectrum, in which 
correlations between C1-H and C3, C4, C5 are observed (Figure 1.26). HMBC typically 
shows correlations between protons and carbons that are one, two and sometimes in 
conjugated system three atoms away; C1-H and C4 are two atoms removed through the 
oxygen bridge. The correlations between C1-H and C3, C5 indicate C3 and C5 are within 
two C atoms from C1-H, whereas in the regioisomers 1.81 and 1.82, C5 would be three 




















Figure 1.26. Key HMBC correlations of 1.83. 
The NOESY spectrum of 1.83 was also used to support its structural assignment 
(Figure 1.27). Of particular importance is the observed correlation between C2-H and C6-
H. The NOESY correlation between the proton on C2 and the C6-CH3 gem-dimethyl group 
suggests this proton is endo, because there would be no correlation of this proton with 
either of the gem-dimethyl groups if it were exo. Moreover, the coupling constant between 
C2-H and the assigned endo C3-H is 9.1 Hz that is greater than that of C2-H and the 
assigned exo C3-H which is 4.5 Hz. These observations support the stereochemical 







Figure 1.27. Key NOESY correlations of 1.83. 
1.6.2.3 Stereoselective Prenylation of 1.81 
With 1.81 in hand, we investigated the stereoselective prenylation. We first 
screened conditions to generate the desired enolate intermediate. We treated cycloadduct 
1.81 with various strong bases in THF at -78 ºC, followed by quenching with D2O to 
analyze deuterium incorporation via NMR. We screened commonly used strong bases such 
as LDA, LiNEt2, LiNMe2, NaHMDS on deprotonation of 1.81, and we found that both 
















elimination product based on NMR results (Scheme 1.11). This indicated successful 
formation of the desired enolate intermediate as well as the highly stereoselective 
protonation of the enolate. For LiNEt2 and LiNMe2, both bases yielded a complex mixture. 
 
 
Scheme 1.11. Deuterium incorporation studies of 1.81. 
With effective formation of the desire enolate intermediate, we next turned our 
attention to alkylating the enolate with prenyl halide reagents. We initiated our 
investigation using commercially available prenyl bromide as the alkylating reagent. We 
first treated 1.81 with LDA in THF at –78 ºC for 30 min, whereupon freshly distilled prenyl 
bromide was added. The solution was stirred at -78 ºC for over 2 h; however, no new 
product was formed based on TLC analysis. Instead of directly terminating the reaction, 
we added D2O to quench the reaction. We found no alkylation product 1.78 in the reaction 
mixture, and deuterium incorporated 1.82’ was found instead which indicated no alkylation 



























In order to facilitate the alkylation process, we could increase the nucleophilicity 
of the enolate and the electrophilicity of the alkylating reagent. As for increasing the 
nucleophilicity of the enolate, we tested adding dissociating reagent 
hexamethylphosphoramide (HMPA) with prenyl bromide after successful generation of the 
enolate. We initially added 10% HMPA with the prenyl bromide which only observed 
small amount of conversion of 1.81 to 1.78 accompanied with 1.82’ after D2O quench. We 
next increased the amount of HMPA to 23% and prolonged the reaction time to 2 h at –78 
ºC. However, there were still significant amounts of deuterium incorporated 1.82’ isolated 
(45%) after the reaction was quenched with D2O (Equation 1.25). 
 
  
At the same time, we examined different alkylating reagent to facilitate the 
alkylation process. For example, we converted prenyl bromide (1.84) into prenyl iodide 
(1.85) by treatment of NaI in acetone (Equation 1.26). Without further purification, prenyl 























































THF at –78 ºC, and the solution was stirred at –78 ºC for 1 h (Equation 1.27). Gratifyingly, 
we observed the complete conversion of the enolate into its prenylation product 1.78 in 
45% yield without isolation of any epimeric prenylation product after the D2O quench. 
 
With further experimentation, we found treating 1.81 with NaHMDS in THF at –
78 ºC for 30 min followed by the treatment of enolate with freshly prepared prenyl iodide 
at –78 ºC for 30 min afforded 1.78 in 65% yield (Equation 1.28). At meantime, we also 
alkylated the diastereoisomer 1.82 using the same reaction condition to obtain 66% of 1.78 






























1.7 STUDIES OF ENANTIOSELECTIVE 1,3-DIPOLARCYCLOADDITION 
1.7.1 Enantioselective 1,3-Dipolar Cycloaddition 
With the successful approach to the core oxa-tricyclo structure and efficient 
installation of the prenyl group, we explored the enantioselective 1,3-dipolarcycloaddition. 
With extensive searching of precedents, we found three different strategies for constructing 
the tricyclic core structure enantioselectively. One of the strategies features a chiral Rh-
catalyzed tandem carbonyl ylide formation-1,3 dipolar cycloaddition sequence, which is 
also the best-studied strategy among all three strategies.27 The transition metal remains 
associated with the carbonyl ylide in 1.88 even after its formation, thus providing the chiral 
environment because the chiral ligand remains appended to the transition metal (Figure 
1.28A). Hashimoto reported the 1,3-dipolar cycloaddition of α-diazo-β-ketoester 1.90 with 
terminal acetylenes 1.91 in the presence of N-tetrachlorophthaloyl-t-leucine ligated 
catalyst, Rh2(S-TCPTTL)4 afforded cycloadducts 1.93 and 1.94 with high regio- and 
enantioselectivities (Figure 1.28B).83 
 








































Figure 1.28. (A) Concept of chiral Rh catalyzed 1,3-dipolar cycloaddition. (B) Examples 
of chiral Rh catalyzed 1,3-dipolar cycloaddition. 
The chiral Rh(II) catalysis builds on the formation of the Rh-associated carbonyl 
ylide species; however, the dissociation of the Rh(II) from the carbonyl ylide is a potential 
concern. To improve the chiral Rh(II) catalysts strategy, the second strategy that use of 
chiral Lewis acid in combination with achiral Rh catalysts were proposed and developed.27 
The Rh catalysts generate carbonyl ylide with diazo compound 1.95, and the chiral Lewis 
acid either activates the carbonyl ylide species or the dipolarophile depending on the 
































































the cycloadducts were determined by the chiral Lewis acid without depending on the 
formation of transition metal associated carbonyl ylide species. Suga group reported the 
example of Yb(III)/Ph-Pybox 1.100 complex promoting the 1,3-dipolar cycloaddition of 
diazo compound 1.98 and 1.99 to form 1.101 with high exo- and enantioselectivities 
(Figure 1.29B).84  
 
 
Figure 1.29. (A) Concept of chiral Lewis acid catalyzed 1,3-dipolar cycloaddition of 
carbonyl ylides generated by achiral Rh catalyst. (B) Examples of chiral 
Lewis acid catalyzed 1,3-dipolar cycloaddition. 
Lastly, chiral auxiliaries were also being used in the enantioselective 1,3-dipolar 
















































group to form 1.102, which could further generate 1,3-dipoles 1.103 thus forming chiral 
cycloadduct 1.104. However, we were not aware of any enantioselective carbonyl ylide 
cycloadditions were performed by this method, other 1,3-dipoles such as nitrones, 
diazoalkanes, and azomethines with chiral auxiliaries have been studied.86-88 
 
 
Figure 1.30. Concept of chiral auxiliary promoted enantioselective 1,3-dipolar 
cycloaddition of carbonyl ylides 
With the knowledge of three different strategies for constructing the tricyclic core 
structure enantioselectively via 1,3-dipolar cycloaddition, we sought to explore the chiral 
rhodium catalysis since it is the best studied the method, and it would not add extra steps 
to our synthesis. 
1.7.2 Chiral Rh-Catalyzed 1,3-Dipolar Cycloaddition 
Doyle and coworkers demonstrated that the Rh(II)-catalyzed reaction of 4-
nitrobenzaldehyde (1.105) and ethyl diazoacetate (1.106) afforded diastereomeric 
dioxolanes 1.107, and the ratio of diastereomers depended on the ligand of the Rh(II) 
catalysts. 89  They postulated of the formation of Rh-associated carbonyl ylide as the 























MEOX)4 (MEOX = methyl 2-oxooxazolidine-4-carboxylate) to form the all-cis 
cycloadduct as a major product with 28% ee (Figure 1.31A). Hodgson and coworkers 
reported the first example of catalytic asymmetric 1,3-dipolar cycloaddition of carbonyl 
ylide in 1997.90 The diazo carbonyl compound 1.108 was designed to undergo 1,3-dipolar 
cycloaddition intramolecularly to generate 1.109, and modest enantioselectivity was 
achieved by employment of chiral Rh(II) catalyst Rh2(S-DOSP)4 (Figure 1.31B). A 
following study of the same cycloaddition reaction revealed that using of Rh2(R-DDBNP)4 
improved the enantioselectivity dramatically. 91  The strategy was then expanded to 
intermolecular 1,3-dipolar cycloaddition reactions. Treatment of 2-diazo-3,6-diketoester 
1.110 with different dipolarophiles including styrenes, arylacetylenes, and strained alkenes 
afforded cycloadducts 1.113-1.115 with modest to good enantioselectivities (Figure 
1.31C). 92 - 94  Cu(I)/ chiral bisoxazoline catalysts were also studied in the 1,3-dipolar 
cycloaddition reactions, but only slight enantioselectivities were observed.92 
































































































Figure 1.31. Early examples of enantioselective 1,3-dipolar cycloaddition. 
Hashimoto and coworkers have done extensive pioneering studies to develop 
highly enantioselective 1,3-dipolar cycloaddition reactions.27,95 The optimal chiral Rh(II) 
catalyst was identified by screening the amino acid residue and the aromatic moiety of the 
ligand.96 They also examined the 1,3-dipolar cycloadditions of electron deficient carbonyl 
ylides and electron rich dipolarophiles. In the reaction of diazo carbonyl compound 1.116 
with electron rich dipolarophile indole derivative 1.117, Rh2(S-TCPTTL)4 was employed 
to furnish exclusive exo tetracyclic cycloadduct 1.118 with high enantioselectivities 
(Figure 1.32A).28 This procedure can also be applied to formyl substituted carbonyl ylide 
precursor 1.120 with 1.119, the cycloadduct 1.121 could be subsequently converted to 
natural product descurainin (Figure 1.32B).15,16 Other examples including the use of 




Figure 1.32. Examples of chiral Rh-catalyzed 1,3-dipolar cycloaddition of carbonyl 
ylides with various dipolarophiles. 
1.7.3 Studies of the Chiral Rh-Catalyzed Enantioselective 1,3-Dipolar Cycloaddition 
Based upon the previous studies of chiral Rh catalyzed 1,3-dipolarcycloadditions, 
we first examined the reaction of 1.20 with 1.18 in the presence of Rh2(S-TCPTTL)4 
because this catalyst gave the highest enantiomeric excess (ee) in related reactions (Table 
1.5).15,16 Treatment of 1.20 and 1.18 in the presence of Rh2(S-TCPTTL)4 in CH2Cl2 at room 
temperature did not afford any product, starting materials were recovered instead (Entry 
























































TCPTTL)4 in CH2Cl2 was heated under reflux which furnished 1.68 in 26% yield and 6% 
ee (Entry 2). Different solvents were screened including CF3C6H5 and toluene at room 
temperature (Entries 3 and 4). The reaction in CF3C6H5 did not form any cycloadduct 1.68, 
while the reaction in toluene furnished cycloadduct 1.68 with 38% yield and 15% ee. We 
next attempted to lower the reaction temperature to increase the enantioselectivity. 
Relatively similar yield (36%) and ee (16%) was obtained by treating the solution of 1.20 
and 1.18 in the presence of Rh2(S-TCPTTL)4 in toluene at 0 ºC (Entry 5). The attempt to  
use excess of 1.18 (5 eq.) afforded 1.81 in 36% yield and 15% ee (Entry 6). Slow addition 
of 1.20 to the solution of 1.18 was conducted which furnished 1.81 in 40% yield and 13% 
ee (Entry 7). Finally we attempted increasing catalyst loading to 10 mol% which formed 



















entry solvent temperature yield (%)a ee (%)b 
1 CH2Cl2 rt NA NA 
2 CH2Cl2 reflux 26 6 
3 CF3C6H5 rt NA NA 
4 toluene rt 38 15 
5 toluene 0 ºC 36 16 
6c toluene rt 36 15 
7d toluene rt 40 13 
8e toluene rt 32 12 
a yields are based upon products purified by column chromatography but are not optimized. b 
enantiomeric excesses (ee) were determined via analytical normal phase HPLC column 
(CHIRALCELÒ OD-H) eluting with i-PrOH/hexane (20:80, v/v). c 5 eq. of 1.18 was used. d 1.18 
and catalyst were premixed in toluene, 1.20 in toluene was slowly added via syringe pump over 30 
min. e 10 mol% was used. 
After surveying different catalyst loadings, solvents and temperatures, we 






















toluene overnight at room temperature gave 1.81 in 38% yield in 15% ee (Table 1.5, Entry 
1) (Figure 1.33).28 Toward improving the ee of this process, we screened a series of other 
catalysts known to promote enantioselective dipolar cycloadditions of carbonyl ylides. Of 
these, Rh2(S-TFPTTL)4 gave 1.81 with comparable ee, whereas the ee obtained using 
Rh2(S-BPTTL)4 and Rh2(S-TBSP)4 were lower (Entries 2, 3, 4) (Figure 1.33).95,100,101 On 
the other hand, no ee was observed using Rh2(S-PTTL)4 or Rh2(S-BPTV)4 (Entries 5, 6) 
(Figure 1.33).101 Although these preliminary studies support the feasibility of developing 
new catalysts that might be used to synthesize individual enantiomers of melicolone A or 
B, the low ees and the fact that melicolone A or B were isolated as racemates persuaded us 




















entry catalyst yield (%)a ee (%)b 
1 Rh2(S-TCPTTL)4 38 15 
2 Rh2(S-TFPTTL)4 32 13 
3 Rh2(S-BPTTL)4 38 6 
4 Rh2(S-TBSP)4 16 7 
5 Rh2(S-PTTL)4 35 0 
6 Rh2(S-BPTV)4 25 0 
 
a yields are based upon products purified by column chromatography but are not optimized. b 
enantiomeric excesses (ee) were determined via analytical normal phase HPLC column 
























Figure 1.33. Structures of chiral dirhodium(II) complexes. 
1.8 COMPLETION OF THE TOTAL SYNTHESES OF (±)-MELICOLONES A AND B 
1.8.1 Base Induced Aldol Cyclization Sequence 
With 1.65 in hand, we next investigated strategies to induce the aldol cyclization of 
the 1,3-dicarbonyl species onto the ketone carbonyl group to construct another five-
membered ring. We first investigated selective removal of the methyl group on the 
vinylogous methyl ester to expose the 1,3-dicarbonyl moiety. However, there is another 
methyl ester group in 1.78, which could potentially cause selectivity issues. Moreover, 
Padwa has reported the oxa-tricyclic core structure decomposes in acidic conditions.78 
Armed with this knowledges, we treated 1.78 with freshly distilled trimethylsilyl iodide 
(TMS-I) in CHCl3 followed by the addition of MeOH (Equation 1.30). Gratifyingly, we 
isolated 1.122 in 62% yield after chromatography purification and another 10% inseparable 
mixture with the correct mass based on LCMS. We assumed the inseparable mixture to be 
the isomer of 1.122 which could ultimately be cyclized to aldol product as well. 
X = Cl: Rh2(S-TCPTTL)4
X = F: Rh2(S-TFPTTL)4
















R = iPr: Rh2(S-BPTV)4










We then investigated the base induced aldol cyclization of 1.122. We treated 1.122 
with freshly distilled 1,8-diazabicycl[5.4.0]underc-7-ene (DBU) in THF at 0 ºC for 30 min, 




With the successful development of a two-step sequence to prepare 1.16, we next 
turned our attention to develop a one-pot procedure to convert 1.78 to 1.16. According to 
the reported trimethylsilyl iodide (TMS-I) deprotection mechanism by Jung, the TMS-I 
first cleaves the methyl ether to afford the alkyl iodide and a trimethylsilyl ether, which 
was then converted to its alcohol product by the addition of methanol.102 We proposed that 
after forming the trimethylsilyl ether intermediate, we should be able to directly treat the 
intermediate with tetrabutylammonium fluoride (TBAF) to deprotect the silyl ether and 
induce the aldol cyclization. To test our hypothesis, we treated 1.78 with TMS-I in MeCN 
at room temperature, and after forming the trimethylsilyl ether, we cooled the solution to 
0 ºC and added TBAF solution (Equation 1.32). However, we were not able to isolate the 
































desired cyclization product, and we obtained complex mixture. We also tried directly 
treating the trimethylsilyl ether intermediate with DBU, but unfortunately, we were not 




After these unsuccessful attempts to develop a one-pot sequence to convert 1.78 to 
1.16, we developed a two-step procedure without purification of the enol intermediate. We 
treated 1.78 with TMS-I in CHCl3, followed by the addition of MeOH to convert the 
trimethylsilyl ether to the corresponding enol. After working up the reaction, we directly 
treated the crude product with DBU in THF at 0 ºC, and then allowed the reaction to warm 
to room temperature. We thus isolated 1.16 via the two-step, one separation sequence in 


























1) TMS–I, CHCl3, rt; MeOH
then










1.8.2 Epoxide Formation and Regioselective Epoxide Opening 
With 1.16 in hand, the remining step to complete the total syntheses of (±)-
melicolones A and B was to construct the tetrahydropyran moiety. Such conversion has 
been well documented via the sequence of epoxide formation followed by hydoxy epoxide 
openings. We first investigated the epoxidation of 1.16 with m-chloroperoxybenzoic acid 
(m-CPBA) to determine if there are any substrate control present in 1.16 that would afford 
some facial selectivity for the epoxidation. We treated 1.16 with m-CPBA in CH2Cl2 for 





To improve the diastereoselectivity of the epoxidation step, we turned our attention 
to investigate other epoxidation strategies via catalyst control. Shi reported the 
enantioselective epoxidation reactions of disubstituted and trisubstituted alkenes using 
oxone (potassium peroxymonosulfate) and the D-fructose-derived catalyst 1.124 (Equation 
1.35).103 The reaction is proposed to proceed through a dioxirane intermediate that is 
generated from the oxidation of the catalyst ketone by oxone. The dioxirane species would 
transfer oxygen to the alkene forming the epoxide.104 Planar and spiro transition states 
























With the promising precedent of Shi epoxidation, we investigated the Shi 
epoxidation of 1.16. Chiral ketone 1.124 was prepared from D-fructose according to the 
literature procedure.103 The intermediate 1.16 was treated with chiral ketone 1.124 and 
oxone in the buffer solutions, but we did not isolate any of the desired epoxide products; a 
complex mixture was obtained instead (Equation 1.36). We have also investigated other 
reaction conditions Shi reported on the epoxidation of trisubstituted olefins, but we did not 




















There are also examples of using chiral (salen)Mn (III) complexes to 
enantioselectively epoxidize trisubstituted olefins that have been reported by Jacobsen, so 
there are still potential solutions to improve the stereoselectivity of the epoxidation step.106 
However, since both epoxide isomers can be converted to melicolone natural products, and 
melicolones A and B were isolated as racemates, so we decided to complete the synthesis 
with the current epoxide mixture first. 
The epoxide 1.123 was not stable at ambient temperature nor on silica gel, so we 
decided to use the mixture of two diastereomeric epoxides to investigate the selective 
epoxide opening strategies. Such selective epoxide opening in the presence of acids to form 
six-membered ring are well precedented in the literature (Figure 1.34).107-109 Wang used 
Oxone, K2CO3, Bu4NHSO4
Na2B4O7•10H2O, Na2(EDTA)











































formic acid to promote the intramolecular cyclization of hydroxy epoxide 1.125 to form 
the tetrahydropyran derivative 1.126 in their total synthesis of coriandrone B (Figure 
1.34A).107 Inoue reported the use of 1N HCl in EtOH to selectively open the epoxide 1.127 
to form six-membered tetrahydropyran moiety of 1.128 in the synthesis of an NG-121 
model compound (Figure 1.34B).108 Nicolaou reported the use of camphorsulfonic acid 
(CSA) with 1.129 to achieve the construction of the tetrahydropyran system via the 
intramolecular hydroxy epoxide opening to generate 1.130 (Figure 1.34C).109 Reagent-
controlled switching of 5-exo to 6-endo cyclization has also been demonstrated by 
Morimoto (Figure 1.34D).110 Triisopropylsilyl trifluoromethanesulfonate (TIPSOTf) was 
employed to promote the cyclization of bishomoepoxy alcohols 1.131 to give TIPS ether 
substituted tetrahydropyran derivative 1.132, and the formation of tetrahydrofuran 
derivatives was suppressed by the disfavored steric interactions of the TIPS ether and 
geminal dimethyl groups.110 
 106 
 
Figure 1.34. Reported examples of the selective tetrahydropyran moiety formation from 
the hydroxy epoxide species 
Encouraged by these promising reports, we initiated our investigation of selective 
epoxide opening by screening acid catalyzed reaction conditions (Scheme 1.12). We first 
investigated the procedure reported by Wang, and treated epoxide 1.123 with formic acid 
in EtOAc. Unfortunately, a complex mixture was formed and the desired product was not 
observed.107 The treatment of epoxide 1.123 with catalytic amount of HCl in Et2O also 



















































reported by Inoue, 1N HCl in EtOH at room temperature, but this reaction did not form 
any desired product either.108 Gratifyingly, a reaction of epoxide 1.123 with 10 mol% CSA 
in CH2Cl2 from -40 ºC to rt, according to the procedure reported by Nicolaou, afforded a 
mixture of the desired final natural products 1.1 and 1.2 in 95% combined yield.109 The 
mixture of 1.1 and 1.2 was not separable on silica gel chromatography, instead we 
developed a method on C18 column reverse phase HPLC to separate 1.1 and 1.2 effectively 
which ultimately afforded 1.1 in 49% and 1.2 in 45%. 
 
 
Scheme 1.12. Selective epoxide opening of 1.123. 
With the successful formation of the melicolones A (1.1) and B (1.2) in a two-step 
sequence, we next turned our attention to develop a one-pot procedure for converting 1.16 
to 1.1 and 1.2. Epoxide formation and epoxide opening steps were both conducted in 
CH2Cl2, and both steps were clean and efficient. Accordingly, we treated 1.16 with 













(±)-Melicolone A (1.1): R1 = OH, R2 = H
(±)-Melicolone B (1.2): R1 = H, R2 = OH
conditions result
cat. HCOOH, EtOAc, rt no product detected
cat. HCl, Et2O, rt no product detected
1N-HCl, EtOH, rt no product detected
10 mol% CSA, CH2Cl2, -40 ºC to rt 95% (1.1 and 1.2 combined)
O
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CSA (10 mol%) was added, and the solution was stirred at room temperature for another 
30 min. We were glad to observe the complete conversion of 1.16 to the mixture of 1.1 and 
1.2. Further purification afforded a mixture of 1.1 and 1.2 in 85% combined yield with the 





In summary, we have accomplished the first total syntheses of (±)-melicolone A 
and (±)-melicolone B, which are epimeric isomers derived from rearranged acetophenones. 
The synthesis is remarkably concise and efficient which only requires nine longest linear 
steps from the commercially available starting materials and eight isolated intermediates 
in 12.3% combined overall yield. The synthesis features a novel rhodium(II) catalyzed 1,3-
dipolar cycloaddition reactions of carbonyl ylide generated from an aliphatic aldehyde with 
rhodium carbene and an unsaturated vinylogous ester dipolarophile. The cycloaddition 
generated the oxabicycloheptane core in an unusual and highly regioselective (16:1) and 
stereoselective (15:1) way which could be used as the unified intermediate to approach to 
other melicolone natural products with the same tetracyclic core structure. The unusual 
regio and stereoselectivity were dominated by the steric effects instead of the more 
commonly observed electronic effects. Studies of enantioselective 1,3-dipolar 
MCPBA, CH2Cl2, rt
then
(±)-Melicolone A (1.1): R1 = OH, R2 = H
(±)-Melicolone B (1.2): R1 = H, R2 = OH
1.16
85% (dr = 1.1:1)














cycloadditions promoted by chiral rhodium(II) catalysts demonstrated the feasibility of 
constructing the oxabicycloheptane core enantioselectively; however, further screen of 
chiral catalysts are needed to improve the ee of the reaction. Stereoselective prenylation of 
the oxabicycloheptane cycloadduct sets the stage for the following base induced aldol 
cyclization to generate the penultimate tricyclic intermediate. Final epoxidation of the 
prenyl group and acid-catalyzed regioselective epoxide opening sequence affords a 1.1 : 1 
















































































TMS–I, CHCl3, rt; MeOH
then
DBU, THF, 0 °C to rt
75%













(±)-Melicolone A (1.1): R1 = OH, R2 = H
(±)-Melicolone B (1.2): R1 = H, R2 = OH
1.16
85% (dr = 1.1:1)













DESIGN, SYNTHESIS AND EVALUATION OF NOVEL 
CARBAZOLE BASED PHOTOCAGES 
Chapter 2: Photocages 
2.1 INTRODUCTION  
Photocages are light-reactive protecting groups that can be appended to a molecule 
to render it chemically and biological inert. Photocages can be removed under mild 
conditions without the need for chemical reagents through exposure of the protected 
compound to light to release biologically or chemically active molecules. These unique 
protecting groups can be removed in a temporal and spatial controlled fashion thus 
releasing the active molecules. 111  Although photocages were originally designed and 
synthesized by synthetic chemists, the applications in synthetic chemistry are minimal. One 
well known example was reported by Nicolaou and coworkers in their total synthesis of 
calicheamicin γ1, where the o-nitrobenzyl group was utilized to protect a secondary 
amine.112 A similar protection strategy was employed by Gareau and coworkers in their 
study of total synthesis of N-methyl leukotriene C4.113 In biology, the use of photocages 
attracted considerable interest in biology due to the precise control of the decaging process, 
which could enable the detailed studies of the role of bioactive molecules.114 There are 
numerous applications in biology including the control of protein functions,115 cellular 
stimulation,116 regulation of gene express,117 and neuronal stimulation or inhibition.118  
Barltrop and Schofield reported the first example of photosensitive protecting 
groups in 1962 as the strategy to protect amino acids.119 Upon irradiation with UV light, 
the Cbz group appended to the glycine moiety was removed from 2.1, generating free 
glycine 2.2 and benzyl alcohol 2.3 (Equation 2.1). Barton, Sheehan, and Woodward later 
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The term “cage” was first proposed by Hoffman in his synthesis and study of 
adenosine triphosphate (ATP) derivatives, even though a year earlier Engles and coworkers 
had synthesized a cyclic adenosine monophosphate (AMP) derivative; however, they did 
not use the term “cage”, and decaging was not the main focus of their study.123,124 Even 
though the term “cage” was coined by Hoffman, photocages were often referred to as 
photoremovable (or photolabile) protecting groups (PPGs). 
The promising biological applications of photocages sparked the interests of 
chemists to develop various new photocages. The requirements for the development of a 
good photocage depend on the application, so it is unnecessary to fulfill all the 
requirements, some of which remain challenges in developing an optimal photocage.  
The first requirement of a photocage is that it should have good decaging 
efficiencies at given wavelengths, and the wavelengths are usually above 300 nm for 
biological studies to avoid possible damage to the biological entity caused by the irradiation 
of light. The decaging efficiency of a photocage is defined as ε•Φ at a given wavelength. ε 
refers to the molar absorptivity of the molecule, which is relevant to the property of the 
chromophore moiety. Φ refers to the quantum yield of the decaging process. The quantum 












+ +  CO2 (2.1)
2.1 2.2 2.3
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photons at the irradiation wavelength λ, np/mol (Equation 2.2). That is, the quantum yield 
of decaging Φ is equal to the rate constant of substrate release from the excited state (krel) 
divided by the sum of all of the rate constants of other potential photochemical pathways 
from the excited state (Σ k) (Equation 2.3). Moreover, the release of the caged molecule 
should also be the primary photochemical process, and it should be faster than the 
biological response that is under investigation. Commonly, there are multiple steps 
regarding ground-state and excited-state intermediates that precede the actual decaging of 
the target molecule, so the basic knowledge of the mechanism is necessary in the study.  
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There are also other requirements for useful photocages. For example, caged 
molecules and their byproducts after the photochemical reaction should have good 
solubility in the target media (usually aqueous media for biological studies), and they 
should be stable in the target media and non-toxic to the biological entities under 
investigation. 
Synthetically, caged molecules should be prepared in high yields and the 
purification should be facile. It is very important that caged molecules can be isolated 
cleanly without contamination of other uncaged substrates. 
In view of the above requirements, chemists have developed various photocages 
with different properties that have been utilized in biological studies. Even though there is 
no one photocage that can meet all the requirements, depending on different purposes of 
biological studies, photocages have been demonstrated to be powerful and useful tools in 
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the biology. However, with the new demands in biological studies, scientists are still 
pursuing to develop novel photocages nowadays. Herein, we will briefly review some of 
the most common and widely utilized photocages based upon their structure features and 
decaging mechanisms in this chapter. Scopes and limitations of different photocages will 
also be presented. 
2.2 NITROARYL PHOTOCAGES 
2.2.1 o-Nitrobenzyl Photocages 
 
The o-nitrobenzyl group 2.4, is one of the most widely utilized photocage, was first 
used as a photocage as early as 1970, even though there were earlier reports on its 
photochemistry. Since then, a large number of the o-nitrobenzyl analogues have been 
synthesized and studied as photocages. Thanks to the pioneering studies by Bartlop and 
Woodward, o-nitrobenzyl photocages have been well-studied, and the decaging 
mechanism is well-understood.125-129 Despite being widely used as photocages, they also 
have some inherent disadvantages that limit their use in some specific cases, which will be 
discussed later in this chapter. 
The mechanism of the decaging process of o-nitrobenzyl groups has been studied 
over the years. Because of these contributions, we now have a relatively clear 






LG = phosphates, carboxylates, carbonates,carbamates,
thiolates, phenolates, and alkoxides
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excited singlet state 2.5, whereupon an intramolecular hydrogen abstraction occurs 
followed by internal conversion (IC) to form the aci-nitro tautomers 2.8 and 2.9. The 
energy barrier for retautomerization of 2.8 to 2.4 is relatively low, but in some solvents 
(MeOH, MeCN) the equilibration between 2.8 and 2.9 is competitive with reformation of 
2.4. It is also possible for 2.5 to enter the excited triplet state through inter-system crossing 
(ISC), at which point an intramolecular hydrogen transfer can occur, forming the aci-nitro 
intermediate 2.8 upon ISC back to the ground state. The rate constant of decay for 
intermediates 2.8 and 2.9 depends heavily on aromatic ring substitution, solvent, and pH 
of the system. The aci-nitro intermediate 2.9 may undergo an irreversible cyclization to 
create intermediate 2.10, which upon subsequent ring opening, forms hemiacetal 2.11. 
Intermediate 2.11 collapses to form the 2-nitrosobenzaldehyde 2.12 while concomitantly 




Scheme 2.1. Decaging mechanism for o-nitrobenzyl photocages. 
There are a number of problems associated with o-nitrobenzyl photocages that are 
mostly due to the generation of the nitroso aldehyde product. The nitroso products usually 
have a higher molar absorptivity than the photocaged molecules at the decaging 
wavelength, which would adversely affect the light absorption of the photocaged 
compounds. Moreover, the nitroso products are generally reactive, and in some cases, the 
nitroso products react with the substrate itself or the decaged molecule. One example of 
the side reaction of nitroso products is the condensation reaction with primary amines. The 
undesired side reaction between nitroso product and primary amine was found by Givens 
































































raised the concern for the application of o-nitrobenzyl photocages for amino-containing 
compounds due to the potential side reactions that would diminish the efficiency of the 
decaging process. Furthermore, the nitroso products sometimes can be toxic toward the 
biological entities under investigation, which limits the application in biological studies.114 
Consequently, there have been extensive efforts to mitigate these issues. The introduction 
of alkyl groups at the benzylic position of the photocage resulted in enhanced uncaging 
rates and biologically less reactive nitroso ketones as reaction products. 
One of the appealing aspects of o-nitrobenzyl photocages is their ability of decaging 
with various leaving groups such as phosphates, carboxylates, carbonates, carbamates, 
thiolates, phenolates, and alkoxides. However, the decaging efficiency is heavily affected 
by the leaving group ability. For a good leaving group such as phosphate, release of the 
leaving group is synchronous with the formation of the aci-nitro intermediate 2.9, having 
a rate on the order of milliseconds. However, for a bad leaving group such as alkoxide, the 
decaging rate would depend on the rate of the collapse of the cyclic intermediate 2.10. The 
pH was found to be important in some cases as well. At neutral pH, the decay of 
intermediate 2.11 was found to be significantly slower than the decay of the aci-nitro 
intermediate 2.9. Therefore, the release of bad leaving groups is often challenging for the 
o-nitrobenzyl photocages, and other possible solutions were also proposed such as the use 
of carbonate linkers and carbamate linkers (Equation 2.4). They are generally better leaving 
groups than alkoxides and will lead to better decaging efficiencies, and subsequently the 
carbonates or carbamates will undergo thermal fragmentation to furnish the free alcohols 





There are biological applications of the o-nitrobenzyl group 2.4, due to its fast 
release of substrates. Deiters group, Chin group and Schutlz group have reported the 
collaboration studies of the photocontrol of tyrosine phosphorylation process in 
mammalian cells via genetic encoding of photocaged tyrosine. 132 , 133  Caged tyrosine 
derivative 2.17 was generically encoded into proteins in mammalian cells, which was then 
photolyzed to release free tyrosine derivative 2.18 upon irradiation of UV light (365 nm) 
(Figure 2.1). The released tyrosine derivative 2.18 was later found being phosphorylated 
in mammalian cells. 
 
Figure 2.1. Photocaged tyrosine derivatives in biological applications. 
2.2.2 o-Nitrobenzyl Photocage Derivatives 
Since the early reports of o-nitrobenzyl photocages, a number of o-nitrobenzyl 
derivatives were reported. These new o-nitrobenzyl photocages were developed to increase 






























include different substitutions at the benzylic position of the o-nitrobenzyl photocages and 
changes of the aromatic chromophores.  
An early example of the modification at the benzylic position of o-nitrobenzyl 
photocages was reported by Woodward.122 Various substituents at benzylic position were 
evaluated to avoid the side reactions with nitroso aldehyde products formed after decaging. 
One of the drawbacks of adding a substituent at the benzylic position is creating a chiral 
center, which would be problematic if chiral molecules have to be protected, unless the 
added substituent is identical to the aromatic chromophore. Photocage 2.19 fits into this 
category which o-nitrophenyl was added as the substituent at the benzylic position (Figure 
2.2).  Despite the chirality issue, many substituents at the benzylic position were found to 
be beneficial for the decaging efficiencies of the photocages. A simple addition of methyl 
group at the benzylic position led to a new photocage derivative 1-(2-nitrophenyl)ethyl 
2.20, which has a better quantum yield compared with o-nitrobenzyl cages. Reichmanis 
reported the examples of pivalate ester of 2.20 with Φ = 0.09 in polymer and Φ = 0.64 in 
acetonitrile compared with 2.4 with Φ = 0.04 in polymer and Φ = 0.13 in acetonitrile.134,135 
Other reports on the application of 1-(2-nitrophenyl)ethyl photocages including the 
decaging of biologically active carboxylic acids in plant cells and on solid support were 
published shortly after.136,137 Specht and Goeldner proposed the introduction of an electron 
withdrawing group, in this case the trifluoromethyl group, at the benzylic carbon of 2.21 
gave a dramatic increase in the quantum yield in the case of choline and arseniocholine 
ether derivatives.138 The addition of the methyl group at the benzylic position led to the 
formation of nitroso ketone product instead of nitroso aldehyde, which was less reactive, 
thus diminishing the side reactions. They were able to be demonstrated as the efficient 




Figure 2.2. Select examples of o-nitrobenzyl photocages with substituents at benzylic 
position. 
Due to the issues including generation of a chiral center, limited impacts on the 
absorbance, and synthetic challenges, modifications of the benzylic position were 
relatively limited compared with modifications on aromatic rings. A second electron 
withdrawing group was added to the aromatic ring to increase the rate of the H-abstraction 
process thus facilitating the formation of the aci-nitro intermediates (Figure 2.3). 2,6-
Dinitrobenzyl derivative 2.22 was designed, and it was found to have a superior decaging 
efficiency compared with parent substrate.139,140 The 6-nitroveratryl 2.23 and the related 6-
nitropiperonylmethyl derivative 2.24 were designed to have a redshift of the effective 
irradiation wavelength, but the increased absorbance did not convert to increased decaging 
efficiency, and the quantum yield of 6-nitropiperonylmethyl derivatives were typically one 
order magnitude less than that of o-nitrobenzyl derivatives.114,141 This example reveals 
another challenge when designing a photocage. Namely the increase in absorbance may 
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Figure 2.3. Select examples of o-nitrobenzyl photocages with modification of aromatic 
rings. 
 
Another important example of an o-nitrobenzyl photocage is the nitrodibenzofuran 
(NDBF) photocage. NDBF (2.5) photocage was first reported by Ellis-Davies and 
coworkers in 2006 belongs to the o-nitrobenzyl photocages group.142 Various biological 
applications have been reported utilizing NDBF as the photocage, including solid phase 
peptide synthesis, protein function regulation, fluorescence activation, and Ca2+ controlled 
release.143-148 The first example of NDBF was reported by Ellis-Davies and coworkers, 
wherein NDBF was modified with the EGTA functional group to cage Ca2+ ions (Figure 
2.4).Error! Bookmark not defined. Upon irradiation of light, the EGTA group underwent 
fragmentation that caused the binding affinity for Ca2+ to drop significantly, thus releasing 
free Ca2+. NDBF-EGTA caged Ca2+ was decaged with one-photon (350 nm) irradiation to 
initiate contraction of skinned guinea pig cardiac muscle. Two-photon photolysis was 
demonstrated in intact cardiac myocytes with irradiation at 720 nm. Viht and coworkers 
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dependent protein kinase (PKA) (Figure 2.4).149 After caging with NDBF, the 7DP-Pip 
moiety of a tight binding bisubstrate inhibitor (ARC), the affinity of ATP binding pocket 
and ARC was found to drop over 5 orders of magnitude. The inhibitory effects were 
illustrated in disrupting the PKA holoenzyme in cell lysates upon photolysis with a 398 nm 
LED light. Tampé and coworkers reported a caged glutathione derivative NDBF-GSH in 
spatially and temporally controlled 3D protein structures assemble (Figure 2.4). 150 
Glutathione (GSH) was released upon irradiation with light at 365 nm with one-photon or 
at 730 nm with two-photon to trigger the interactions with glutathione S-transferase (GST) 
tagged proteins, which facilitated the 3D assembly of protein structures. Moreover, 
Distefano and coworkers reported NDBF caged peptide using a cysteine residue that can 
be decaged at 365 nm with one-photon irradiation and two-photon irradiation at 800 nm 
(Figure 2.4).Error! Bookmark not defined. The peptide that is known as the substrate for protein 
farnesyltransferase was released in the presence of enzyme which resulted in the formation 




Figure 2.4. Examples of NDBF photocage in biological studies. 
Modifications on NDBF were also reported to increase the decaging efficiency and 
solubility as well as to extend light absorption range. Substitutions on the aromatic ring 
were found to have impacts on absorption profiles especially the two-photon absorption 
(Figure 2.5). Introduction of the methoxy group at the 4-position in MeO-NDBF extended 
two-photon excitation from about 720 nm to 800 nm in releasing thiol peptides. 151 
Substitution with a dimethyl amino group at the same position in DMA-NDBF redshifted 














































oligonucleotides.152 The substitution of polar functional groups such as carboxyl groups 
on the branch chain of COOH-NDBF increased the solubility of the caged molecules.153 
Moreover, different chromophores derived from NDBF were evaluated in both one-photon 
and two-photon irradiations. The Kobayashi group developed photocage NPBF from 
modifying the chromophore of NDBF, which has a two-photon excitation at 840 nm for 
the release of benzoic acids.154 Moreover, computational studies were also exploited to 
direct the modification strategies.155,156  
 
 





























LG = amino acids
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2.2.3. o-Nitro-(2-phenethyl)ethyl Photocages 
 
Hasan and coworkers developed the o-nitrobenzyl one homologue 2.26, and despite 
the structural similarities, 2.26 has a remarkably different decaging mechanism.157 This 
structural change also resulted in a slight improvement in decaging efficiencies over the o-
nitrobenzyl counterparts. However, the addition of a methyl group to the benzylic position 
as shown in 2.27 led to an increase in the decaging efficiencies. For example, in a decaging 
study of 5’-O-nucleoside carbonates, a substrate caged with 2.26 was decaged with a 
slightly higher quantum yield (Φ = 0.042) than the o-nitrobenzyl photocage (Φ = 0.033) 
(Equation 2.5).158 However, the addition of methyl group at the benzylic position in 2.27 
resulting a 10-fold increase in quantum yield (Φ = 0.35). In addition, with the introduction 
of the methyl group, the decaging byproduct is less reactive with amine, which makes the 






2.26 R = H
2.27 R = Me
o-Nitro-(2-phenylethyl) photocages
λ = 365 nm



























+ + CO2 (2.5)
R = H, Me
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The decaging mechanism for o-nitro-(2-phenethyl)ethyl photocages has not been 
well studied, but the product 2.31 is consistent with the proposed mechanism (Scheme 
2.2).158 The decaging process starts with the irradiation of the starting material 2.28, 
followed by an intramolecular hydrogen abstraction at its excited state generating the aci-
nitro intermediate 2.29. Deprotonation of 2.29 by solvent forms intermediate 2.30, 




Scheme 2.2. Proposed mechanism for o-nitro-(2-phenethyl)ethyl photocages. 
This group of photocages was later modified on its aromatic moiety to extend the 
absorbance, as exemplified by 2-(3,4-methyllenedioxy-6-nitrophenyl)propoxycarbonyl 
2.32.159-161  Further modification of the backbone led to the development of biphenyl 
derivatives 2.33 and 2.34.162,163 The extension of the conjugation system helped extend the 
absorbance into visible light region and the two-photon absorption cross section, which has 
been demonstrated by Winssinger and coworkers.164 However, there is no studies on the 





















Figure 2.6. Select examples of modification of o-nitro-(2-phenethyl)ethyl photocages. 
The introduction of the amino group in 2.34 dramatically increased the aqueous 
solubility for the caged compounds, which is very helpful in biological studies. 2.35 have 
been applied in a recent example of the decaging of neurotransmitter GABA by Donato 
and coworkers (Equation 2.6).163 GABA was released upon irradiation with light at 405 
nm for one-photon and 800 nm for two-irradiation. Released GABA 2.37 was shown to 
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2.2.4 o-Nitroanilides Photocages 
In the 1970s, o-nitroanilide derivative 2.38 was first reported as being photoreactive 
by Amit and Patchornik, and it was able to release carboxylic acids while generating 
different byproducts depending on reaction conditions.165,166 Early mechanistic studies 
revealed the decaging reaction was a rearrangement process instead of a solvolysis. In 
particular, no isotopic incorporation was observed when the decaging was carried out in 
H218O.165 Cyclic derivative 2.39 was later found to be capable of decaging carboxylic acid 
derivative under various conditions except for in alcoholic solvents.167 The size of the 
nitrogen heterocyclic ring was found to be crucial for the reactivity, and five-membered 




Figure 2.7. Select examples of o-nitroanilide photocages 
Corrie, Bochet, and coworkers later reported a detailed study on the reaction 
mechanism of caged substrate 2.42. 168 - 170  The study suggested a photoinduced acyl 
migration from the indoline nitrogen atom to one of oxygen atoms of the nitro group, 
forming the reactive N-O acyl intermediate 2.43. Interestingly, intermediate 2.43 proceed 
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R = Me, Ph, 2-naphthyl
R1 = alkyl, aryl
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2.43 underwent a nucleophilic attack either by the solvent (alcohol or water) or by an 
external nucleophile releasing 2.44 with the formation of byproduct nitroindoline 2.45 
(Scheme 2.3 path A). In water, deprotonation of the α position of the nitrogen released 
carboxylic acid 2.46 with the formation of nitrosoindole product 2.47 (Scheme 2.3 path B). 
Different substitution pattern on the indole aromatic ring has a certain extent of impact on 
the ration of the byproduct formation too.171 
 
 
Scheme 2.3. Divergent reaction pathways for o-nitroanilide photocages in different 
solvents. 
The biological applications of o-nitroanilide photocages are relatively limited, and 
in some cases, they were proved to be inferior compared with o-nitrobenzyl photocages.172 
In neuronal studies reported by Ellis-Davies and Kasai, the 7-nitroindoline was utilized in 
the decaging of glutamate and GABA with two-photon irradiation (Figure 2.8A).173,174 
Caged glutamate 2.49 was photolyzed at 720 nm with two-photon excitation, and neuron 
activities were demonstrated in brain cell slices. Another example is the application in 
photochemical synthesis of peptide.175 Photocage 2.41 (DNI) was attached to the carboxyl 

























2.8B). The photochemical acyl transfer from the DNI to an incoming nucleophilic amino 
group was performed with irradiation at 375 nm. Subsequently, the DDZ group was 
decaged at 300 nm which afforded the dipeptide 2.54.  
  
 





















































2.3 ARYLCARBONYL PHOTOCAGES 
2.3.1 Phenacyl Photocages 
 
The phenacyl photocages are grouped based on their structural similarity. They 
share the phenacyl moiety as the chromophore, and typically the leaving group is attached 
α to the carbonyl group. It is known that minor variations on the photocage substrate can 
lead to completely different decaging mechanistic pathways. Sheehan and coworkers 
reported the first example of phenacyl photocage 2.55 for releasing carboxylates.176 The 
mechanism of the decaging process strongly depends on the leaving group, reaction 
conditions, and solvent. 177 - 180  For example, a mechanism that involves hydrogen 
abstraction from a hydrogen-atom donor by the excited state carbonyl group of phenacyl 
ester via a ketal ester intermediate has been confirmed by laser flash photolysis (Scheme 
2.4A). In the presence of an electron donor, a different mechanism involving electron 
transfer from the donor to the carbonyl, followed by release of the leaving group, can also 
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Scheme 2.4. Mechanisms of phenacyl photocages releasing a leaving group 
Phenacyl photocages typically can efficiently release good leaving groups such as 
carbamates, carbonates, sulfonates, and phosphates. 181  Two different kinds of 
modifications including the substitution α to the carbonyl group such as benzoin 
photocages, as well as the substitution on the aromatic ring such as p-hydroxyphenacyl 
photocages have been made to improve the efficiencies of the photocages. 
2.3.2 Phenacyl Derivative Photocages 
2.3.2.1 Benzoin Photocages 
 
The benzoin cage 2.59, which was first reported by Sheehan in 1970s, can be 
regarded as a phenacyl analogue with aryl substitution on the α-carbon atom.176 The 

























λ = 355 nm
LG = carboxylates, phosphates, amines, and fluorides
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better decaging efficiencies compared with other substituted and unsubstituted phenyl 
groups. The decaging process of carboxylates and phosphates from 2.59 proceeds cleanly 
affording the desired substrate and the benzofuran 2.62. Compared with the nitroso 
products formed from the o-nitrobenzyl photocages, 2.62 is chemically and 
photochemically inert. The decaging proceeds cleanly in both polar and nonpolar solvents, 
and the reaction mechanism was found to be independent of the nature of leaving groups. 
Poor leaving groups such as amines can also be decaged from the benzoin photocages. 
 
 
Scheme 2.5. Decaging mechanism for 3’,5’-dimethoxybenzoin photocage. 
2.3.2.2 p-Hydroxyphenacyl Photocages 
The substitution on the aromatic ring of the phenacyl photocages also has 
significant impacts on the decaging process. Sheehan and Umezawa reported the p-
methoxyphenacyl esters were more photoreactive than unsubstituted phenacyl esters.176 






























aromatic ring were developed and employed in the decaging of good leaving groups such 
as carboxylates, phosphates, carbonates, and carbamates.  
 
 
Other substituents were also utilized in the development of substituted phenacyl 
photocages. One of the interesting examples is the p-hydroxyphenacyl photocage 2.63, 
which was reported by Givens in 1996.182,183 The unique aspect of p-hydroxyphenacyl 
photocage is the decaging mechanism, which is significantly different from the 
photoreduction mechanism for the phenacyl photocages. The decaging process starts with 
the irradiation of 2.63 to generate the excited triplet state 2.63’. Subsequent formation of 
the spiroketone 2.64 and expulsion of the leaving group gives the spiroketone 2.64 which 
is prone to hydrolytic ring opening to deliver p-hydroxyphenyl acetic acid 2.65 (Scheme 
2.6). The process to the generate the spiroketone 2.64 resembles the ground state Favorskii 







λ = 300 nm
LG = phosphates, carboxylates
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Scheme 2.6. Decaging mechanism for p-hydroxyphenacyl photocage 
The decaging typically proceeds with good quantum yield, which is dependent on 
leaving group ability. In general, the quantum yield decreases when the basicity of the 
leaving group increases. The quantum yield is also pH dependent, and the optimal quantum 
yield is typically obtained under neutral or slightly acidic conditions. Unlike the nitroso 
byproducts for o-nitrobenzyl photocages, the acid 2.65 has a drastically different UV 
absorption profile from the ketone 2.63, and it does not interfere the absorbance of the 
starting material 2.63. Moreover, 2.65 is photochemically stable and biologically inert, thus 
making 2.63 a good photocage option for biological studies. The applications of p-
hydroxyphenacyl photocage mainly focus on the time-resolved biochemical and 
physiological studies due to fast decaging rates and benign biological natures of 2.65.181  
2.3.3 Photocages with Photoenolization Decaging Mechanism 
Unlike the phenacyl photocages, this group of photocages are classified based on 


















photoenolization and subsequent ground-state transformation of the enol moiety to release 
the substrate. 
2.3.3.1 2-Alkyl Substituted Acetophenone 
 
Klan and Wirz first reported the caging with 2-alkyl substituted acetophenones, and 
demonstrated the successful decaging of substrates including phosphates, carboxylates, 
sulfonates, carbonates, and carbamates.184-188 With the substitutions on the aromatic ring 
of phenacyl photocages, the decaging mechanism changed dramatically. Upon irradiation, 
2.66 is converted to its singlet excited state 2.67 that can partition in different ways 
(Scheme 2.7). For example, 2.67 could undergo an intersystem crossing forming the triplet 
excited state 2.68, which would be transformed through the 1,5-hydrogen abstraction to 
generate diradical intermediate 2.70, that could further decay to two isomeric enols 2.69 
and 2.71. The (Z)-photoenol 2.69 could also be generated from the singlet state 
intermediate 2.67 via enolization, and subsequently undergo a sigmatropic rearrangement 
to regenerate starting material 2.66. The (E)-photoenol 2.71 would cyclize to afford 2.72 
along with the release of substrate (H-LG). The leaving group is released in an 










Scheme 2.7. Decaging mechanism for 2-methylacetophenone photocages. 
2.3.3.2 Ethylene Substituted Acetophenone Photocages 
Tseng and Ullman reported an alternative strategy on the modification of phenacyl 
photocages by attaching the leaving group to the substituted alkyl branch.189 The decaging 
process starts with the irradiation of 2.73 leading to photoenol intermediate 2.74, which 
then tautomerizes back to its keto form 2.75 while expelling the leaving group. The 
decaging rate is not affected by solvents, but it is usually slow with low decaging 
efficiency. Good decaging efficiencies can be achieved by using good leaving groups such 






























determining and sometimes is competitive with the regeneration of 2.73.141 Modifications 
on 2.73 have been reported, but little success was achieved in increasing decaging 
efficiencies compared with parent photocage 2.73.190 Therefore, the use of this type of 
photocages in biological studies is rare. 
  
 
Scheme 2.7. Decaging mechanism for 2-ethylene substituted lacetophenone photocages. 
2.3.3.3 Intramolecular Lactonization Photocages 
Gudmundsdottir and coworkers demonstrated another type of photocages directly 
decaging alkoxide via a sequence of photoenolization and intramolecular lactonization.191 
Upon irradiation with UV light, 2.76 undergoes photoenolization to generate 2.77 via the 
excited triplet state (Scheme 2.9). A [2+2] cycloaddition of 2.77 will form 
benzocyclobutanol 2.78. Cyclization of 2.78 affords lactone 2.79 along with the release of 
alcohols in high yields. Although the direct release of alcohol substrate is a pretty rare trait 
in photocages, this type of photocage has not been widely used due to the low decaging 














Scheme 2.8. Decaging mechanism for intramolecular lactonization photocage 2.76. 
Steinmetz and coworkers reported a different photocage that may be released by a 
photoenolization process, as exemplified by attaching α to the caged group ketoamide 2.80. 
Upon irradiation of 2.80, the zwitterion 2.81 is formed via photoenolization, and 2.81 
releases leaving group while generating 2.82 and 2.83. The rate determining step was found 
to be the release of substrate, and the decaging process was found to have a pretty good 
quantum yield and efficiency. However, the further modifications to expand the absorbance 






























Scheme 2.9. Decaging mechanism for the intramolecular lactonization photocage 2.80. 
2.4 BENZYL BASED PHOTOCAGES 
Benzyl-based photocages are benzyl substituted structures that release substrates 
via a photosolvolysis pathway (Figure 2.9). Upon irradiation, the starting material 2.84 is 
converted to its excited state 2.85, and subsequent heterolytic cleavage or a sequence of 
homolytic cleavage and single electron transfer generates the benzyl cation as well as an 
anionic leaving group ion pair 2.87. Subsequently, the benzyl cation is trapped by 
nucleophiles, generally solvent (ROH), thus releasing the leaving group 2.89. 
Alternatively, the benzyl cation can recombine with the leaving group, leading to the 
regeneration of starting material 2.84. Given the competitive reaction pathway, the 




Figure 2.9. Decaging mechanism for benzyl based photocages 
A number of photocages with the leaving group at the benzylic position have been 
developed (Figure 2.10). The 9-phenylxanthyl photocage 2.90 was reported to directly 
release alcohol upon irradiation with light at 254–300 nm.194 Modifications of 2.90 with a 
sulfur atom gave the 9-phenylthioxanthyl photocage 2.91, which releases primary alcohols 
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was shown to release alcohols with carbonate linkers and carboxylic acids.196 Applications 
including carbohydrates and nucleoside decaging have been reported. 197  The 3-
(dimethylamino)trityl photocage 2.93 was reported to release primary alcohols at 254 nm 
by Wang and coworkers.198 The major concern is the stability of trityl group in acidic 
conditions, as it has been traditionally used as an acid-labile protecting group in organic 
synthesis. Wang and coworkers later developed 2.94 for caging ketones and 
aldehydes.199,200 Biological applications including neural activation and photogeneration 
























λ = 350 nm
LG = carbonates, and carboxylates
3-(Dimethylamino)trityl photocage 2.93
λ = 254 nm
LG = 1º alcohols
Salicyl derivative photocage 2.94
λ < 320 nm




λ = 350 nm
LG = 1º alcohols
 143 
2.5 COUMARIN PHOTOCAGES 
 
Coumarin derivatives 2.95 were first exploited as photocages by Givens and 
coworkers as a means of releasing phosphates, and this report set the stage for the 
development of a new class of coumarin based photocages. Coumarin based photocages 
have attracted attention due to their superior properties including large absorption 
coefficients at longer wavelength (λmax = 350–475 nm) and fast decaging rates. However, 
disadvantages including limited water solubility and relatively low quantum yields also 
limit their utilization. Great efforts have been made to modify the coumarin based 
photocages to address these limitations, and modified coumarin photocages have proven 
to be powerful tools in various biological studies. 
The decaging mechanism for coumarin photocages is proposed to proceed via a 
heterolytic bond cleavage process from the excited singlet state intermediate 2.97 (Scheme 
2.11).203,204 The excited singlet state 2.97 is generated upon irradiation of 2.96, and 2.97 
can either decay back to the ground state 2.96 via fluorescence and nonradiative 
deactivation or undergo heterolytic cleavage to generate 2.98. It is also possible to generate 
2.98 via a homolytic cleavage of 2.97 followed by single electron transfer; however, 
mechanistic studies have revealed little evidence for this reaction pathway. Once ion pair 
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separated ion pair 2.99. Subsequently, the ion pair 2.99 is captured by solvent generating 
coumarin 2.100 along with the leaving group. 
 
 
Scheme 2.10. Decaging mechanism of coumarin photocages. 
One of the major disadvantages of coumarin photocages is inherent with the 
photosolvolysis decaging mechanism. The generation of ion pairs is offset by the quick 
recombination, especially for poor leaving groups such as alcohols, phenols, amines, and 































Modifications including using carbonate or carbamate linkers have been adopted to 
increase the decaging efficiencies; however, the decomposition of the carbonate and 
carbamate can be slow and become the rate limiting step in the decaging process. Hence, 
coumarin photocages are often used for good leaving groups such as phophates and 
sulfonates, and the release rates are typically fast, thus making them useful photocages for 
studies of fast physiological events.205  
A large number of coumarin derivative photocages have been developed in recent 
years (Figure 2.11). An early example of coumarin derivative photocages was 6-bromo-7-
hydroxycoumarin-4-methyl (BHCM), wherein the bromo substituent lowered the pKa of 
the proximal phenol moiety, thus allowing full deprotonation of the phenol at physiological 
pH. The deprotonation of BHCM results in a dramatic increase of the aqueous solubility 
of caged compounds and also a 50 nm red shift of the max absorbance (λmax = 370 nm) 
compared with MCM (λmax = 320 nm). Further modification such as the introduction of the 
diethylamino group at the 7-position led to the significant increases on decaging 
efficiencies as well as the redshift of the max absorbance wavelength of DEAC. Shortly 
after the report of DEAC, Ellis-Davies and coworkers reported the development of 
DEAC450 which has the maximum absorbance (λmax = 470 nm) in the visible light region 
due to the extended conjugation system. The thio-DEAC was reported to possess a very 
high absorbance in the visible light region with λmax = 470 nm too. Finally, BCMAC 
including DEAC450 were modified with amino-dicarboxylate groups which was intended 
to increase the aqueous solubility of the caged compounds.114 
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Figure 2.11. Select examples of modified coumarin photocages 
Biological application such as decaging small molecule inducer cyclofen in zebra 
fish embryos to induce protein expression have been demonstrated with irradiation of green 
light (λ = 488 nm) (Figure 2.12A).206 Feringa and coworkers illustrated the application of 
photocaged fluoroquinolone 2.103 in controlled bacterial patterning studies (Figure 
2.12B).207 2.103 was incorporated into certain regions of agar-plates, which were then 
irradiated by UV light at 312 nm. The released fluoroquinolone inhibited the growth of E. 
coli that was applied on the same regions of agar-plates. The growth of E. coli outside of 
the regions with 2.103 was found not affected. Moreover, the growth of M. luteus was 
found not affected regardless of what region they were applied, since fluoroquinolone 
2.104 does not show antibacterial effects against M. luteus. 
 
MCM































Figure 2.12. Examples of coumarin caged compounds in biological applications.  
2.6 BODIPY DERIVED PHOTOCAGES 
 
The boron dipyrromethene (BODIPY) derivatives were introduced by Winter and 
Weinstain as photocages that released carboxylic acids by irradiation with green light (λ > 
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carbonates, carbamates, phenols, alcohols, and carbon monoxide.210 ,211,212  It quickly 
became a promising photocage due to the compelling properties including narrow 
excitation bandwidth in visible light region, adaptable synthetic chemistry, and 
biocompatibility.213  The decaging of BODIPY photocages is proposed to occur via a 
photosolvolysis mechanism similar to coumarin photocages (Scheme 2.12). Irradiation of 
2.105 with light generates an excited state species, which undergoes heterolytic cleavage 
to form cation 2.106 along with expulsion of the leaving group anion. Trapping 2.106 by 
solvent generates 2.107. 
 
 
Scheme 2.11. Decaging mechanism for BODIPY photocages. 
A thorough structure-reactivity relationship study was carried out by the 
collaborative work of Weinstain, Winter, and Klán, which provided more insights into the 
modification strategies of BODIPY photocages (Figure 2.13). 214  The substitution of 
halogen atoms on 2,6-position was explored and shown to increase the quantum yield. 
Computation studies by Smith, Winter, and coworkers attributed this result to the increased 
formation of a triplet state intermediate via intersystem crossing process due to the heavy 
atom effect.208 Replacement of the fluorine atoms by alkyl groups were also explored to 
increase the decaging efficiencies, since alkyl groups can help stabilize the carbocation 
intermediate 2.106, which would facilitate the decaging process. Switching from the 






















substitutions with ethyl and phenyl groups decreased the decaging efficiencies. This result 
was rationalized by the distortion of the planarity with the introduction of steric bulky 
groups. Substitution at 3,5-positions with alkyl groups stabilized the intermediate 2.106, 
and increases the decaging efficiency. Extended conjugation with conjugated PMB group 
was found to help redshift absorption, but the decaging efficiencies dropped due the 
decreased quantum yields. 
 
 
Figure 2.13. Modification strategies of BODIPY photocages. 
Another interesting aspect of BODIPY photocages is that leaving groups can be 
attached at different positions (Figure 2.14). Urano and coworkers reported the first 
example of leaving group appended to the boron atom. 215  During their studies of 
fluorescence properties of the 4-aryloxy BODIPY derivative 2.111, they observed cleavage 
of B-O bond after visible light irradiation. Following by their original study, they extended 
the conjugation by synthesizing 2.112, and longer wavelength absorption was achieved 
along with decreasing decaging efficiencies.215 Urano first reported the example of leaving 
groups appended to 2,6 position as in 2.113, wherein fulfonamide groups were found to 
release amines under irradiation of visible light. 216  Zhang and coworkers later took 
advantage of the weak N-O bond of oxime ester and designed photocage 2.114 that was 



























Figure 2.14. Select examples of BODIPY photocages with leaving group at different 
positions. 
2.7 OTHER NOTABLE PHOTOCAGES 
There are other reported photocages that do not belong to any of the classes 
discussed so far, and some notable photocages that undergo decaging under visible light 
irradiation will be discussed (Figure 2.15). 9-Aryl substituted xanthene derivatives are 
generally used as fluorophores that absorb visible light. Klán and Wirz first reported that 
the xanthene derivative 2.115 as the 1:1 complex with DDQ successfully release 
carboxylates and phosphates in aqueous solutions under irradiation of light at 546 nm.220 
Shortly after the original report, a 9-COOH xanthene derivative was shown to successfully 
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2.116 was reported by Kalow to release benzoic acid when irradiated by red light at 626nm, 
and a photocyclization pathway was proposed to explain the decaging process.222 - 224 
Benzothiadiazole derivative 2.117 is an example of photocage that takes advantage of the 
“meta-ortho effect”, and carboxylic acids and alcohols are decaged at 430 nm.225 , 226 
Modification of fluorophore 7-hydroxyquinolines resulted in the development of 
photocage 2.118 which was reported to release amines via carbamate linkers with blue light 
irradiation.227 Methylation of the nitrogen atom reduces the pKa of the hydroxyl group, 
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2.8 SUMMARY OF PHOTOCAGES 
Since the first report of photolytic deprotection of Cbz-glycine, the field of 
photocages have grown dramatically, and various application have been developed in 
different fields of research. A wide variety of photocages with different decaging 
mechanisms have been reported over the past half-century. The demands for photocages in 
biological applications have been the constant driving force for development of new 
photocages, since no one photocage fulfills every requirement in every application. 
However, good photocages usually share the superior properties including fast substrate 
release, good absorbance, adequate aqueous solubility, and good photosensitivity. It is 
important to have a number of photocages, so that an appropriate photocage can be used 
for a given application. 
Some of the most commonly used photocages are shown in Figure 2.16. By far the 
most commonly used photocages are still o-nitrobenzyl derivative photocages 2.4. Despite 
the apparent disadvantage of decaging under UV light, advantages including high decaging 
efficiencies, wide variety of leaving groups, and straightforward chemical synthesis make 
it highly used in various applications. NDBF 2.25 as one of the examples of o-nitrobenzyl 
photocages with superior properties is likely to be used or modified in the future studies. 
The o-nitro-(2-phenylethyl) photocages 2.27 are mechanistically related to o-nitrobenzyl 
photocages, which are shown to be particularly effective at two-photon caging. It is 
demonstrated that 2.34 as an example of this class of photocage has superior two-photon 
caging properties. Moreover, the extension of the conjugation system as well as the 
introduction of solubility handle make it a powerful tool in biological applications such as 
siRNA and peptides decaging. Phenacyl photocages 2.55 and its derivative benzoin 
photocage 2.59 are useful especially in photochemical physiology studies due to their fast 
release rates. However, applications in other fields are relatively limited due to their short 
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decaging wavelengths. Coumarin photocages 2.95 are one of the most promising classes 
of photocages due to their superior properties, including fast rate of decaging, large 
absorbance in visible light region, and fluorescent properties. Currently, modification 
efforts are focused on improving the aqueous solubility as well as further redshift its 
decaging wavelength. DEAC 450 which was reported by Ellis-Davies is a great example 
of successful modification of coumarin photocages, and it has been utilized in studies such 
as orthogonal decaging system. One inherent disadvantage of coumarin photocages is they 
are only applicable for decaging good leaving groups due to its photosolvolysis 
mechanism. BODIPY 2.105 as another example of photosolvolysis photocage is shown to 
be promising as well. The fast decaging rate and absorbance in visible light region makes 
it powerful in numerous biological studies.  
Thanks to all the efforts toward photocage development, various photocages have 
been developed and utilized in biological studies; however, there are still many challenges 
remained to be tackled. Most o-nitrobenzyl photocages photolyze with near-UV light 
around 365 nm, which can cause damage to biological entities in studies.229 Moreover, for 
in vivo studies, the penetration ability of UV light is limited, which would lead to low 
decaging efficiencies for caged compounds. For photosolvolysis photocages such as 
coumarin and BODIPY, caged compounds can typically be photolyzed in visible light 
region; however, due to the photosolvolysis mechanism, bad leaving groups cannot be 
released in good efficiencies. The decaging efficiencies of bad leaving groups such as 
alcohols, phenols can still be improved. Finally, the aqueous solubilities of many 
photocaged compounds are moderate, which limit the utilizations in biological studies. 
To this day, research efforts continue to focus on the development of new classes 
photocages and modification of current photocages to better accommodate biological 
applications. Our group has been interested in this field for some time, and we sought to 
 154 
develop new photocages with better properties. We sought to discover new photocages can 
release substrates in longer wavelengths, ideally visible light region. We want the new 
photocages that release substrates with high efficiencies, even with bad leaving groups. 
Moreover, we want the new photocages with good aqueous solubility, that can be widely 
















































Figure 2.16. Summary of the most commonly used photocages. 
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Chapter 3: Design, Synthesis and Evaluation of Novel Carbazole Based 
Photocages 
3.1 DESIGN OF NOVEL CARBAZOLE PHOTOCAGES 
Different heteroatoms typically have different electronic effects on aromatic 
systems that would result in different UV-vis absorption properties. Wong and coworkers 
reported the study of photophysical and electrochemical properties of different heteroatom 
containing tetraphenylenes including oxygen, nitrogen, sulfur, and selenium atoms (Figure 
3.1). 230  In the UV-vis absorption studies of all the tetraphenylene compounds, the 
incorporation of hetero atoms was shown to redshift the absorption compared with 
tetraphenylene without heteroatom incorporation. Moreover, the nitrogen incorporated 
tetraphenylene displayed the absorption with the longest wavelength among other 
heterocycles. The author attributed the observed redshifts to HOMO-LUMO transitions, 
which was the n-π transition of the lone pair electrons on the oxygen, nitrogen, sulfur, 
selenium atoms to the conjugated π system. Moreover, the conformation of heteroatom 
incorporated tetraphenylenes also played a role in determining the photophysical 
properties. With the knowledge of hetero atom effects on tetraphenylene species, we were 
curious to explore if same effects would apply to dibenzo analogues. If similar effects were 
observed on dibenzo analogues, we would be able to observe the change of UV-vis 
absorption of dibenzo analogues bearing different heteroatoms and potentially discover a 




Figure 3.1. Structures of heteroatoms incorporated tetraphenylenes. 
We first investigated the UV-vis spectra of the carbazole and dibenzofuran 
chromophores (Figure 3.2). We observed carbazole has an absorption band in longer 
wavelength ranging from 300 to 350 nm compared with dibenzofuran. The absorption band 
over 300 nm for carbazole indicated that the proposed carbazole photocages are likely to 



















Figure 3.2. Normalized UV-vis spectra of carbazole and dibenzofuran. 
We attribute the absorption band to the n-π* transition of the lone pair electrons of 
nitrogen atom (Figure 3.3). The electron lone pair on the nitrogen atom is higher in energy 
than that of the electron lone pair of the oxygen atom, because nitrogen is less 
electronegative than oxygen. The energies of π* orbitals are relatively the same for 







transition of carbazole requires longer wavelength irradiation with lower energy compared 
with nitrobenzofuran, which requires shorter wavelength irradiation with higher energy. 
 
 
Figure 3.3. Illustration of n-π* transition of carbazole and dibenzofuran. 
Our lab has been interested in the field of photocage chemistry, and we sought to 
develop novel photocages having better properties. Toward this goal, we designed two new 
o-nitrobenzyl photocages 3.5 and 3.6 with the carbazole chromophore but different 
substitution patterns (Figure 3.4). There has been no study on the effects of different 
substitution pattern, so we sought to get more information about it with our study of 3.5 
and 3.6, which would be insightful for developing new photocages. Moreover, we are 
specifically interested in carbazole chromophores since the carbazole has a free nitrogen 
atom present which provides the possibility for further modification such as introduction 









Figure 3.4. Proposed carbazole based photocages 3.5 and 3.6. 
3.2 SYNTHESIS OF CARBAZOLE PHOTOCAGES 
3.2.1 Synthetic efforts toward photocage 3.5 and 3.6 
The synthesis of the photocage 3.5 commenced with the triflation of 3-nitro-4-
methylphenol (3.7) to give triflic ester 3.8 in quantitative yield (Scheme 3.1). A Buchwald-
Hartwig coupling between 3.8 and aniline generated diaryl amine 3.9 in 94% yield. 
Unfortunately, we found the oxidative ring closure of 3.9 in the presence of Pd(OAc)2 and 
Cu(OAc)2 gave a mixture (1:5) of the desired and undesired carbazole isomers 3.10 and 

















Scheme 3.1. Synthesis toward photocage 3.5. 
With this undesired result, we decided to pursue a different strategy. We 
hypothesized that we could favor the formation of 3.10 in the oxidative coupling reaction 
by blocking the undesired reactive site on the ring by introducing a bromine atom (Scheme 
3.2). Mono-brominated phenol 3.12 was obtained in 84% yield by bromination of 3.7 in 
the presence of tetramethylguanidine. Triflation of 3.12 with triflic anhydride afforded 
brominated triflic ester 3.13 in quantitative yield.  
 
 
Scheme 3.2. Synthesis of brominated triflic ester 3.13. 
We then investigated the generation of diaryl amine 3.15 via the Buchwald-Hartwig 
reaction of 3.13 and 3.14 (Scheme 3.3). We screened numerous combinations of palladium 
















































but no product formation was observed under these conditions. All of reaction conditions 
we screened either only gave returned starting material brominated triflic ester 3.13 or 
resulted in detriflation of 3.13 to give bromophenol 3.12 as the major product. 
 
 
Scheme 3.3. Conditions screening of Buchwald-Hartwig reaction of 3.13. 
Fortunately, we found a recent report that showed the oxidative coupling reaction 
for a nitro-diaryl amine in pivalic acid favored the formation of the desired isomers because 
of steric effects.231 Because pivalic acid coordinates to the nitro group to impede the 
approach of active Pd catalyst to the ortho position of the nitro group, bond formation at 
the para position is favored. Gratifyingly, the oxidative coupling reaction of 3.9 in pivalic 
acid afforded a mixture (1.7:1) of 3.10 and 3.11 in 55% yield (Equation 3.1). Although the 
regioselectivity was not ideal, we obtained a sufficient amount of desired product 3.10, so 














Pd2dba3, BINAP, NaOtBu, toluene, 100 ºC recovered 3.13
Pd2dba3, Davephos, K3PO4, toluene, 60 ºC recovered 3.13
Pd2dba3, Davephos, K3PO4, toluene, 100 ºC recovered 3.12
Pd2dba3, Davephos, NaOtBu, toluene, 100 ºC





We next initiated a study of the oxidation of 3.10 to aldehyde 3.16, but to our 
surprise, the methyl group proved to be unreactive under various conditions (Scheme 3.4). 
Conditions included DDQ oxidation, radical bromination, selenium oxidation, IBX 
oxidation, and chromium oxidation were all screened. Unfortunately, none of the reaction 
conditions delivered the desired product, and most conditions only resulted in returned 
starting material. DDQ oxidation in THF at 45 ºC and IBX oxidation at 80 ºC both 
furnished complex mixtures. Moreover, the radical bromination of 3.10 with NBS and 
































DDQ, THF, 45 ºC
NBS, AIBN, CCl4, hv
NBS, AIBN, CCl4, 80ºC
SeO2, 1,4-dioxane, 80 ºC
CrO3, DMP, DCM, – 20 ºC
IBX, DMSO, 80 ºC












Scheme 3.4. Unsuccessful attempts of the oxidation of 3.10. 
We eventually found the Leimgruber-Batcho reaction with DMF-DMA and 
pyrrolidine in DMF converted 3.10 to an enamine intermediate 3.17, which was then 
cleaved by KMnO4 in THF and H2O to yield aldehyde 3.16 in 37% yield over two steps 
(Scheme 3.5). Finally, the methylation of aldehyde 3.16 afforded the photocage 3.5 in 62% 
yield. Several methylation reagents including methyl magnesium bromide, trimethyl 





Scheme 3.5. Final steps to the synthesis of photocage 3.5. 
We next turned our attention to streamline the synthetic route. We realized the 
sequential cyclization of 3.9 and oxidation of 3.10 gave a relatively low yield with a 
mediocre regioselectivity. Fortunately, we found we could easily oxidize the diaryl amine 




























(Scheme 3.6). The subsequent methylation of 3.17 with trimethyl aluminum afforded 
alcohol 3.18 in 89% yield, and the final cyclization of 3.18 was conducted in pivalic acid 
in the presence of Pd(OAc)2 and Cu(OAc)2 in O2 to furnish a mixture (3:1) of 3.5 and 3.19. 
 
 
Scheme 3.6. Revised sequential steps of synthesis toward photocage 3.5. 
Synthesis of photocage 3.2 was carried out in the same transformation sequence, 
which would be summarized in the next section. 
3.2.2 Summary of synthesis of carbazole photocages 3.5 and 3.6 
The synthesis of photocage 3.5 commenced with 4-nitro-3-methyl phenol 3.7 which 
was converted to its triflic ester 3.8 in quantitative yield (Scheme 3.7). 3.8 was coupled 
with aniline in the presence of Pd(OAc)2 and X-Phos to give diaryl amine 3.9 in 94% yield. 
The subsequent oxidation of 3.9 via a Leimgruber-Batcho reaction to afford aldehyde 3.17 
in 86% yield. Aldehyde 3.17 was then methylated with trimethylaluminum to afford 
alcohol 3.18 in 89% yield. The final oxidative cyclization of 3.18 with Pd(OAc)2 in pivalic 









































Scheme 3.7. Synthesis of photocage 3.5. 
Photocage 3.6 was prepared in an analogous manner (Scheme 3.8). Starting from 
4-nitro-3-methyl phenol (3.20), triflation with triflic anhydride afforded 3.21 in 
quantitative yield. 3.21 was coupled with aniline in the presence of Pd(OAc)2 and X-Phos 
to give diaryl amine 3.22 in 95% yield. The subsequent oxidation of 3.22 via a Leimgruber-
Batcho reaction condition to give aldehyde 3.23 in 80% yield. Aldehyde 3.23 was then 
















































oxidative cyclization of 3.24 with Pd(OAc)2 in pivalic acid afforded photocage 3.6 in five 
steps and 29% overall yield from 3.20. 
 
 
Scheme 3.8. Synthesis of photocage 3.6. 
3.3 BENZOIC ACID MODEL SYSTEM STUDY 
With the novel photocages 3.5 and 3.6 in hand, we next characterized their decaging 
properties in a model system study; we also used a known photocage as a comparison. We 
selected NDBF (3.4) as our comparison target. We conducted the synthesis of NDBF 
according to the literature procedure (Scheme 3.9). 232  Starting from commercially 
available starting material 3.25 and 3.26, Ullmann coupling in the presence of Cu(I) 
afforded diaryl ether 3.27 in 70% yield. Methylation of 3.27 with trimethylaluminum 










































reaction condition to form NDBF in 25% yield. NDBF was obtained in three steps with an 
overall yield of 18%. 
 
Scheme 3.9. Synthesis of photocage NDBF (3.4). 
With NDBF in hand as the benchmark comparison, we investigated decaging 
properties using a benzoic acid model system. Benzoic acid is often picked as the releasing 
target in similar photocage evaluation studies, because it is a good leaving group.233 
Benzoic acid also has a strong UV absorption that can be easily monitored by LC after 
being decaged. Moreover, the chemical “caging” process was straightforward. Benzoate 
esters can be readily formed between benzoic acid and alcohol cages under various 
conditions, and typically the reactions are efficient thus affording target benzoate esters in 
high yield and good purity. Accordingly, we prepared the corresponding benzoate esters 




























The UV-vis spectra of 3.29–3.32 were obtained at different concentrations varying 
from 0.01 mM to 0.1 mM in THF, and the molar absorptivity was calculated and plotted in 




























































absorption than 3.32. Moreover 3.29 has a moderate absorption at 420 nm. Both 3.29 and 
3.30 have larger molar absorptivity values than 3.32 at wavelengths above 350 nm. 
However, 3.31 showed very weak absorption over 300 nm. We rationale this observance 
as the steric interactions between the nitro group and the benzoate group as well as the 




Figure 3.5. UV-vis spectra of photocaged benzoic compounds 3.29–3.32.    
Comparative decaging studies were conducted by irradiating 0.1 mM solutions of 
3.29, 3.30 and 3.32 in THF at 390 nm and 400 nm using a fluorimeter (Figure 3.6). Same 
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decaging study was also performed on 3.31 at 400 nm, but trace amounts of decaging were 
detected. Aliquots were taken every 10 min and analyzed by C18 column on reverse phase 
HPLC using 60% MeCN in water as the eluent. The decaging percentage was calculated 
based on the peak areas of the starting material, benzoic acid and the nitrosoketone product. 
Upon irradiation at 390 nm for 60 min, 87% of 3.29 and 70% of 3.30 were decaged, 
whereas only 42% of the NDBF analog 3.32 was decaged. A similar trend was observed 
upon irradiation at 400 nm where 82% of 3.29 was decaged and 42% of 3.30 was decaged, 
after 60 min; however, decaging of 3.32 was only 22%. These results indicate that our 
newly design photocage 3.5 and 3.6 can release small molecules such as benzoic acids by 
single photon excitation at wavelengths in the visible region more readily than their NDBF 






Figure 3.6. (a) Decaging of 3.29, 3.30 and 3.32 (0.1 mM in THF) at 390 nm was 
measured over time by HPLC. (b) Decaging of 3.29, 3.30 and 3.32 (0.1 mM 
in THF) at 400 nm was measured over time by HPLC.     
Extending the absorption spectrum to longer wavelength is only one goal that needs 
to be addressed when developing new caging molecules. High molar extinction 
coefficients, ε, and quantum yields of decaging, Φ, are also important because together 
these parameters define decaging efficiencies, ε•Φ. The extinction coefficients of 3.29, 
3.30 and 3.32 were determined by UV-vis absorptions at different concentrations according 
to Lambert-Beer’s law, and quantum yields were determined using ferrioxalate actinometer 
as the standard at excitation wavelengths (Table 3.1). 235  In the event, the decaging 
efficiency of 3.29 at 390 nm was 40-fold greater than 3.32, while 3.30 was degaged 25-
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fold more efficiently than 3.32. At 400 nm, 3.29 shows a more superior efficiencies with a 
150-fold increase compared with NDBF-derived compound 3.32, while 3.30 showed 
moderate increase at 20-fold better than 3.32. 















3.29 6105 0.11 672 4490 0.1 449 
3.30 4727 0.09 425 2871 0.02 57 
3.32 572 0.03 17 260 0.01 3 
3.4 TYROSINE DECAGING STUDY 
3.4.1 Introduction of caged tyrosines 
With the successful demonstration of chemical caging and efficient decaging of 
benzoic acids with irradiation of visible light, we next investigated the decaging of different 
substrates with the newly designed photocage 3.5, therefore, expanding the scope of 
decaging substrates of photocage 3.5. As we have discussed previously, o-nitrobenzyl 
photocages are typically efficient at decaging good leaving groups such as carboxylic acids, 
phosphates, carbonates, and carbamates. However, for bad leaving groups such as phenols 
and alcohols, the decaging rates are moderate. The decaging of phenols and alcohols can 
be mitigated using the carbonate linkers, however, as we discussed previously, the 
decomposition of carbonate linkers can sometimes be the rate limiting steps in the decaging 
process. Therefore, a more direct release of phenols and alcohols would be advantageous.  
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Tyrosine phosphorylation is a key step in signal transductions and regulations of 
enzymatic activities. A phosphate (PO43-) group is installed on the phenolic hydroxy group 
of amino acid tyrosine on a protein in the presence of adenosine triphosphate (ATP) 
through tyrosine kinases. Scientists have demonstrated the photocaged tyrosine 
derivatives, which are formed through formation of the phenol ether, can be powerful tools 
in the studies of information transduction. To illustrate the role of individual steps in 
information transduction, both fast reveal of protein phosphorylation sites and rapid protein 
kinase activation are needed. The photolysis of caged tyrosine derivatives meets both 
requirements thus providing the foundation of detailed studies of information transduction. 
Deiters group, Chin group and Schutlz group have reported the collaboration studies of the 
photocontrol of tyrosine phosphorylation process in mammalian cells via genetic encoding 
of photocaged tyrosine.236,237 Caged tyrosine derivative 3.33 was generically encoded into 
proteins in mammalian cells, which was then photolyzed to release a free tyrosine 
derivative upon irradiation of UV light (365 nm) (Figure 3.7). The released tyrosine 
derivative was later phosphorylated in mammalian cells. 
 
 














We decided to showcase the utility of photocage 3.5 by caging tyrosine derivatives. 
o-Nitrobenzyl photocages typically have lower efficiencies releasing phenol derivatives 
than good leaving groups such as carboxylic acids. Improved decaging efficiencies of 
releasing phenols can be a promising trait for new photocages. Moreover, potential 
biological applications with caged tyrosine derivatives could be further developed based 
on these decaging studies of caged tyrosine. 
3.4.2 Synthesis of the caged tyrosine compound 
The first task was to synthesize modified tyrosine substrates. In the event, the Cbz 
protected tyrosine 3.35 was converted to its methyl ester 3.36 in 89% yield according to a 




To make photocage 3.5 more useful in biological applications, further 
modifications are needed to improve its water solubility. To achieve this objective, 
hydrophilic functional groups such as carboxylic acids can be attached to the carbazole 
nitrogen atom. One of the most commonly used hydrophilic groups to increase water 
solubility is the amino dicarboxylate functional group, and it could be readily appended to 
the nitrogen atom of photocage 3.5 via a simple substitution reaction with bromo 













Namely, a solution of 3.37 and t-butyl bromoacetate in the presence of Hunig’s base (N,N-
diisopropylethylamine) in DMF was stirred overnight at room temperature to generate 3.38 




A solution of 3.5 was then treated with NaH at 0 ºC to deprotonate the nitrogen 
atom, and 3.38 was added to generate 3.39 in 73% yield. 
 
 
With 3.39 in hand, we next investigated its reaction with the tyrosine derivative 
3.36. We intended to first convert alcohol 3.39 to its corresponding methanesulfonic ester, 
which would be further substituted with the tyrosine hydroxyl group. However, treatment 
of 3.39 with methanesulfonyl chloride (MsCl) in the presence of Et3N in CH2Cl2 did not 
generate mesylate 3.40, but the chlorine derivative 3.41 was isolated in 55% instead 


























Examples of chlorine derivatives being formed by treating benzyl alcohols with 
tosyl chloride (TsCl) have been reported in literature.240 Similarly, mesylate would be 
possible to be further replaced by chlorides in solutions to generate 3.41. To avoid this side 
reaction, we decided to use mesyl anhydride (Ms2O) instead of mesyl chloride. Ms2O was 
readily prepared by treating methanesulfonic acid with phosphorous pentoxide (P2O5).241 
A solution of 3.39 was treated with Ms2O in the presence of Et3N to furnish 3.40 in 77% 




With 3.40 in hand, we investigated the reaction of 3.40 with 3.36. A solution of 
3.40 and 3.36 containing K2CO3 in DMF was stirred at 80 ºC overnight (Equation 3.11). 
Unfortunately, only trace amounts of 3.41 were observed on LCMS, and the hydrolysis 






























We then turned our attention to the Mitsunobu reaction to form ether 3.41 (Equation 
3.12). We first treated 3.39 and 3.36 with Ph3P and diethyl azodicarboxylate (DEAD) in 
THF at 0 ºC, and the solution was stirred overnight at room temperature. However, only 
unreacted 3.39 was recovered after the reaction. Unreacted 3.38 was also recovered from 
the reaction of 3.39 and 3.36 with Ph3P and DEAD in toluene at room temperature. 
Gratifyingly, a solution of 3.36 and 3.40 in the presence of Bu3P and 1,1’-

















The final deprotection of t-butyl ester group of 3.41 was conducted with the 
treatment of HCl in dioxane to afford 3.42 in 95% yield (Equation 3.13). 
 
 
3.4.3 Decaging studies of caged tyrosine compound 
Decaging studies were conducted by irradiating 0.1 mM solutions of 3.42 in H2O 
at 360, 370, 380, 390, and 400 nm using a fluorimeter over 60 min (Figure 3.8). Aliquots 













3.36, Ph3P, DEAD, THF, 0 ºC to rt recovered 3.39
3.36, Ph3P, DEAD, toluene, rt recovered 3.39

















C18 column using gradients from 0% to 100% MeCN in water over 30 min as the mobile 
phase. Decaging percentages were calculated based on the disappearance of 3.42 and 
appearance of 3.36. We observed 81% of 3.42 was released after 60 min irradiation at 360 
nm. At 370 nm, 63% decaging of 3.42 was observed after 60 min irradiation. For longer 
wavelengths, 45% decaging was detected at 380 nm, 26% at 390 nm, and 16% at 400 nm 
after 60 min respectively.  
 
 
Figure 3.8. Decaging of 3.42 (0.1 mM in H2O) from 360–400 nm was measured over 
time by HPLC.  
The decaging results of the photocaged tyrosine derivative indicate the release of 
bad leaving group phenol derivatives is less efficient than releasing good leaving groups 
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such as carboxylic acids. In order to achieve an ideal decaging outcome (over 80% 
decaging) over 60 min, irradiation at 360 nm was needed. Although, the decaging of 
tyrosine derivatives at wavelengths near visible light region were not as fast as we 
expected, the successful decaging are still promising results for potential applications 
which do not require ultra-fast decaging rates. 
3.5 FLUOROQUINOLONE DECAGING STUDY 
3.5.1 Introduction of fluoroquinolone and its applications with photocages  
With the successful demonstration of decaging benzoic acids and tyrosine 
derivatives, we turned our attention to explore the application of newly designed photocage 
in biological studies.  
Since their discovery in the early 1960s, quinolone derivatives have generated 
considerable clinical and scientific interests owing to their use as antibiotics to treat 
bacterial infections.242 The early modification of introducing a fluorine atom onto the ring 
dramatically increased the potency of quinolone derivatives that were later classified as 
fluoroquinolone derivatives.  Fluoroquinolone antibiotics are widely utilized due to their 
ideal attributes including high potency, good bioavailability, oral and intravenous 
formulation and low side effects. Since the first derivative nalidixic acid was developed in 
1960s, four generations of fluoroquinolones have been developed based on their spectra of 
activities, and multiple derivatives have been marketed since 1960s (Figure 3.9).243 
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The mechanism of action of fluoroquinolone derivatives are well studied.244,245 
Fluoroquinolones function by inhibiting the replication and transcription process of 
bacterial DNA that is required for the proper functioning of the bacteria. During replication 
and transcription, duplex DNA uncoils into a single-stranded structure by the DNA gyrase 
or DNA topoisomerase enzymes. DNA gyrase, which contains two A subunits (gyr A) and 
two B subunits (gyr B), is a critical enzyme to prevent the detachment of gyrase from the 
DNA. Fluoroquinolone derivatives inhibit this enzyme by binding gyr A and prevent 
bacteria from replicating or even synthesizing proteins. 
The structure-activity relationships of quinolone derivatives have been well-
studied. 246  Figure 3.10 shows the core structure of fluoroquinolone derivatives and 
positions that can be modified to manipulate the activities. Among them, positions 2,3 and 
4 are of the great importance. Position 3 must be a carboxyl group and position 4 must be 
an oxygen atom because these groups are essential for gyrase binding and bacterial 
transport. At position 2, a hydrogen atom was found optimal, because any larger group at 
this position creates a disfavored steric hinderance to the adjacent 3 and 4 positions. The 
fluorine at position 6 was one of the earliest modifications, which resulted in a 10-fold 
increase in gyrase inhibition, and 5 to 100-fold improvement in MIC compared with any 
other halogen atoms. Substitutions on positions 1,5 and 7 were found to have moderate 
effects on antibacterial potency. At position 8, a carbon atom and associated substituents 




















Figure 3.10. The structures of quinolone antibiotics. 
As mentioned previously, the presence of a carboxyl group at position 3 is essential 
for the antibacterial effect of fluoroquinolone derivatives. Hence the generation of ester 
with this carboxyl group has been employed as the strategy to suppress the activities. In 
the field of photocage chemistry, photocages were appended to the carboxyl group to 
render it biologically inert. After irradiation, the ester bond was cleaved to release 
fluoroquinolone derivatives with a free carboxyl group which restored antibacterial effects. 
Feringa and coworkers illustrated the application of photocaged fluoroquinolone 3.43 in 
controlled bacterial patterning studies (Figure 3.11A).247 3.43 was incorporated into certain 
regions of agar-plates, which were then irradiated by UV light at 312 nm. The released 
fluoroquinolone inhibited the growth of E. coli that was applied on the same regions of 
agar-plates. The growth of E. coli that was outside of the regions with 3.43 was not affected. 
Moreover, the growth of M. luteus was not affected, regardless of what region they were 
applied, since fluoroquinolone 3.44 does not show antibacterial effects against M. luteus. 
In another example from Feringa, the photocaged fluoroquinolone 3.45 and photocaged 
benzylpenicillin 3.46 were demonstrated in the application of orthogonal control of 
bacterial growth by light (Figure 3.11B).248 3.45 released fluoroquinolone, which can 
inhibit the growth of E. coli upon irradiation of light at 380 nm. 3.46 released 
benzylpenicillin, which can inhibit the growth of S. aureas upon irradiation of light at 312 
nm. When a mixture of 3.45 and 3.46 was added into a mixture solution of E. coli and S. 
aureas. E. coli can be selected out of the mixture by the means of releasing benzylpenicillin 




Figure 3.11. Select examples of photocaged antibiotics. 
We anticipated that our modified photocage 3.39 would be able to effectively cage 
fluoroquinolone via esterification reactions to form 3.48. Subsequently, fluoroquinolone 
3.44 would be liberated from 3.48 with irradiation of visible light around 400 nm. The 



































































a bacterial growth inhibition assay can be conducted with 3.48 to illustrated the potency of 
modified photocage 3.39 in biological studies. 
 
 
Figure 3.12. Proposed bacterial growth inhibition assay with photocaged 
fluoroquinolone. 
3.5.2 Synthesis of the caged fluoroquinolone compound 
We started our investigation by synthesizing a photocaged fluoroquinolone 
antibiotic. Fluoroquinolone 3.44 was first synthesized according to the literature procedure 
(Scheme 3.10).247 Namely, the condensation of 4-fluoroaniline (3.49) with diethyl ethoxy 



































incubate with E. coli




ether was heated under reflux to generate 3.52 in 80% yield. Alkylation of 3.52 with ethyl 
bromide in the presence of K2CO3 in DMF at 80 ºC gave 3.53 in 67% yield. The final 




Scheme 3.10. Synthesis of fluoroquinolone 3.44. 
We next investigated the reaction of the modified photocage 3.39 with 
fluoroquinolone 3.44 to generate 3.48. The ester formation, to our surprise, is not easy to 
promote, and we screened various reaction conditions (Scheme 3.11). We first examined 
the Steglich esterification reaction by treating 3.39 and 3.44 in the presence of 4-













































room temperature, but we only recovered 3.39 and 3.44. Heating the solution of 3.39, 3.44, 
DMAP and DCC in CH2Cl2 under reflux to promote the formation of ester 3.48, but again 
only returned staring material 3.39 was isolated. The same reaction in DMF at 80 ºC 
afforded a complex mixture. We next converted 3.44 to its acid chloride by reacting with 
SOCl2, followed by the addition of photocage 3.39. We were able to confirm the successful 
formation of acid chloride by LCMS, but the acid chloride did not react with 3.48 to give 
3.48 in CH2Cl2 at room temperature or in DMF at 100 ºC. 3.39 was recovered under both 
reaction conditions. We also investigated the Yamaguchi esterification reaction by treating 
3.44 with 3.54 to generate a mixed anhydride followed by the treatment with 3.39; 
however, no product formation was observed, and 3.39 was recovered. Finally, we 
discovered heating the solution of 3.39 and 3.44 in the presence of 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI•HCl) and DMAP in 
DMF at 70 ºC for 24 h furnished desired ester 3.48 in 55% yield. 
 190 
 
Scheme 3.11. Conditions screening of forming caged fluoroquinolone. 
Deprotection of t-butyl ester groups of 3.48 in 4M HCl in dioxane for 8 h afforded 











3.44, DMAP, DCC, CH2Cl2, rt recovered 3.39
3.44, DMAP, DCC, CH2Cl2, reflux recovered 3.39





3.44, SOCl2, cat. DMF, reflux, then 3.34 Et3N, DMAP, CH2Cl2, rt
3.44, SOCl2, cat. DMF, reflux, then 3.34 Et3N, DMF, 100 ºC
3.44, EDCI•HCl, DMAP, DMF, 70 ºC, 24 h


















3.5.3 Decaging studies of the caged fluoroquinolone 
With caged fluoroquinolone 3.55 in hand, we investigated its decaging at 400 nm. 
Decaging studies were conducted by irradiating 0.01 mM solutions of 3.55 in H2O at 400 
nm using a fluorimeter over 12 and 30 min, respectively (Figure 3.13). For 12 min 
irradiation experiment, aliquots were taken every 2 min, and for 30 min irradiation 
experiments, aliquots were taken every 5 min. Aliquots were analyzed using reverse phase 
HPLC with C18 column using gradient eluents from 0% to 100% MeCN in water over 30 
min as the mobile phase. Decaging percentages were calculated based on the disappearance 
of 3.55 and appearance of 3.48. We observed 58% of 3.55 was released after 30 min 
irradiation (Figure 3.13a). 22% decaging of 3.55 was observed after 12 min irradiation 



























Figure 3.13. (a) Decaging of 3.55 (0.01 mM in H2O) at 400 nm over 30 min. (b) 
Decaging of 3.55 (0.01 mM in H2O) at 400 nm over 12 min. 
3.5.4 Bacterial growth inhibition assay 
With the demonstration of successful decaging of fluoroquinolone 3.48 from the 
3.55, we next conducted the bacterial growth inhibition assay. First, we investigated the 
concentration of fluoroquinolone 3.48 that effectively inhibits the growth of E. coli.  
Saturated E. coli solution was prepared by incubating the E. coli (BL21 (de3)) with Luria 
Broth Base medium (5 g/L yeast extract; 10 g/L casein peptone; 10 g/L NaCl) at 37 ºC 
overnight. The overnight cultures of E. coli were diluted with LB medium to an O.D.600 of 
0.1, and 100 μL of this cell suspension was added to 100 μL medium containing antibiotics 
ranging from 1 µM to 4 µM. The control group was set by adding 100 μL of cell suspension 
with an O.D.600 of 0.1 to 100 μL medium without antibiotics. Cells were grown in a 
microtiter plate at 37 °C and cell density (O.D. at 600 nm) was measured every 10 min for 
6 h, with a 15 sec shaking step before each measurement, in a microplate reader. Graphs 
were background-corrected by subtracting the O.D.600 at time. The O.D.600 changes were 
plotted in Figure 3.14. Bacterial growths were partially inhibited at concentrations ranging 
from 1 µM to 3 µM compared with control group, and complete inhibition occurred at 4 
µM (Figure 3.14). 
 194 
 
Figure 3.14. Time curves for growth of E. coli at different concentrations (0, 1, 1.5, 2, 3, 
and 4 µM) of 3.55. 
We investigated the inhibitory effects of the solution of 3.55 after irradiation with 
light at 400 nm. An aqueous solution of 3.55 (0.01 mM) was irradiated at 400 nm, and 100 
μL of aliquots were taken after 1, 2, 5 and 10 min. 100 μL of the cell suspension with an 
O.D.600 of 0.1 in Luria Broth Base medium was added to each of the aliquots taken after 1, 
2, 5 and 10 min irradiation. The control group was set by adding 100 μL of cell suspension 
with an O.D.600 of 0.1 to 100 μL solution of 3.55 (0.01 mM) without irradiation of light. 
Cells were grown in a microtiter plate at 37 °C, and cell density (O.D. at 600 nm) was 
measured every 10 min for 6 h, with a 15 sec shaking step before each measurement, in a 
microplate reader. Graphs were background-corrected by subtracting the O.D.600 at time. 
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The O.D.600 changes were plotted in Figure 3.15. First, no inhibitory effect was observed 
in the control group, where the solution of 3.55 was not irradiated (Figure 3.14 curve 0 
min). The result from the control group indicates after forming the ester 3.55, the 
antibacterial effects of quinolone derivative 3.48 was completely suppressed. Partial 
inhibitory effects were observed for groups with aliquots that were irradiated for 1,2, and 
5 mins at 400 nm (Figure 3.15 curve 1, 2, 5 min). Moreover, complete inhibition was 
observed for the group with aliquots that were irradiated for 10 min (Figure 3.15 curve 10 
min). 
 
Figure 3.15. Time curves for growth of E. coli when incubated with a solution (0.01 mM 
in H2O) of 3.55 that had been irradiated for 1, 2, 5, and 10 min.  
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3.5.5 Summary of caged fluoroquinolone studies 
In summary, we synthesized caged fluoroquinolone 3.55 from modified photocage 
3.39 in two steps. The decaging studies of 3.55 in H2O were conducted to demonstrate the 
efficient release of fluoroquinolone 3.48 at 400 nm. The biological application of 3.55 was 
also demonstrated by the bacterial growth inhibition assay. Antibacterial effects of 3.48 
were suppressed after forming caged fluoroquinolone 3.55. Fluoroquinolone 3.48 was then 
released from 3.55 after irradiation with light at 400 nm, and antibacterial effects were 
restored as demonstrated by the inhibitory effects on the bacterial growth. 
3.6 SUMMARY 
We have successfully developed two new carbazole photocages 3.5 and 3.6 to 
tackle the challenges existing in the field of photocage chemistry. Namely, the challenges 
are decaging of substrates in visible light region, efficiently release poor leaving groups, 
and possess adequate aqueous solubility. We were able to demonstrate the superior 
decaging properties of 3.5 and 3.6 compared with reported NDBF photocage as was 
illustrated by the benzoic acid model system study. Caged benzoic acid 3.29 underwent 
decaging to release benzoic acid at 400 nm with great efficiency. Whereas 3.30 released 
benzoic efficiently at 390 nm. NDBF caged benzoic acid 3.32 only had moderate decaging 
percentage at both 400 and 390 nm over 60 min. Photophysical properties including 
extinction coefficients, ε, quantum yields of decaging, Φ, and decaging efficiencies, ε•Φ. 
of 3.29 and 3.30 both showed improvement compared with NDBF derivative 3.32. To 
demonstrate the ability to release bad leaving groups, modified photocage 3.39 was caged 
with phenol derivatives. A caged tyrosine derivative 3.42 was synthesized and the decaging 
properties were evaluated at wavelength from 360 nm to 400 nm. Efficient decaging was 
achieved at 360 nm over 60 min, and moderate decaging was observed from 370 nm to 400 
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nm over 60 min. Although no kinetic studies of releasing tyrosine have been reported, most 
applications with caged tyrosine were performed in UV light region. The decaging profile 
of 3.42 from 360 to 400 nm provides the foundation for future biological applications with 
caged tyrosine compounds. Lastly, a caged fluoroquinolone was evaluated to demonstrate 
the potency of modified photocage 3.39 in biological applications. Caged fluoroquinolone 
3.55 was successfully synthesized, and decaging properties were evaluated with irradiation 
at 400 nm. The antibacterial effects of caged fluoroquinolone 3.44 were evaluated before 
and after irradiation with E. coli solution. No inhibitory effects were against bacterial 
growth observed before irradiation, and partial to complete inhibitory effects were 
observed after irradiation for 1 min to 10 min. 
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Chapter 4 Experimental Procedures 
4.1 GENERAL EXPERIMENTAL METHODS 
Solvents were purified unless otherwise noted before use as follows. 
Tetrahydrofuran (THF) was dried by filtration through two columns of activated neutral 
alumina prior to use. Acetonitrile (MeCN) was dried by filtration through two columns of 
activated molecular sieves. Toluene was filtered through one column of activated neutral 
alumina and Q5 reactant. Methylene chloride (CH2Cl2), pyridine (pyr.), and triethylamine 
(Et3N) were freshly distilled over CaH2. Trimethylsilyl iodide (TMS-I) was freshly distilled 
prior to use. All other reagents and solvents were reagent grade and were purchased and 
used as received unless otherwise noted. Reactions were performed under a nitrogen or 
argon atmosphere in round-bottom flasks sealed under rubber septa with magnetic stirring, 
unless otherwise noted. Water sensitive reactions were performed with flame-dried 
glassware, stir-bars, and steel needle. Reaction temperatures are reported as the 
temperatures of the bath surrounding the vessel. Sensitive reagents and solvents were 
transferred using plastic syringes and steel needles using standard techniques. 
Proton nuclear magnetic resonance (1H NMR) and carbon nuclear magnetic 
resonance (13C NMR) spectra were acquired in CDCl3 unless otherwise noted. Chemical 
shifts are reported in parts per million (ppm, δ), downfield from tetramethylsilane (TMS, 
δ=0.00ppm) and are referenced to residual solvent (CDCl3, δ = 7.26 ppm (1H) and 77.16 
ppm (13C)). Coupling constants (J) are reported in hertz (Hz) and the resonance multiplicity 
abbreviations used are: s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; dt, doublet of 
triplets; dd, doublet of doublets; ddd, doublet of doublet of doublets; dddd, doublet of 
doublet of doublet of doublets; m, multiplet; comp, overlapping multiplets of magnetically 
non-equivalent protons. The abbreviation br stands for broad. Infrared (IR) spectra were 
 199 
obtained with a thermo scientific Nicolet 380 spectrometer. Thin-layer chromatography 
(TLC) was performed on EMD 60 F254 glass-backed pre-coated silica gel plates and were 
visualized using one or more of the following methods: UV light (254 nm) and staining 
with basic potassium permanganate (KMnO4) acidic p-anisaldehyde (PAA) or CAM. Flash 
chromatography was performed using glass columns and with Silicycle® SiliaFlash F60® 
(40-63 μm) silica gel eluting with the solvents indicated according to the procedure of 
Still.249  
Methyl (E)-3-methoxybut-2-enoate is commercially available from Synthonix or 
can be prepared according to literature procedure. 250  p-Toluenesulfonyl azide was 
prepared according to the literature procedure and the 1H and 13C spectra were consistent 
with those previously reported. 251 
4.2 EXPERIMENTAL PROCEDURES FOR CHAPTER 1 
 
 
2,2-Dimethyl-3-((triethylsilyl)oxy)propanoic acid (1.30). zw-4-meli1. Et3SiCl 
(6.700 g, 44.45 mmol) was added to a solution of hydroxy pivalic acid (1.22) (5.000 g, 
42.33 mmol) in pyridine (100 mL) at 60 ºC. The solution was stirred at 60 ºC for 8 h. After 
cooling to room temperature, the solvent was removed under reduced pressure. The residue 
was dissolved in CH2Cl2 (100 mL), washed with 1 N HCl solution (3 x 50 mL), H2O (3 x 
50 mL), and brine (50 mL). The organic fraction was dried (Na2SO4), filtered, and 
concentrated under reduced pressure to give crude 1.30 as colorless oil. The crude material 
was purified via flash column chromatography eluting hexanes : EtOAc (10:1) to give 





(s, 6 H), 0.96 (t, J = 8.0 Hz, 9 H), 0.62 (q, J = 8.0 Hz, 6 H); 13C NMR (126 MHz, CDCl3) 
δ 188.6, 174.7, 138.7, 125.5, 97.9, 55.5, 20.0; IR (neat) νmax 2957, 1703, 1101, 904, 818, 
725 cm-1; HRMS (ESI) m/z calcd for C11H24O3SiNa+ (M+Na)+, 255.1387; found 255.1390. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 3.60 (s, 2 H, C1-H), 1.19 (s, 6 
H, C2-H), 0.96 (t, J = 8.0 Hz, 9 H, Et3Si), 0.62 (q, J = 8.0 Hz, 6 H, Et3Si). 
 
 
Methyl 4,4-dimethyl-3-oxo-5-((triethylsilyl)oxy)pentanoate (1.31). zw-4-meli2. 
Carbonyl diimidazole (CDI) (2.698 g, 16.64 mmol) was added to the solution of 1.30 
(3.516 g, 15.13 mmol) in THF (50 mL). The solution was stirred at room temperature for 
1 h. In a separate flask, i-PrMgBr (16.64 mL, 49.93 mmol) was added dropwise to a 
solution of monomethyl malonate (2.680 g, 22.70 mmol) in THF (50 mL) at 0 ºC. The 
solution was stirred at 0 ºC for 30 min, room temperature for 30 min and 45 ºC for 1 h. The 
solution of monomethyl malonate dianion was added dropwise to the solution of acyl 
imidazolide at 0 ºC, and the resulting mixture was stirred overnight at room temperature. 
Aqueous 10% citric acid (30 mL) was added, and the aqueous layer was separated and 
extracted with CH2Cl2 (3 x 30 mL). The combined organic fractions were washed with 
H2O (3 x 30 mL) and brine (30 mL), dried (Na2SO4), and concentrated under reduced 
















column chromatography eluting hexanes : CH2Cl2 (5:1) to give 2.706 g (62%) mixture of 
1.31 as a mixture (3.5:1) of keto-enol tautomers as colorless oil. 1H NMR (500 MHz, 
CDCl3) δ 12.24 (s, 0.22 H), 5.09 (s, 0.22 H), 3.73 (s, 0.66 H), 3.72 (s, 2.34 H), 3.62 (s, 1.56 
H), 3.57 (s, 1.56 H), 3.54 (s, 0.44 H), 1.13 (s, 4.7 H), 1.10 (s, 1.3 H), 0.96-0.91 (comp, 9), 
0.61-0.53 (comp, 6 H); 13C NMR (126 MHz, CDCl3) δ 207.7, 183.6, 173.6, 168.5, 87.7, 
70.0, 69.3, 52.3, 51.3, 50.1, 45.9, 42.5, 22.3, 21.4, 6.87, 6.85, 4.5, 4.4; IR (neat) νmax 2955, 
1746, 1709, 1437, 1321, 1239, 1146, 1098, 1005, 906, 804, 727 cm-1; HRMS (ESI) m/z 
calcd for C14H28O4SiNa+ (M+Na)+, 311.1649; found 311.1659. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 12.24 (s, 0.22 H, -OH), 5.09 (s, 
0.22 H, C3’-H), 3.73 (s, 0.66 H, C5’-H), 3.72 (s, 2.34 H, C5-H), 3.62 (s, 1.56 H, C1-H or 
C3-H), 3.57 (s, 1.56 H, C1-H or C3-H), 3.54 (s, 0.44 H, C1’-H), 1.13 (s, 4.7 H, C2-H), 1.10 
(s, 1.3 H, C2’-H), 0.96-0.91 (comp, 9 H, Et3Si), 0.61-0.53 (comp, 6 H, Et3Si). 
 
 
Methyl 2-diazo-4,4-dimethyl-3-oxo-5-((triethylsilyl)oxy)pentanoate (1.32). zw-
4-meli3. Et3N (1.546 g, 15.28 mmol) was added dropwise to the solution of 1.31 (2.204 g, 
7.64 mmol) and TsN3 (2.260 g, 11.46 mmol) in MeCN (35 mL) at 0 ºC. The solution was 
stirred at room temperature for 12 h, whereupon 10% aq. NaOH (30 mL) was added. The 

























were washed with H2O (3 x 30 mL) and brine (30 mL). The organic fraction was dried 
(MgSO4), filtered and concentrated under reduced pressure to give crude 1.32 as yellow 
oil. The crude material was purified via flash column chromatography eluting hexanes : 
CH2Cl2 (10:1 to 5:1) to give 2.162 g (90%) of 1.32 as yellow oil. 1H NMR (500 MHz, 
CDCl3) δ 3.81 (s, 2 H), 3.80 (s, 3 H), 1.26 (s, 6 H), 0.91 (t, J = 8.0 Hz, 9 H), 0.55 (q, J = 
8.0 Hz, 6 H); 13C NMR (126 MHz, CDCl3) δ 195.6, 161.8, 68.3, 52.3, 50.4, 21.4, 6.8, 4.4; 
IR (neat) νmax 2955, 2877, 1704, 1365, 1230, 1098, 1004, 816, 726, 672 cm-1; HRMS (ESI) 
m/z calcd for C14H26N2O4SiNa+ (M+Na)+, 337.1554; found 337.1565. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 3.81 (s, 2 H, C1-H), 3.80 (s, 3 




Methyl 2-diazo-4,4-dimethyl-3,5-dioxopentanoate (1.20). zw-4-meli4. IBX 
(7.479 g, 26.71 mmol) was added to a solution of 1.32 (2.100 g, 6.678 mmol) in DMSO 
(40 mL) and H2O (601.7 mg, 33.39 mmol) at room temperature, and the solution was stirred 
overnight at room temperature. The reaction mixture was partitioned between Et2O (30 
mL) and H2O (30 mL), and the organic layer was separated and washed with H2O (3 x 20 
















to give crude 1.20 as yellow oil. The crude material was purified via flash column 
chromatography eluting hexanes : EtOAc (7:1) to give 1.178 g (89%) of 1.20 as yellow oil. 
1H NMR (500 MHz, CDCl3) δ 9.59 (s, 1 H), 3.79 (s, 3 H), 1.39 (s, 6 H); 13C NMR (126 
MHz, CDCl3) δ 200.4, 191.2, 161.7, 57.7, 52.5, 20.7; IR (neat) νmax 2149, 1716, 1650, 
1439, 1320, 1130, 1011, 905, 727 cm-1; HRMS (ESI) m/z calcd for C8H10N2O4Na+ 
(M+Na)+, 221.0533; found 221.0537. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 9.59 (s, 1 H, CHO), 3.79 (s, 3 




oxo-7-oxabicyclo[2.2.1]heptane-1-carboxylate (1.59). az-3-206-1. A solution of 1.20 (20 
mg, 0,10 mmol), 1.58 (21 mg, 0.12 mmol) and Rh2(OPiv)4 (1.2 mg, 0.0020 mmol) in 
toluene (1.5 mL) was stirred under reflux under N2 for 1 h. The solution was cooled to rt, 
diluted with CH2Cl2 (1 mL), washed with H2O (3 X 1mL) and brine (1 mL), dried 
(Na2SO4), filtered and concentrated in vacuo to give crude 1.20 as white solid. The crude 
material was purified via flush column chromatography eluting hexanes : EtOAc (8:1) to 
give 20 mg (58%) 1.59 as white solid. 1H NMR (500 MHz, CDCl3-d) δ 4.23 (d, 1 H, J = 



















Hz), 2.05-1.95 (comp, 2 H), 1.90 (dd, 1 H, J = 14.5, 2.8 Hz), 1.68 (dd, 1 H, 14.5, 9.5 Hz), 
1.26 (s, 3 H), 1.20 (s, 3 H), 1.07 (s, 3 H). 13C NMR (500 MHz, CDCl3-d) δ 208.5, 167.4, 
108.5, 88.6, 84.0, 73.0, 64.8, 64.3, 55.5, 52.5, 49.8, 49.6, 42.1, 24.7, 24.4, 18.0.   
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3-d) δ 4.23 (d, 1 H, J = 5.4 Hz, C10-
H), 3.90-3.84 (m, 4 H, C16-H), 3.76-3.73 (m, 4 H, C7-H and C11-H), 3.00 (s, 3 H, C12-
H), 2.71 (dd, 1 H, J = 11.0, 5.4 Hz, C8-H), 2.05-1.95 (comp, 2 H, C9-H), 1.90 (dd, 1 H, J 
= 14.5, 2.8 Hz, C13-H), 1.68 (dd, 1 H, 14.5, 9.5 Hz, C13-H), 1.26 (s, 3 H, C15-H), 1.20 (s, 
3 H, C1-H or C2-H), 1.07 (s, 3 H, C1-H or C2-H). 13C NMR (500 MHz, CDCl3-d) δ 208.5 
(C4), 167.4 (C6), 108.5 (C14), 88.6 (C5), 84.0 (C10), 73.0 (C11), 64.8 (C16 or C17), 64.3 
(C16 or C17), 55.5 (C12), 52.5 (C7), 49.8 (C3), 49.6 (C8), 42.1 (C13), 24.7 (C15), 24.4 




















































oxo-7-oxabicyclo[2.2.1]heptane-1-carboxylate (1.62). az-3-225-3. A solution of 1.20 (24 
mg, 0.12 mmol), 1.57 (23 mg, 0.14 mmol) and Rh2OAc4 (1.1 mg, 0.0024 mmol) in CH2Cl2 
(1 mL) was stirred under reflux for 3 h. The solution was cooled to rt, washed with H2O (3 
X 1 mL) and brine, dried (Na2SO4), filtered and concentrated in vacuo to give crude 1.62 








hexanes : EtOAc (7:1) to give 18 mg (45%) 1.62 as colorless oil. 1H NMR (500 MHz, 
CDCl3-d) δ 4.56 (s, 1 H), 3.94 (s, 4 H), 3.88 (dt, 1 H), 3.78 (s, 3 H), 3.69 (t, 1 H), 1.96 (dd, 
1 H), 1.80 (d, 1 H), 1.60 (m, 2 H), 1.28 (s, 3 H), 1.23 (s, 3 H), 1.04 (s, 3 H). 13C NMR (500 
MHz, CDCl3-d) δ 210.9, 166.5, 110.2, 88.5, 85.5, 69.0, 64.7, 64.7, 64.4, 52.8, 48.6, 42.3, 
32.3, 23.3, 19.6. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3-d) δ 4.56 (s, 1 H, C10-H), 3.94 (s, 
4 H, C15-H), 3.88 (dt, 1 H, C11-H), 3.78 (s, 3 H, C7-H), 3.69 (t, 1 H, C8-H), 1.96 (dd, 1 
H, C9-H), 1.80 (d, 1 H, C12-H), 1.60 (m, 2 H, C9-H and C12-H), 1.28 (s, 3 H, C14-H), 
1.23 (s, 3 H, C1-H or C2-H), 1.04 (s, 3 H, C1-H or C2-h). 13C NMR (500 MHz, CDCl3-d) 
δ 210.9 (C4), 166.5 (C6), 110.2 (C13), 88.5 (C5), 85.5 (C10), 69.0 (C8), 64.7 (C15 or C16), 
64.7 (C15 or C16), 64.4 (C11), 52.8(C7), 48.6 (C3), 42.3 (C12), 32.3 (C9), 23.3 (C1 or 
C2), 19.6 (C1 or C2). 
 
 
Preparation of 1.64, 1.65, and 1.66. A solution of 1.20 (50 mg, 0.26 mmol), 1.63 
(50 mg, 0.32 mmol) and Rh2OAc4 (2.2 mg, 0.0052 mmol) in CH2Cl2 (2 mL) was stirred 











































1 mL) and brine (1 mL), dried (Na2SO4), filtered and concentrated in vacuo to give crude 
mixture of 1.64, 1.65 and 1.66 as colorless oil. The crude material was purified via flush 
column chromatography eluting hexanes : EtOAc (5:1) to give 30 mg (35%) 1.64, 3.4 mg 




oxo-7-oxabicyclo[2.2.1]heptane-1-carboxylate (1.64). az-3-245-3. 1H NMR (500 MHz, 
CDCl3-d) δ 4.41 (d, 1 H, J = 5.4 Hz), 3.91-3.88 (m, 4 H), 3.76 (s, 3 H), 3.36 (dd, 1 H, J = 
9.4, 6.4 Hz), 2.74 (s, 2 H), 2.32 (dd, 1 H, J = 12.7, 9.4 Hz), 1.94 (td, 1 H, J = 12.2, 5.9 Hz), 
1.31 (s, 3 H), 1.22 (s, 3 H), 1.05 (s, 3 H). 13C NMR (500 MHz, CDCl3-d) δ 209.0, 203.2, 




NMR Assignment. 1H NMR (500 MHz, CDCl3-d) δ 4.41 (d, 1 H, J = 5.4 Hz, C9-
H), 3.91-3.88 (m, 4 H, C14-H), 3.76 (s, 3 H, C6-H), 3.36 (dd, 1 H, J = 9.4, 6.4 Hz, C7-H), 
2.74 (s, 2 H, C11-H), 2.32 (dd, 1 H, J = 12.7, 9.4 Hz, C8-H), 1.94 (td, 1 H, J = 12.2, 5.9 
Hz, C8-H), 1.31 (s, 3 H, C13-H), 1.22 (s, 3 H, C1-H or C2-H), 1.05 (s, 3 H, C1-H or C2-


























90.1 (C4), 83.6 (C9), 64.8 (C14), 64.7 (C15), 52.7 (C6), 51.4 (C7), 51.2 (C11), 48.9 (C16), 




























































oxo-7-oxabicyclo[2.2.1]heptane-1-carboxylate (1.65). az-3-245-2-1. 1H NMR (500 
MHz, CDCl3-d) δ 4.33 (d, 1 H, J = 4.9 Hz), 3.92-3.86 (m, 4 H), 3.78 (s, 3 H), 3.64 (dd, 1 
H, J = 10.4, 5.7 Hz), 3.13 (d, 1 H, J = 14.0 Hz), 2.79 (d, 1 H, J = 14.0 Hz), 2.20-2.13 (m, 
2 H), 1.32 (s, 3 H), 1.24 (s, 3 H), 1.19 (s, 3 H). 13C NMR (500 MHz, CDCl3-d) δ 207.8, 
205.8, 166.5, 108.0, 90.7, 84.9, 64.8, 64.4, 54.4, 53.05, 53.01, 50.0, 30.4, 24.4, 24.1, 18.3.  
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3-d) δ 4.33 (d, 1 H, J = 4.9 Hz, C9-
H), 3.92-3.86 (m, 4 H, C14-H and C15-H), 3.78 (s, 3 H, C6-H), 3.64 (dd, 1 H, J = 10.4, 5.7 
Hz, C7-H), 3.13 (d, 1 H, J = 14.0 Hz, C11-H), 2.79 (d, 1 H, J = 14.0 Hz, C11-H), 2.20-
2.13 (m, 2 H, C8-H), 1.32 (s, 3 H, C13-H), 1.24 (s, 3 H, C1-H or C2-H), 1.19 (s, 3 H, C1-
H or C2-H). 13C NMR (500 MHz, CDCl3-d) δ 207.8 (C3), 205.8 (C10), 166.5 (C5), 108.0 
(C12), 90.7 (C4), 84.9 (C9), 64.8 (C14), 64.4 (C15), 54.4 (C7), 53.05 (C11), 53.01 (C6), 




















































oxabicyclo[2.2.1]heptane-1-carboxylate (1.66). az-3-245-2-2. 1H NMR (500 MHz, 
CDCl3-d) δ 4.61 (s, 1 H), 3.92-3.88 (m, 4 H), 3.78 (s, 3 H), 3.24 (dd, 1 H, J = 9.0, 4.6 Hz), 
2.86 (d, 1 H, J = 13.9 Hz), 2.79 (d, 1 H, J = 13.9 Hz), 2.62 (ddd, 1 H, J = 13.9, 4.6, 1.2 









(500 MHz, CDCl3-d) δ 209.4, 203.3, 165.8, 108.0, 88.3, 85.7, 64.7, 64.6, 52.9, 50.6, 49.9, 
48.8, 30.3, 24.4, 23.0, 19.9. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3-d) δ 4.61 (s, 1 H, C9-H), 3.92-3.88 
(m, 4 H, C14-H and C15-H), 3.78 (s, 3 H, C6-H), 3.24 (dd, 1 H, J = 9.0, 4.6 Hz, C8-H), 
2.86 (d, 1 H, J = 13.9 Hz, C11-H), 2.79 (d, 1 H, J = 13.9 Hz, C11-H), 2.62 (ddd, 1 H, J = 
13.9, 4.6, 1.2 Hz, C7-H), 1.99 (dd, 1 H, J = 13.6, 9.0 Hz, C7-H), 1.34 (s, 3 H, C13-H), 1.26 
(s, 3 H, C1-H or C2-H), 1.10 (s, 3 H, C1-H or C2-H). 13C NMR (500 MHz, CDCl3-d) δ 
209.4 (C3), 203.3 (C10), 165.8 (C5), 108.0 (C12), 88.3 (C4), 85.7 (C9), 64.7 (C14), 64.6 
(C15), 52.9 (C6), 50.8 (C8), 49.9 (C11), 48.8 (C16), 30.3 (C7), 24.4 (C13), 23.0 (C1 or 













































































oxabicyclo[2.2.1]heptane-1-carboxylate (1.73). az-3-291. A solution of 1.20 (30 mg, 
0.15 mmol), 1.72 (21 mg, 0.18 mmol) and Rh2OAc4 (1.3 mg, 0.0030 mmol) in CH2Cl2 (1 
mL) was stirred under reflux under N2 for overnight. The solution was cooled to rt, washed 
with H2O (3 X 1 mL) and brine (1 mL), dried (Na2SO4), filtered and concentrated in vacuo 
to give crude 1.73 as colorless oil. The crude material was purified via flush column 










1H NMR (500 MHz, CDCl3) δ 4.47 (d, J = 5.3 Hz, 1 H), 3.84 (s, 3 H), 3.71 (s, 3 H), 3.39 
(t, J = 7.7 Hz, 1 H), 3.17 (s, 3 H), 2.45 (dd, J = 12.9, 9.2 Hz, 1 H), 2.02 (dt, J = 12.3, 5.8 
Hz, 1 H), 1.30 (s, 3 H), 1.12 (s, 3 H). 13C NMR (126 MHz, CDCl3) δ 209.5, 171.5, 165.6, 
90.2, 83.5, 61.4, 52.7, 48.9, 42.4, 32.3, 31.7, 23.2, 20.1. HRMS (ESI) m/z calcd for 
C13H19NO6Na+ (M+Na)+, 308.1105; found 308.1114.  
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 4.47 (d, J = 5.3 Hz, 1 H, C9-H), 
3.84 (s, 3 H, C12-H), 3.71 (s, 3 H, C6-H), 3.39 (t, J = 7.7 Hz, 1 H, C7-H), 3.17 (s, 3 H, 
C11-H), 2.45 (dd, J = 12.9, 9.2 Hz, 1 H, C8-H), 2.02 (dt, J = 12.3, 5.8 Hz, 1 H, C8-H), 1.30 
(s, 3 H, C1-H or C2-H), 1.12 (s, 3 H, C1-H or C2-H). 13C NMR (126 MHz, CDCl3) δ 209.5 
(C3), 171.5 (C10), 165.6 (C5), 90.2 (C4), 83.5 (C9), 61.4 (C12), 52.7 (C6), 48.9 (C13), 



































































Figure 4.8. Key NOESY correlations of 1.73. 
 
 
(E)-N,3-Dimethoxy-N-methylbut-2-enamide (1.80). zw-4-meli5. 
MeO(Me)NH•HCl (5.170 g, 53.00 mmol) and trimethylaluminum (17.67 mL, 35.34 mmol) 
were slowly added sequentially to a solution of 1.79 (2.300 g, 17.67 mmol) in CH2Cl2 (50 
mL) at 0 ºC. The solution was transferred to an oil bath preheated to 40 ºC and stirred for 
4 h. The reaction was then cooled to 0 °C, and H2O (10 mL) and saturated aqueous Rochelle 
salt (30 mL) were added. The ice-bath was removed, and the resulting mixture was stirred 







the combined organic fractions were dried (Na2SO4), filtered and concentrated under 
reduced pressure to give crude 1.80 as colorless oil. The crude material was purified via 
flash column chromatography eluting hexanes : EtOAc (5:1 to 3:1) to give 1.969 g (70%) 
of 1.80 as colorless oil. 1H NMR (500 MHz, CDCl3) δ 5.52 (s, 1 H), 3.64 (s, 3 H), 3.60 (s, 
3 H), 3.15 (s, 3 H), 2.26 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 171.9, 169.0, 88.6, 61.2, 
55.1, 32.4, 18.9; IR (neat) νmax 1738, 1650, 1366, 1233, 1217, 906, 839, 725 cm–1; HRMS 
(ESI) m/z calcd for C7H14NO3+ (M+H)+, 160.0968; found 160.0970. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 5.52 (s, 1 H, C4-H), 3.64 (s, 3 
H, C2-H or C7-H), 3.60 (s, 3 H, C2-H or C7-H), 3.15 (s, 3 H, C6-H), 2.26 (s, 3 H, C1-H).  
 
 
(E)-5-Methoxyhexa-1,4-dien-3-one (1.18). zw-4-meli6. Vinyl magnesium 
bromide (42.31 mL, 29.62 mmol) was added dropwise to a solution of 1.80 (1.570 g, 9.862 
mmol) in THF (50 mL) at 0 ºC, and the resulting solution was stirred overnight at room 
temperature. The reaction mixture was poured into saturated aqueous NH4Cl (30 mL) at 0 
ºC. The resulting mixture was extracted with CH2Cl2 (3 x 20 mL). The combined organic 
extracts were dried (Na2SO4), filtered and concentrated under reduced pressure to give 
crude 1.18 as yellow oil. The crude material was purified via flash column chromatography 















MHz, CDCl3) δ 6.35 (dd, J = 17.4, 10.5 Hz, 1 H), 6.12 (d, J = 17.4 Hz, 1 H), 5.59 – 5.54 
(comp, 2 H), 3.63 (s, 3 H), 2.28 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 188.6, 174.7, 
138.7, 125.5, 97.9, 55.5, 20.0; IR (neat) νmax 1617, 1570, 1403, 1266, 1172, 1117, 1062, 




NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 6.35 (dd, J = 17.4, 10.5 Hz, 1 
H, C6-H), 6.12 (d, J = 17.4 Hz, 1 H, C7-H trans), 5.59 – 5.54 (comp, 2 H, C4-H and C7-
H cis), 3.63 (s, 3 H, C2-H), 2.28 (s, 3 H, C1-H). 
 
	
Preparation of 1.81, 1.82, 1.83. A solution of 9 (400 mg, 3.17 mmol), 11 (571 mg, 
2.89 mmol) and Rh2(HNAc)4 (25.3 mg, 0.0578 mmol) in toluene (10 mL) was stirred at 
100 ºC for 1 h. The reaction was cooled to room temperature, and the solvent was removed 
under reduced pressure. The residue was dissolved in CH2Cl2 (5 mL), which was washed 
with H2O (3 x 5 mL) and brine (5 mL). The solution was dried (Na2SO4), filtered and 
concentrated under reduced pressure to give crude mixture of 1.81, 1.82 and 1.83 as yellow 




























EtOAc (8:1) to give 522 mg (61%) of 1.81 as white solid: mp 117–121 ºC, 32.2 mg (4%) 




oxabicyclo[2.2.1]heptane-1-carboxylate (1.81). zw-4-meli7. 1H NMR (500 MHz, 
CDCl3) δ 5.38 (s, 1 H), 4.48 (d, J = 5.3 Hz, 1 H), 3.80 (s, 3 H), 3.64 (s, 3 H), 3.09 (dd, J = 
9.3, 6.3 Hz, 1 H), 2.39 (dd, J = 12.9, 9.3 Hz, 1 H), 2.25 (s, 3 H), 2.11 – 2.02 (m, 1 H), 1.28 
(s, 3 H), 1.10 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 209.1, 194.3, 175.6, 165.7, 97.0, 
90.5, 83.7, 55.9, 52.7, 52.6, 49.0, 31.1, 23.1, 20.21, 20.17; IR (neat) νmax 2364, 1736, 1580, 
1439, 1265, 1113, 1045, 733, 703 cm-1; HRMS (ESI) m/z calcd for C15H21O6+ (M+H)+, 
297.1333; found 297.1339.  
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 5.38 (s, 1 H, C11-H), 4.48 (d, J 
= 5.3 Hz, 1 H, C3-H), 3.80 (s, 3 H, C8-H), 3.64 (s, 3 H, C13-H), 3.09 (dd, J = 9.3, 6.3 Hz, 
1 H, C5-H), 2.39 (dd, J = 12.9, 9.3 Hz, 1 H, C4-H endo), 2.25 (s, 3 H, C14-H), 2.11 – 2.02 
(m, 1 H, C4-H exo), 1.28 (s, 3 H, C2-H), 1.10 (s, 3 H, C1-H). 13C NMR (126 MHz, CDCl3) 
δ 209.1 (C9), 194.3 (C10), 175.6 (12), 165.7 (C7), 97.0 (C11), 90.5 (C6), 83.7 (C3), 55.9 
(C13), 52.7 (C5 or C8), 52.6 (C5 or C8), 49.0 (C15), 31.1 (4), 23.1 (C1), 20.21 (C2 or 






























































oxabicyclo[2.2.1]heptane-1-carboxylate (1.82). zw-4-meli8. 1H NMR (500 MHz, 
CDCl3) δ 5.72 (s, 1 H), 4.38 (d, J = 5.6 Hz, 1 H), 3.83 (s, 3 H), 3.69 (s, 3 H), 3.48 (dd, J = 
11.2, 4.6 Hz, 1 H), 2.36 (dd, J = 12.7, 4.6 Hz, 1 H), 2.27 (s, 3 H), 2.21 (ddd, J = 12.7, 11.2, 
5.6 Hz, 1 H), 1.31 (s, 3 H), 1.29 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 208.5, 194.8, 




















1747, 1583, 1440, 1264, 1114, 1061, 896, 732, 703 cm-1; HRMS (ESI) m/z calcd for 
C15H21O6+ (M+H)+, 297.1333; found 297.1343. 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 5.72 (s, 1 H, C11-H), 4.38 (d, J 
= 5.6 Hz, 1 H, C3-H), 3.83 (s, 3 H, C8-H), 3.69 (s, 3 H, C13-H), 3.48 (dd, J = 11.2, 4.6 Hz, 
1 H, C5-H), 2.36 (dd, J = 12.7, 4.6 Hz, 1 H, C4-H endo), 2.27 (s, 3 H, C14-H), 2.21 (ddd, 







































































CDCl3) δ 5.44 (s, 1 H), 4.65 (s, 1 H), 3.85 (s, 3 H), 3.69 (s, 3 H), 3.10 (dd, J = 9.1, 4.5 Hz, 
1 H), 2.65 (ddd, J = 13.5, 4.5, 1.1 Hz, 1 H), 2.32 (s, 3 H), 2.15 (dd, J = 13.5, 9.1 Hz, 1 H), 
1.32 (s, 3 H), 1.16 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 209.8, 195.2, 175.5, 166.1, 
96.6, 88.3, 86.6, 55.7, 52.8, 50.2, 48.8, 31.6, 23.0, 20.2, 19.9; IR (neat) νmax 1742, 1578, 
1439, 1265, 1146, 1063, 1036, 733, 702 cm-1; HRMS (ESI) m/z calcd for C15H21O6+ 
(M+H)+, 297.1333; found 297.1339. 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 5.44 (s, 1 H, C11-H), 4.65 (s, 1 
H, C3-H), 3.85 (s, 3 H, C8-H), 3.69 (s, 3 H, C13-H), 3.10 (dd, J = 9.1, 4.5 Hz, 1 H, C4-H), 
2.65 (ddd, J = 13.5, 4.5, 1.1 Hz, 1 H, C5-H exo), 2.32 (s, 3 H, C14-H), 2.15 (dd, J = 13.5, 




















































meli10. A solution of 1.81 (210 mg, 0.709 mmol) in THF (2 mL) was added dropwise to a 








was stirred at –78 ºC for 30 min. Freshly prepared prenyl iodide (278 mg, 1.42 mmol) in 
THF (2 mL) was added dropwise. The resulting solution was stirred at –78 ºC for 30 min. 
Saturated aqueous NH4Cl (2 mL) was added, and the mixture was extracted with CH2Cl2 
(3 x 2 mL). The combined organic layers were washed with H2O (3 x 2 mL) and brine (2 
mL), dried (Na2SO4), filtered and concentrated under reduced pressure to give crude 1.78 
as yellow oil. The crude material was purified via flash column chromatography eluting 
hexanes : EtOAc (8:1) to give 168 mg (65%) of 1.78 as yellow oil. 1H NMR (500 MHz, 
CDCl3) δ 6.37 (s, 1 H), 4.91 – 4.87 (m, 1 H), 4.34 (d, J = 5.7 Hz, 1 H), 3.85 (s, 3 H), 3.74 
(s, 3 H), 2.90 (d, J = 13.1 Hz, 1 H), 2.62 (dd, J = 14.4, 5.5 Hz, 1 H), 2.48 (dd, J = 14.4, 8.0 
Hz, 1 H), 2.22 (s, 3 H), 1.79 (dd, J = 13.1, 5.7 Hz, 1 H), 1.67 (s, 3 H), 1.60 (s, 3 H), 1.26 
(s, 3 H), 1.12 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 208.3, 196.1, 175.1, 166.0, 135.9, 
117.9, 98.5, 93.0, 83.9, 64.8, 56.0, 52.9, 49.3, 34.2, 34.0, 26.1, 24.3, 20.4, 18.5, 18.3; IR 
(neat) νmax 1776, 1732, 1578, 1439, 1265, 11136, 1065, 895, 733, 703 cm-1; HRMS (ESI) 
m/z calcd for C20H28O6Na+ (M+Na)+, 387.1778; found 387.1784. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 6.37 (s, 1 H, C12-H), 4.91 – 
4.87 (m, 1 H, C17-H), 4.34 (d, J = 5.7 Hz, 1 H, C10-H), 3.85 (s, 3 H, C7-H), 3.74 (s, 3 H, 
C15-H), 2.90 (d, J = 13.1 Hz, 1 H, C9-H), 2.62 (dd, J = 14.4, 5.5 Hz, 1 H, C16-H), 2.48 
(dd, J = 14.4, 8.0 Hz, 1 H, C16-H), 2.22 (s, 3 H, C14-H), 1.79 (dd, J = 13.1, 5.7 Hz, 1 H, 

























or C2-H), 1.12 (s, 3 H, C1-H or C2-H). 13C NMR (126 MHz, CDCl3) δ 208.3 (C4), 196.1 
(C11), 175.1 (C13), 166.0 (C6), 135.9 (C18), 117.9 (C17), 98.5 (C12), 93.0 (C5), 83.9 
(C10), 64.8 (C8), 56.0 (C15), 52.9 (C7), 49.3 (C3), 34.2 (C9), 34.0 (C16), 26.1 (C19 or 





carboxylate (1.16). zw-4-meli12. Freshly distilled TMS-I (57 mg, 0.29 mmol) was added 
to a solution of 1.78 (80 mg, 0.22 mmol) in CHCl3 (4 mL), and the solution was stirred at 
room temperature for 15 min. MeOH (2 mL) was added, and the resulting solution was 
concentrated under reduced pressure. The residue was dissolved in CH2Cl2 (4 mL), and the 
solution was washed with NaHSO3 (3 x 2 mL), NaHCO3 (3 x 2 mL) and brine (5 mL), 
dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was 
dissolved in THF (4 mL) at 0 ºC, DBU (67 mg, 0.44 mmol) was added, and the solution 
was stirred at room temperature for 15 min. Saturated aqueous NH4Cl (2 mL) was added, 
and the mixture was extracted with CH2Cl2 (3 x 2 mL). The combined organic layers were 
dried (Na2SO4), filtered and concentrated under reduced pressure to give crude 1.16 as 
colorless oil. The crude material was purified via flash column chromatography eluting 
hexanes : EtOAc (6:1) to give 58 mg (75%) of 1.16 as white solid: mp 109–112 ºC. 1H 








H), 3.78 (s, 3 H), 2.37 (dd, J = 15.5, 7.2 Hz, 1 H), 2.28 – 2.23 (m, 1 H), 2.14 (s, 3 H), 2.03 
(d, J = 13.3 Hz, 1 H), 1.80 (dd, J = 13.3, 5.1 Hz, 1 H), 1.69 (s, 3 H), 1.58 (s, 3 H), 1.26 (s, 
3 H), 0.94 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 205.2, 177.0, 168.7, 134.8, 118.6, 112.9, 
100.7, 87.1, 85.9, 58.9, 52.6, 49.5, 37.8, 29.3, 26.1, 22.4, 20.7, 19.5, 18.0; IR (neat) νmax 
2359, 2340, 1737, 1653, 1616, 1582, 1456, 1129, 985, 892, 771 cm-1; HRMS (ESI) m/z 
calcd for C19H26O6Na+ (M+Na)+, 373.1622; found 373.1626.  
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 13.84 (s, 1 H, -OH), 5.15 (t, J = 
7.2 Hz, 1 H, C16-H), 4.06 (d, J = 5.1 Hz, 1 H, C10-H), 3.78 (s, 3 H, C7-H), 2.37 (dd, J = 
15.5, 7.2 Hz, 1 H, C15-H), 2.28 – 2.23 (m, 1 H, C15-H), 2.14 (s, 3 H, C14-H), 2.03 (d, J = 
13.3 Hz, 1 H, C9-H), 1.80 (dd, J = 13.3, 5.1 Hz, 1 H, C9-H), 1.69 (s, 3 H, C18-H or C19-
H), 1.58 (s, 3 H, C18-H or C19-H), 1.26 (s, 3 H, C1-H or C2-H), 0.94 (s, 3 H, C1-H or C2-
H). 13C NMR (126 MHz, CDCl3) δ 205.2 (C11), 177.0 (C13), 168.7 (C6), 134.8 (C17), 
118.6 (C16), 112.9 (C12), 100.7 (C5), 87.1 (C4), 85.9 (C10), 58.9 (C8), 52.6 (C7), 49.5 
(C3), 37.8 (C9), 29.3 (C15), 26.1 (C18 or C19), 22.4 (C1 or C2), 20.7 (C1 or C2), 19.5 




























(±)-Melicolone A (1.1) and (±)-melicolone B (1.2). zw-4-meli13 and zw-4-
meli14. A solution of 1.16 (30 mg, 0.086 mmol) in CH2Cl2 (1 mL) was added to a solution 
of m-chloroperbenzoic acid (MCPBA) (24 mg, 0.094 mmol) in CH2Cl2 (1 mL), and the 
solution was stirred at room temperature for 30 min. The reaction mixture was then 
transferred to a cooling bath at -40 ºC, whereupon (+)-camphor-10-sulfonic acid (2.0 mg, 
0.0086 mmol) was added. The cooling bath was removed, and the solution was stirred at 
room temperature for 30 min. The reaction was quenched with Et3N (0.5 mL), and then 
washed with Na2CO3 (3 x 1 mL), H2O (3 x 1 mL) and brine (1 mL). The organic fraction 
was dried (Na2SO4), filtered and concentrated under reduced pressure to give crude mixture 
of 1 and 2 as colorless oil. The crude material was purified via preparative reverse phase 
HPLC using Eclipse XDB-C18 column (9.4 x 250 mm). HPLC purification gave 14 mg 
(44%) of (±)-melicolone A (1.1) and 13 mg (41%) of (±)-melicolone B (1.2), each as 
colorless oils. (±)-melicolone A (1.1) HRMS (ESI) m/z calcd for C19H27O7 (M+H)+, 
367.1751; found 367.1757. (±)-melicolone B (1.2) HRMS (ESI) m/z calcd for C19H27O7 
(M+H)+, 367.1751; found 367.1754. 
 
HPLC purification of (±)-melicolone A (1.1) and (±)-melicolone B (1.2): 
The crude mixture of (±)-melicolone A (1.1) and (±)-melicolone B (1.2) was 
purified via preparative reverse phase HPLC using Eclipse XDB-C18 column (9.4 x 250 
(±)-Melicolone A (1.1): R1 = OH, R2 = H








mm). Gradient elution was used with MeCN/H2O (0:100, v/v) at 0 min to MeCN/H2O 
(30:70, v/v) at 25 min. (±)-melicolone A (1) was collected with a retention time of 20.197 
min, and (±)-melicolone B (2) was collected with a retention time of 18.683 min. 
 
 
Figure 4.15. HPLC traces for the mixture of (±)-melicolone A (1.1) and (±)-melicolone 









Comparison of natural and synthetic (±)-melicolones A and (±)-melicolones B 
Table 4.1. Comparison of 1H spectra for natural and synthetic (±)-melicolone A (1.1) in 
CD3OD. 







1H NMR (δ in ppm, multiplicity, J in Hz) 
Synthetic (500 MHz) Natural (500 MHz) 
0.86 (s, 3 H) 0.86 (s, 3 H) 
1.11 (s, 3 H) 1.11 (s, 3 H) 
1.38 (s, 3 H) 1.38 (s, 3 H) 
1.54 (s, 3 H) 1.54 (s, 3 H) 
1.55 (dd, J = 12.2, 4.2 Hz, 1 H)a 1.56 (dd, J = 12.2, 4.5 Hz, 1 H) 
1.65 (dd, J = 12.8, 5.3 Hz, 1 H) 1.65 (dd, J = 12.8, 5.2 Hz, 1 H) 
1.98 (t, J = 12.2 Hz, 1 H) 1.98 (dd, J = 12.2, 12.2 Hz, 1 H) 
2.37 (s, 3 H) 2.37 (s, 3 H) 
2.41 (d, J = 12.8 Hz, 1 H) 2.41 (d, J = 12.8 Hz 1 H) 
3.65 (dd, J = 12.2, 4.2 Hz, 1 H) 3.65 (dd, J = 12.2, 4.5 Hz, 1 H) 
3.80 (s, 3 H) 3.80 (s, 3 H) 
4.12 (d, J = 5.3 Hz, 1 H) 4.12 (d, J = 5.2 Hz, 1 H) 
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Table 4.2. Comparison of 13C spectra for natural and synthetic (±)-melicolone A (1.1) in 
CD3OD. 
  
13C NMR (δ in ppm) 





















Table 4.3. Comparison of 1H NMR spectra for natural and synthetic (±)-melicolone A 
(1.1) in DMSO-d6. 
1H NMR (δ in ppm, multiplicity, J in Hz) 
Synthetic (600 MHz)a Natural (500 MHz) 
0.79 (s, 3 H) 0.79 (s, 3 H) 
1.02 (s, 3 H) 1.02 (s, 3 H) 
1.30 (s, 3 H) 1.30 (s, 3 H) 
1.45 (dd, J = 12.1, 4.2 Hz, 1 H) 1.45 (dd, J = 12.2, 4.5 Hz, 1 H) 
1.48 (s, 3 H) 1.48 (s, 3 H) 
1.57 (dd, J = 12.7, 5.3 Hz, 1 H) 1.57 (dd, J = 12.8, 5.2 Hz, 1 H) 
1.84 (t, J = 12.1, 1 H) 1.84 (dd, J = 12.2, 12.2 Hz, 1 H) 
2.30 (d, J = 12.1 Hz, 1 H)b 2.30 (d, J = 12.8 Hz, 1 H) 
2.32 (s, 3 H) 2.32 (s, 3 H) 
3.55 (ddd, J = 12.1, 4.3 Hz, 1 H) 3.55 (ddd, J = 12.2, 5.0, 4.5 Hz, 1 H) 
3.71 (s, 3 H) 3.72 (s, 3 H) 
4.09 (d, J = 5.1 Hz, 1 H) 4.10 (d, J = 5.2 Hz, 1 H) 
5.02 (br, 0.25 H) 5.06 (br, 1 H)  
5.38 (d, J = 5.0 Hz, 1 H) 
aThe spectrum was obtained at 50 ºC. bThe downfield peak of the d was partially obscured 
















1H NMR (δ in ppm, multiplicity, J in Hz) 
Synthetic (500 MHz) Natural (500 MHz) 
0.89 (s, 3 H) 0.89 (s, 3 H) 
1.10 (s, 3 H) 1.10 (s, 3 H) 
1.43 (s, 3 H) 1.43 (s, 3 H) 
1.50 (s, 3 H) 1.50 (s, 3 H) 
1.64 (dd, J = 13.9, 6.9 Hz, 1 H) 1.63 (dd, J = 13.9, 6.9 Hz, 1 H) 
1.83 (dd, J = 13.4, 5.3 Hz, 1 H) 1.83 (dd, J = 13.0, 5.2 Hz, 1 H) 
2.23 (dd, J = 13.9, 3.4 Hz, 1 H) 2.23 (dd, J = 13.9, 3.4 Hz, 1 H) 
2.38 (s, 3 H) 2.38 (s, 3 H) 
2.52 (d, J = 13.4 Hz, 1 H) 2.52 (d, J = 13.0 Hz, 1 H) 
3.77 (dd, J = 4.9, 3.4 Hz, 1 H) 3.77 (dd, J = 4.9, 3.4 Hz, 1 H) 
3.79 (s, 3 H) 3.79 (s, 3 H) 
4.07 (d, J = 5.2 Hz, 1 H) 4.07 (d, J = 5.2 Hz, 1 H) 
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Table 4.5. Comparison of 13C spectra for natural and synthetic (±)-melicolone B (1.2) in 
CD3OD. 
  
13C NMR (δ in ppm) 

























A solution of 1.20 (20 mg, 0.10 mmol), 1.18 (15mg, 0.12 mmol) and Rh2(S-
TCPTTL)4 (3.6 mg, 0.0020 mmol) in toluene (1 mL) was stirred at room temperature 
overnight. The solvent was removed under reduced pressure. The residue was dissolved in 
CH2Cl2 (1 mL), which was washed with H2O (3 x 1 mL) and brine (1 mL). The solution 
was dried (Na2SO4), filtered and concentrated under reduced pressure to give crude mixture 
of 1.81 as yellow oil. The crude material was purified via flash column chromatography 
eluting hexanes : EtOAc (8:1) to give 11 mg (38%) of 1.81 as white solid. 
 
HPLC traces for enantioenriched 1.81 









































 Retention time (min) Area (μV*sec) % area Height (μV) Int Type 
1 23.563 5574770 50.11 153355 bb 






 Retention time (min) Area (μV*sec) % area Height (μV) Int Type 
1 23.379 7696480 57.66 185663 bb 

















4.3 EXPERIMENTAL PROCEDURES FOR CHAPTER 3 
 
 
3-Methyl-4-nitrophenyl trifluoromethanesulfonate (3.8). az-1-002. A solution 
of 3.7 (2.00 g, 13.1 mmol) in pyridine (1.58 mL, 19.6 mmol) and CH2Cl2 (60 mL) was 
cooled to 0 ºC. Triflic anhydride (3.68 g, 15.7 mmol) was added dropwise over 10 min. 
The ice water bath was then removed, and the solution was stirred at room temperature for 
3 h. Saturated NaHCO3 (30 mL) was added, and the mixture was extracted with CH2Cl2 (3 
x 30 mL). The combined organic fraction was successively washed with water (3 x 30 mL) 
and brine (3 x 30 mL). The organic fraction was dried (Na2SO4), filtered, and concentrated 
in vacuo to give 3.70 g (~100%) crude 3.8 as a viscous oil (95% pure). The crude material 
was directly used to carry out the next step without further purification. 1H NMR (400 
MHz, CDCl3) δ 8.11 – 7.84 (d, J = 2.16 Hz, 1 H), 7.56 – 7.35 (comp, 2 H), 2.65 (s, 3 H). 
13C NMR (126 MHz, CDCl3) δ 149.2, 147.1, 134.6, 134.4, 126.0, 119.9, 118.1, 117.4, 20.2. 
IR (CH2Cl2) νmax 1533, 1426, 1350, 1208, 1136, 937, 850, 732 cm-1. HRMS (CI), m/z 
calculated for C8H7NO5F3S+ (M+H)+, 285.9997; found 285.9995. 
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.11 – 7.84 (d, J = 2.16 Hz, 1 















3-Methyl-4-nitro-N-phenylaniline (3.9). az-3-1213-3. Aniline (0.372 mL, 4.09 
mmol) was added to the solution of 3.8 (1.06 g, 3.72 mmol), Pd(OAc)2 (41.6 mg, 0.186 
mmol), Cs2CO3 (1.44 g, 4.46 mmol), and X-Phos (88.5 mg, 0.186 mmol) in toluene (30 
mL) under N2. The solution was stirred at 100 oC for 2 h. The solution was cooled to room 
temperature and diluted with CH2Cl2 (30 mL). The solution was successively washed with 
water (3 x 30 mL) and brine (3 x 30 mL). The organic fractions were dried (Na2SO4), 
filtered, and concentrated in vacuo to give crude 3.9 as a dark brown syrup. The crude 
material was purified via flash column chromatography eluting with hexanes : EtOAc (8:1) 
to give 797 mg (94%) 3.9 as an orange solid. 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 
2.2 Hz, 1 H), 7.35 – 7.29 (comp, 2 H), 7.19 (dt, J = 8.3, 0.6 Hz, 1 H), 7.15 (dd, J = 8.3, 2.2 
Hz, 1 H), 7.10 – 7.07 (comp, 2 H, C1-H), 7.05 – 6.99 (m, 1 H), 2.51 (s, 3 H). 13C NMR 
(126 MHz, CDCl3) δ 149.7, 142.5, 141.6, 133.5, 129.7, 124.5, 122.5, 121.5, 118.9, 112.2, 
19.8. IR (CH2Cl2) vmax 3393, 1522, 1495, 1316, 745 cm-1. HRMS (CI) m/z calculated for 
C13H12N2O2•+ M•+, 228.0899; found 228.0900. 
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 2.2 Hz, 1 H, C9-H), 
7.35 – 7.29 (comp, 2 H, C2-H, C4-H), 7.19 (dt, J = 8.3, 0.6 Hz, 1 H, C7-H), 7.15 (dd, J = 
8.3, 2.2 Hz, 1 H, C6-H), 7.10 – 7.07 (comp, 2 H, C1-H, C5-H), 7.05 – 6.99 (m, 1 H, C3-





















2-Nitro-4-(phenylamino)benzaldehyde (3.17). az-2-218. DMF-DMA (947 mg, 
7.97 mmol) and pyrrolidine (566 g, 7.97 mmol) were added to a solution of 3.9 (900 mg, 
3.98 mmol) in DMF (20 mL) under N2. The solution was heated at 135 ºC for 3 h. The 
mixture was added to a solution of NaIO4 (1.69 g, 7.97 mmol) in water (20 mL) and DMF 
(20 mL) at 0 ºC. The solution was stirred at room temperature for 3 h, and diluted with 
CH2Cl2 (50 mL). The mixture was filtered and washed with water (3 x 50 mL) and brine 
(3 x 50 mL).  The organic fraction was dried (Na2SO4), filtered, and concentrated in vacuo 
to give crude 3.17 as a dark brown syrup. The crude material was purified via flash column 
chromatography eluting with hexanes : EtOAc (6:1) to give 828 mg (86%) 3.17 as a red 
solid. 1H NMR (500 MHz, CDCl3) δ 10.12 (s, 1 H), 7.84 (d, J = 8.6 Hz, 1 H), 7.38 – 7.33 
(comp, 3 H), 7.17 – 7.12 (comp, 3 H), 7.08 (dd, J = 8.6, 2.3 Hz, 1 H), 6.37 (s, 1 H). 13C 
NMR (126 MHz, CDCl3) δ 186.4, 152.5, 149.8, 138.7, 131.6, 130.0, 125.5, 122.3, 120.9, 























NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 10.12 (s, 1 H, CHO-H), 7.84 (d, 
J = 8.6 Hz, 1 H, C8-H), 7.38 – 7.33 (comp, 3 H, C2, C4, C7-H), 7.17 – 7.12 (comp, 3 H, 
C1, C3, C5-H,), 7.08 (dd, J = 8.6, 2.3 Hz, 1 H, C6-H), 6.37 (s, 1 H, N-H). 
 
 
1-(2-Nitro-4-(phenylamino)phenyl)ethan-1-ol (3.18). az-3-1212-4. Al(CH3)3 
(3.60 mL, 5.86 mmol) was added slowly to a solution of 3.17 (710 mg, 2.93 mmol) in 
CH2Cl2 (30 mL) under N2 at 0 ºC. The solution was stirred at 0 ºC for 1 h. 1 M aq. NaOH 
(15 mL) was slowly added, and the mixture was stirred for another 30 min. The solution 
was extracted with CH2Cl2 (3 x 30 mL). The organic fraction was washed with H2O (3 x 
30 mL) and brine (30 mL), then dried (Na2SO4) and concentrated in vacuo to give crude 
3.18 as a brown syrup. The crude material was purified via flash column chromatography 
eluting with hexanes : EtOAc (5:1) to give 672mg (89%) 3.18 as a viscous brown oil. 1H 
NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.6 Hz, 1 H), 7.49 (d, J = 2.4 Hz, 1 H), 7.36 – 7.28 
(comp, 2 H), 7.22 (dd, J = 8.6, 2.4 Hz, 1 H), 7.12 – 7.09 (comp, 2 H), 7.05 (td, J = 7.3, 1.1 
Hz, 1 H), 5.91 (s, 1 H), 5.28 (q, J = 6.4 Hz, 1 H), 1.54 (d, J = 6.4 Hz, 3 H). 13C NMR (126 
MHz, CDCl3) δ 149.0, 144.0, 141.1, 131.7, 129.8, 128.7, 123.3, 121.2, 119.8, 110.9, 65.4, 











NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.6 Hz, 1 H, C7-H), 
7.49 (d, J = 2.4 Hz, 1 H, C8-H), 7.36 – 7.28 (comp, 2 H, C1, C5-H), 7.22 (dd, J = 8.6, 2.5 
Hz, 1 H, C6-H), 7.12 – 7.09 (comp, 2 H, C3, C4-H), 7.05 (td, J = 7.3, 1.1 Hz, 1 H, C2-H), 
5.91 (s, 1 H, N-H), 5.28 (q, J = 6.4 Hz, 1 H, C9-H), 1.54 (d, J = 6.4 Hz, 3 H, C10-H). 
 
 
1-(2-Nitro-9H-carbazol-3-yl)ethan-1-ol (3.5). az-4-cage1. The solution of 3.18 
(700 mg, 2.71 mmol), Pd(OAc)2 (30.1 mg, 0.136 mmol), Cu(OAc)2 (981 mg, 5.42 mmol) 
in PivOH (15 mL) was heated at 110 ºC under O2 for 24 h. The solution was cooled to 
room temperature and diluted with CH2Cl2 (15 mL). The solution was filtered by vacuum 
filtration, and saturated NaHCO3 (100 mL) was slowly added to neutralize the solution. 
The mixture was washed with brine (3 x 50 mL). The organic fraction was dried (Na2SO4), 
filtered, and concentrated in vacuo to give crude 3.5 as a dark brown syrup. The crude 
material was purified via flash column chromatography eluting with hexanes : EtOAc (4:1) 
to give 270 mg (40%) 3.5 as a brown oil. 1H NMR (400 MHz, CDCl3) δ 8.47 (br, 1 H), δ 
8.44 (s, 1 H), 8.12 (ddd, J = 7.9, 1.4, 0.8 Hz, 1 H), 8.04 (s, 1 H), 7.58 – 7.45 (comp, 2 H), 
7.31 (ddd, J = 7.9, 6.8, 1.1 Hz, 1 H), 5.56 (q, J = 6.3 Hz, 1 H), 1.69 (d, J = 6.3 Hz, 3 H). 




















121.7, 121.6, 120.8, 118.9, 111.4, 107.6, 66.2, 29.8, 24.6. HRMS (ESI) m/z calculated for 




NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.47 (br, 1H, N-H), δ 8.44 (s, 
1H, C8-H), 8.12 (ddd, J = 7.9, 1.4, 0.8 Hz, 1H, C1-H), 8.04 (s, 1H, C5-H), 7.58 – 7.45 
(comp, 2H, C3-H, C4-H), 7.31 (ddd, J = 7.9, 6.8, 1.1 Hz, 1H, C2-H), 5.56 (q, J = 6.3 Hz, 




3-Methyl-4-nitrophenyl trifluoromethanesulfonate (3.21). az-0201-3. A 
solution of 3.20 (2.00 g, 13.1 mmol) in pyridine (2.64 mL, 19.7 mmol) and CH2Cl2 (60 
mL) was cooled to 0 ºC. Triflic anhydride (3.68 g, 15.7 mmol) was added dropwise over 
10 min. The ice water bath was then removed, and the solution was stirred at room 
temperature for 3 h. Saturated NaHCO3 (30 mL) was added, and the mixture was extracted 
with CH2Cl2 (3 x 30 mL). The combined organic fraction was successively washed with 
water (3 x 30 mL) and brine (3 x 30 mL). The organic fraction was dried (Na2SO4), filtered, 
















The crude material was directly used to carry out the next step without further purification. 
1H NMR (400 MHz, CDCl3) δ 8.17 – 7.96 (d, J = 9.7 Hz, 1 H), 7.30-7.26 (comp, 2 H), 
2.66 (s, 3 H). 13C NMR (126 MHz, CDCl3) δ 151.3, 148.3, 137.0, 127.1, 125.4, 119.9, 
117.4, 20.6.  IR (DCM) 1530, 1427, 1210, 1133, 946, 814. HRMS (CI) m/z calculated for 
C8H7NO5F3S+ (M+H)+, 285.9997; found 285.9998. 
 
 
NMR Assignment 1H NMR (400 MHz, CDCl3) δ 8.17 – 7.96 (d, J = 9.7 Hz, 1 H, 
C3-H), 7.30-7.26 (comp, 2 H, C1-H, C2-H), 2.66 (s, 3 H, C4-H). 
 
 
3-Methyl-4-nitro-N-phenylaniline (3.22). az-0201-1. Aniline (717 mg, 7.71 
mmol) was added to the solution of 3.21 (2.00 g, 7.01 mmol), Pd(OAc)2 (157 mg, 0.701 
mmol), Cs2CO3 (2.74 g, 8.41 mmol), and X-Phos (500 mg, 1.05 mmol) in toluene (70 mL) 
under N2. The solution was stirred at 100 ºC for 2 h. The solution was cooled to room 
temperature and diluted with CH2Cl2 (30 mL). The solution was successively washed with 
water (3 x 30 mL) and brine (3 x 30 mL). The organic fractions were dried (Na2SO4), 
filtered, and concentrated in vacuo to give crude 3.22 as a dark brown syrup. The crude 
material was purified via flash column chromatography eluting with hexanes : EtOAc (8:1) 














Hz, 1 H, C7-H), 7.38 (dd, J = 8.5, 7.4 Hz, 2 H), 7.19 (dt, J = 7.4, 1.1 Hz, 2 H), 7.17 – 7.11 
(m, 1 H), 6.82 (dd, J = 9.0, 2.6 Hz, 1 H), 6.78 – 6.76 (d, J = 2.6 Hz, 1 H), 6.16 (s, 1 H), 
2.61 (s, 3 H). 13C NMR (126 MHz, CDCl3) δ 148.8, 140.3, 139.4, 137.7, 129.7, 128.1, 
124.3, 121.7, 117.2, 112.1, 22.3. IR (CH2Cl2) vmax 3330, 1576, 1273, 1254, 1076, 747 cm-
1. HRMS (CI) m/z calculated for C13H13N2O2+ (M+H)+, 229.0977; found 229.0971. 
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 9.0 Hz, 1 H, C7-H), 
7.38 (dd, J = 8.5, 7.4 Hz, 2 H, C2-H, C4-H), 7.19 (dt, J = 7.4, 1.1 Hz, 2 H, C1-H, C5-H), 
7.17 – 7.11 (m, 1 H, C3-H), 6.82 (dd, J = 9.0, 2.6 Hz, 1 H, C6-H), 6.78 – 6.76 (d, J = 2.6 





2-Nitro-5-(phenylamino)benzaldehyde (3.23). az-2-209. DMF-DMA (3.30 g, 
27.4 mmol) and pyrrolidine (1.91 g, 27.4 mmol) were added to a solution of 3.22 (3.10 g, 
13.7 mmol) in DMF (70 mL) under N2. The solution was heated at 135 ºC for 3 h. The 
mixture was added to a solution of NaIO4 (5.84 g, 27.4 mmol) in water (30 mL) and DMF 
(30 mL) at 0 ºC. The solution was stirred at room temperature for 3 h, and diluted with 




















(3 x 100 mL).  The organic fraction was dried (Na2SO4), filtered, and concentrated in 
vacuo to give crude 3.23 as a dark brown syrup. The crude material was purified via flash 
column chromatography eluting with hexanes : EtOAc (6:1) to give 2.66 g (80%) 3.23 as 
a yellow solid. 1H NMR (500 MHz, CDCl3) δ 10.43 (s, 1 H), 8.03 (d, J = 9.0 Hz, 1 H), 7.35 
(t, J = 7.8 Hz, 2 H), 7.17 – 7.11 (m, 4 H), 7.02 (dd, J = 9.0, 2.7 Hz, 1 H), 6.38 (s, 1 H). 13C 
NMR (126 MHz, CDCl3) δ 189.4, 150.1, 139.7, 138.7, 135.3, 130.0, 127.8, 125.5, 122.4, 





NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 10.43 (s, 1 H, CHO-H), 8.03 (d, 
J = 9.0 Hz, 1 H, C7-H), 7.35 (t, J = 7.8 Hz, 2 H, C2, C4-H), 7.17 – 7.11 (m, 4 H, C1, C3, 




1-(2-Nitro-5-(phenylamino)phenyl)ethan-1-ol (3.24). az-4-0506. Al(CH3)3 (12.4 
mL, 24.8 mmol) was added slowly to a solution of 3.23 (3.00 mg, 12.4 mmol) in CH2Cl2 
(60 mL) under N2 at 0 ºC. The solution was stirred at 0 ºC for 1 h. 1M aq. NaOH (30 mL) 
was slowly added, and the mixture was stirred for another 30 min. The solution was 



















mL) and brine (30 mL), then dried (Na2SO4) and concentrated in vacuo to give crude 3.24 
as a brown syrup. The crude material was purified via flash column chromatography 
eluting with hexanes : EtOAc (4:1) to give 2.88 g (90%) 3.24 as a viscous brown oil. 1H 
NMR (500 MHz, CDCl3) δ 7.96 (d, J = 9.1 Hz, 1 H), 7.32 (t, J = 7.7 Hz, 2 H), 7.22 (d, J = 
2.6 Hz, 1H), 7.16 – 7.12 (comp, 2 H), 7.09 (t, J = 7.4 Hz, 1 H), 6.82 (dd, J = 9.1, 2.6 Hz, 1 
H), 6.26 (s, 1 H), 5.51 (q, J = 6.3 Hz, 1 H), 1.48 (d, J = 6.3 Hz, 3 H). 13C NMR (126 MHz, 
CDCl3) δ 149.8, 145.2, 139.7, 138.8, 129.9, 128.5, 124.7, 121.9, 112.5, 66.4, 24.1. HRMS 
(ESI) m/z calculated for C14H14N2O3Na+ (M+Na)+, 281.0897; found 281.0898. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 9.1 Hz, 1 H, C7-H), 
7.32 (t, J = 7.7 Hz, 2 H, C2, C4-H), 7.22 (d, J = 2.6 Hz, 1 H, C8-H), 7.16 – 7.12 (comp, 2 
H, C1, C5-H), 7.09 (t, J = 7.4 Hz, 1 H, C3-H), 6.82 (dd, J = 9.1, 2.6 Hz, 1 H, C6-H), 6.26 





1-(3-Nitro-9H-carbazol-2-yl)ethan-1-ol (3.6). az-3-0102-cage2. The solution of 
3.24 (800 mg, 3.10 mmol), Pd(OAc)2 (35.1 mg, 0.157 mmol), Cu(OAc)2 (1.12 g, 6.20 
mmol) in PivOH (15 mL) was heated at 110 ºC under O2 for 24 h. The solution was cooled 




















filtration, and saturated NaHCO3 (100 mL) was slowly added to neutralize the solution. 
The mixture was washed with brine (3 x 50 mL). The organic fraction was dried (Na2SO4), 
filtered, and concentrated in vacuo to give crude 3.6 as a dark brown syrup. The crude 
material was purified via flash column chromatography eluting with hexanes : EtOAc (4:1) 
to give 333 mg (42%) 3.6 as a brown oil. 1H NMR (400 MHz, CDCl3) δ 8.74 (s, 1 H), 8.04 
(dt, J = 7.9, 1.1 Hz, 1 H), 7.79 (s, 1 H), 7.49 (ddd, J = 7.9, 6.7, 1.1 Hz, 1 H), 7.45 (ddd, J = 
7.9, 1.5, 0.9 Hz, 1 H), 7.31 (ddd, J = 7.9, 6.7, 1.5 Hz, 1 H), 5.68 (q, J = 6.3 Hz, 1 H), 1.62 
(d, J = 6.3 Hz, 3 H). 13C NMR (101 MHz, CDCl3) δ 140.8, 127.7, 121.2, 121.1, 118.9, 
111.5, 108.5, 66.6, 24.6. HRMS (ESI) m/z calculated for C14H12N2O3Na+ (M+Na)+, 
279.0740; found 279.0744. 
 
 
NMR Assignment .1H NMR (400 MHz, CDCl3) δ 8.74 (s, 1 H, C5-H), 8.04 (dt, J 
= 7.9, 1.1 Hz, 1 H, C4-H), 7.79 (s, 1 H, C8-H), 7.49 (ddd, J = 7.9, 6.7, 1.1 Hz, 1 H, C2-H), 
7.45 (ddd, J = 7.9, 1.5, 0.9 Hz, 1 H, C1-H), 7.31 (ddd, J = 7.9, 6.7, 1.5 Hz, 1 H, C3-H), 





















1-(2-Nitro-9H-carbazol-3-yl)ethyl benzoate (3.29). az-4-cage1ba. A solution of 
3.5 (20 mg, 0.077 mmol), benzoic acid (9.4 mg, 0.077 mmol), 4-dimethylaminopyridine 
(0.94 mg, 0.0077 mmol) and N,N'-dicyclohexylcarbodiimide (17 mg, 0.092 mmol) in 
CH2Cl2 (1 mL) was stirred at room temperature in dark for 2 h where upon water was 
added, and the solution was diluted with EtOAc (1 mL), and washed with citric acid (3 x 1 
mL), H2O (3 x 1 mL) and brine (3 x 1 mL). The organic fraction was dried (Na2SO4) and 
concentrated in vacuo to give crude 3.29 as orange solid. The crude material was purified 
via flash column chromatography eluting with hexanes : EtOAc (8:1) to give 17 mg (62%) 
3.29 as an orange solid. 1H NMR (400 MHz, CDCl3) δ 8.98 (s, 1 H), 8.33 (s, 1 H), 8.15 (s, 
1 H), 8.12 – 8.08 (m, 3 H), 7.60 – 7.55 (m, 1 H), 7.51 – 7.49 (m, 2 H), 7.49 – 7.43 (m, 2 
H), 7.30 – 7.26 (m, 1 H), 6.73 (q, J = 6.4 Hz, 1 H), 1.90 (d, J = 6.4 Hz). 13C NMR (126 
MHz, CDCl3) δ 133.2, 130.4, 129.8, 128.6, 128.4, 122.1, 121.6, 120.8, 118.6, 111.4, 107.6, 





NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.98 (s, 1 H, N-H), 8.33 (s, 1 H, 
C8-H), 8.15 (s, 1 H, C5-H), 8.12 – 8.08 (m, 3 H, C1-H, C2-H, C4-H), 7.60 – 7.55 (m, 1 H, 
C12-H), 7.51 – 7.49 (m, 2 H, C10-H, C14-H), 7.49 – 7.43 (m, 2 H, C11-H, C13-H), 7.30 





















1-(3-Nitro-9H-carbazol-2-yl)ethyl benzoate (3.30). az-3-1219-2. A solution of 
3.6 (20 mg, 0.077 mmol), benzoic acid (9.4 mg, 0.077 mmol), 4-dimethylaminopyridine 
(0.94 mg, 0.0077 mmol) and N,N'-dicyclohexylcarbodiimide (17 mg, 0.092 mmol) in 
CH2Cl2 (1 mL) was stirred at room temperature in dark for 2 h where upon water (1 mL) 
was added, and the solution was diluted with EtOAc (1 mL), and washed with citric acid 
(3 x 1 mL), H2O (3 x 1 mL) and brine (3 x 1 mL). The organic fraction was dried (Na2SO4) 
and concentrated in vacuo to give crude 3.30 as a yellow solid. The crude material was 
purified via flash column chromatography eluting with hexanes : EtOAc (8:1) to give 18 
mg (65%) 3.30 as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.62 (s, 1 H), 8.41 (s, 1 
H), 8.12 - 8.08 (comp, 2 H), 7.91 (ddt, J = 7.9, 1.3, 0.7 Hz, 1 H), 7.66 – 7.60 (m, 1 H), 7.53 
– 7.46 (comp, 3 H), 7.40 (s, 1 H) 7.36 (dt, J= 8.1, 0.8 Hz, 1 H), 7.29 (ddd, J = 8.1, 7.2, 1.0 
Hz, 1 H), 6.80 (q, J = 6.4 Hz, 1 H), 1.79 (d, J = 6.4 Hz, 3 H). 13C NMR (126 MHz, CDCl3) 
δ 165.4, 142.1, 140.6, 137.4, 133.2, 130.2, 129.7, 128.5, 127.6, 122.8, 122.4, 121.1, 121.0, 
118.8, 111.2, 107.7, 69.9, 29.7, 22.7. HRMS (ESI) m/z calculated for C21H16N2O4Na+ 


























NMR Assignment. 1H NMR (400 MHz, CDCl3-d) δ 8.62 (s, 1 H, C5-H), 8.41 (s, 
1 H, N-H), 8.12 - 8.08 (comp, 2 H, C10-H, C14-H), 7.91 (ddt, J = 7.9, 1.3, 0.7 Hz, 1 H, 
C4-H), 7.66 – 7.60 (m, 1 H, C12-H), 7.53 – 7.46 (comp, 3 H, C1-H, C11-H, C13-H), 7.40 
(s, 1 H, C8-H) 7.36 (dt, J= 8.1, 0.8 Hz, 1 H, C2-H), 7.29 (ddd, J = 8.1, 7.2, 1.0 Hz, 1 H, 




yl)ethyl)azanediyl)diacetate (3.39). az-3-cage1nr. NaH (35.2 mg, 0.881 mmol) was 
added to a solution of 3.5 (150 mg, 0.587 mmol) in DMF (5 mL) at 0oC. The solution was 
stirred at room temperature for 30 min, whereupon 3.38 (206 mg, 0.587 mmol) was slowly 
added to the solution at 0oC. The solution was stirred for overnight. The mixture was 
concentrated in vacuo and then it was diluted with CH2Cl2 (10 mL), washed with water (15 
mL X 3) and brine (15 mL), dried (Na2SO4), filtered, and concentrated in vacuo to give 
crude 3.39 as a viscous dark oil. The crude material was purified via flash column 
chromatography eluting with hexanes : ethyl acetate (8:1) to give 222 mg (73 %) of 3.39 
as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 8.46 (s, 1 H), 8.18 (s, 1 H), 8.17 – 8.13 (m, 
1 H), 7.56 (d, J = 3.8 Hz, 2 H), 7.31 (dt, J = 8.0, 4.0 Hz, 1 H), 5.56 (q, J = 6.2 Hz, 1 H), 
4.58 (t, J = 7.3 Hz, 2 H), 3.46 (s, 4 H), 3.14 (t, J = 7.3 Hz, 2 H), 1.70 (d, J = 6.3 Hz, 3 H), 
1.45 (s, 18 H). 13C NMR (500 MHz, CDCl3) δ 170.5, 146.0, 142.7, 138.5, 131.6, 128.0, 








NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.46 (s, 1 H, C6-H), 8.18 (s, 1 
H, C5-H), 8.17 – 8.13 (m, 1 H, C1-H), 7.56 (d, J = 3.8 Hz, 2 H, C3-H, C4-H), 7.31 (dt, J 
= 8.0, 4.0 Hz, 1 H, C2-H), 5.56 (q, J = 6.2 Hz, 1 H, C7-H), 4.58 (t, J = 7.3 Hz, 2 H, C9-H), 
3.46 (s, 4 H, C11-H), 3.14 (t, J = 7.3 Hz, 2 H, C10-H), 1.70 (d, J = 6.3 Hz, 3 H, C8-H), 





32. A solution of 3.39 (20 mg, 0.038 mmol), 3.44 (17 mg, 0.077 mmol), EDCI•HCl (15 
mg, 0.077 mmol) and DMAP (20 mg, 0.15 mmol) in DMF (3 mL) was stirred at 80 ºC for 
24 h. The solution was diluted with EtOAc (2 mL), and washed with H2O (3 x 2 mL) and 
brine (2 mL). The organic fraction was dried (Na2SO4) and evaporated in vacuo to give 






















eluting with hexanes : EtOAc (2:1) to give 16 mg (55%) 3.48 as a yellow solid. 1H NMR 
(500 MHz, CDCl3-d) δ 8.73 (s, 1H), 8.39 (s, 1H), 8.22 (dd, J = 8.9, 2.8 Hz, 1H), 8.16 (d, J 
= 7.9 Hz, 1H), 8.13 (s, 1H), 7.48 – 7.43 (m, 2H), 7.41 – 7.34 (m, 2H), 7.23 – 7.21 (m, 1H), 
6.71 (q, J = 6.4 Hz, 1H), 4.48 (t, J = 7.6 Hz, 2H), 4.15 (q, J = 7.2 Hz, 2H), 3.04 (t, J = 7.6 
Hz, 2H), 1.84 (d, J = 6.4 Hz, 3H), 1.44 (t, J = 7.2 Hz, 3H), 1.39 (s, 18H). 13C NMR (126 
MHz, CDCl3) δ 170.5, 165.6, 159.0, 148.9, 145.7, 142.6, 138.4, 129.3, 128.0, 127.2, 121.9, 
121.8, 120.2, 119.8, 113.4, 113.2, 110.5, 109.3, 105.5, 70.0, 57.2, 56.0, 52.7, 49.2, 43.1, 
29.7, 28.2, 22.9, 14.5. 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 8.73 (s, 1H, C13-H), 8.39 (s, 
1H, C6-H), 8.22 (dd, J = 8.9, 2.8 Hz, 1H, C18-H), 8.16 (d, J = 7.9 Hz, 1H, C16-H), 8.13 
(s, 1H, C5-H), 7.48 – 7.43 (m, 2H, C1, C3-H), 7.41 – 7.34 (m, 2H, C2, C4-H), 7.23 – 7.21 
(m, 1H, C2-H), 6.71 (q, J = 6.4 Hz, 1H, C7-H), 4.48 (t, J = 7.6 Hz, 2H, C9-H), 4.15 (q, J 
= 7.2 Hz, 2H, C14-H), 3.04 (t, J = 7.6 Hz, 2H, C10-H), 1.84 (d, J = 6.4 Hz, 3H, C8-H), 



























carbonyl)oxy)ethyl)-2-nitro-9H-carbazol-9-yl)ethyl)azanediyl)diacetic acid (3.55). az-
4-286. 4M HCl in dioxane (1 mL) was added to 3.48 (15 mg, 0.020 mmol) at 0 ºC. The 
solution was stirred at room temperature for 8 h. The solution was concentrated in vacuo 
to give 12 mg (97%) 3.55 as yellow solid. 1H NMR (500 MHz, MeOD) δ 8.89 (s, 1H), 8.86 
(s, 1H), 8.55 (s, 1H), 8.25 – 8.17 (comp, 2H), 7.96 (dd, J = 9.7, 4.6 Hz, 1H), 7.67 (dq, J = 
10.0, 5.6, 4.3 Hz, 2H), 7.59 (t, J = 7.7 Hz, 1H), 7.36 (t, J = 7.5 Hz, 1H), 6.89 (q, J = 6.3 Hz, 
1H), 5.00 (tt, J = 11.4, 5.6 Hz, 2H), 4.51 (q, J = 7.2 Hz, 2H), 4.43 (s, 4H), 3.92 – 3.81 (m, 
2H), 3.74 (t, J = 5.8 Hz, 1H), 3.58 (dd, J = 5.5, 4.2 Hz, 1H), 1.84 (d, J = 6.4 Hz, 3H), 1.53 
(t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, MeOD) δ 167.1, 149.5, 127.6, 121.2, 121.0, 118.0, 

















Figure A.1. View of 1.81 showing the atom labeling scheme. Displacement ellipsoids are 











X-ray experimental for C15H20O6:   Crystals grew as clear, colorless needles by 
slow evaporation from THF and water.  The data crystal was cut from a larger crystal and 
had approximate dimensions; 0.47 x 0.19 x 0.15 mm.  The data were collected at -173 °C 
on a Nonius Kappa CCD diffractometer using a Bruker AXS Apex II detector and a 
graphite monochromator with MoKa radiation (l = 0.71073Å).  Reduced temperatures 
were maintained by use of an Oxford Cryosystems 700 low-temperature device.  A total 
of 1043 frames of data were collected using w-scans with a scan range of 0.7° and a 
counting time of 34 seconds per frame.  Details of crystal data, data collection and 
structure refinement are listed in Table A.1.  Data reduction were performed using SAINT 
V8.27B.252  The structure was solved by direct methods using SHELXT253 and refined 
by full-matrix least-squares on F2 with anisotropic displacement parameters for the non-H 
atoms using SHELXL-2016/6.254  Structure analysis was aided by use of the programs 
PLATON255, OLEX2256 and WinGX.257  The hydrogen atoms bound to carbon atoms 
were calculated in idealized positions.   
The function, Sw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(s(Fo))2 + 
(0.0519*P)2 + (0.3482*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.103, with R(F) 
equal to 0.0392 and a goodness of fit, S, = 1.05.  Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.258 The data were checked for 
secondary extinction but no correction was necessary.  Neutral atom scattering factors 
and values used to calculate the linear absorption coefficient are from the International 
Tables for X-ray Crystallography (1992). 259  All figures were generated using 
SHELXTL/PC.260 Tables of positional and thermal parameters, bond lengths and angles, 
torsion angles and figures are found elsewhere. 
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Table A.1.  Crystal data and structure refinement for 1.81. 
Identification code  az-4-74 
Empirical formula  C15H20O6 
Formula weight  296.31 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions a = 10.1929(12) Å a= 90º 
 b = 15.9357(17) Å b= 93.468(6)º 
 c = 8.9926(10) Å g = 90º. 
Volume 1458.0(3) Å3 
Z 4 
Density (calculated) 1.350 Mg/m3 
Absorption coefficient 0.104 mm-1 
F(000) 632 
Crystal size 0.47 x 0.19 x 0.15 mm3 
Theta range for data collection 2.375 to 28.818º. 
Index ranges -13<=h<=13, -21<=k<=21, -12<=l<=12 
Reflections collected 22631 
Independent reflections 3798 [R(int) = 0.0480] 
Completeness to theta = 25.242º 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7458 and 0.6576 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3798 / 0 / 195 
Goodness-of-fit on F2 1.053 
Final R indices [I>2sigma(I)] R1 = 0.0392, wR2 = 0.0980 
R indices (all data) R1 = 0.0527, wR2 = 0.1034 
Extinction coefficient n/a 
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